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Summary 
An estimated 50% of all people carry the stomach bacterium Helicobacter pylori (H. 
pylori).  This organism is responsible for gastric problems like gastritis and gastric 
ulcers, and is one of the major causes of gastric cancer worldwide. Large numbers of 
people carry this organism asymptomatically and many questions remain about why 
serious symptoms develop in a subset of infected humans.  
These extremely recombinant bacteria may take different evolutionary trajectories in 
different people, and some genomic changes may be associated with gastric cancer.  
To test this, and learn more about the genetics of cancer-associated H. pylori, different 
approaches were used.  
First, evolution of H. pylori populations was investigated looking at both core and 
accessory genomes and revealed traces of the long and complex history of the 
Americas in the bacterial genomes, as well as a similar evolution in core and 
accessory genome. This was the first time accessory genome of H. pylori was studied 
that way. Secondly, evolution occurring in the bacterial genome during colonisation 
of a single host was studied in mice model. This analysis revealed small changes 
during the passage from a human host to a mice host, and during the long-term 
colonisation of mice stomach. Then a Genome Wide Association Study (GWAS) 
approach was applied to a large isolate collection sampled across Europe comprising 
strains isolated from cancer patients and strains from asymptomatic or gastritis-
suffering patients. This approach identified 11 polymorphisms in 9 genes (3 cagPAI 
genes, babA, hpaA, 1 outer membrane protein coding gene HP1055 and 3 other core 
genes (HP0747, HP0709 and HP0468) associated with cancer and a preliminary risk 
score was built to identify high risk strains. Finally, variations observed among 
clinical isolates of H. pylori from European patients with different pathologies in 
terms of motility and ability to trigger cytokine production in two types of cells were 
quantified. Motility variations were not associated with the disease type, but a link 
was observed for cytokine production. This was compared to genomic variations, 
confirming the role of known genomic factors such as cagPAI genes and sheding light 
to possible functions of a number of new genes. 
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1 Introduction 
1.1 The human stomach  
The gastrointestinal system is a complex interplay of organs allowing digestion and 
absorption of ingested food and liquids. The stomach is part of this system, and one of 
its functions is to regulate acid secretion to maintain sterilisation of ingested nutrients 
(Smolka and Schubert 2017). 
1.1.1 Anatomy 
The stomach is divided into 5 regions: The cardia which corresponds to the entrance 
of the stomach, the pylorus which is the exit of the stomach, and three areas inside 
named fundus, corpus (body) and antrum (Figure 1.1).  
 
Figure 1.1 Normal anatomy of the human stomach 
 
The fundus and corpus are acidic environments, due to the presence of acid-secreting 
glands. The epithelium of the antrum, on the other hand, produces alkaline secretions 
(Soybel 2005). The entire stomach is richly vascularized and comprises several layers 
of tissue. The inner lining is the mucosa (mucous membrane). Under this layer is the 
submucosa, composed of connective tissue. Below this there is a muscle layer called 
the muscularis propria (or muscularis externa). Finally, the serosa (or visceral 
peritoneum) is the fibrous membrane covering the outside of the stomach (―Canadian 
Cancer Society‖ 2017; Soybel 2005). 
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1.1.2 Physiology 
Stomach physiology has three main functions. First function is to store food, for at 
least 2 hours. The specificities of the gastroesophageal junction and pylorus make this 
possible. Second function is to mix and mechanically breakdown food. This is 
achieved through contraction and relaxation of the muscle layers of the stomach. 
Finally, and maybe the most important function of the stomach is food digestion. This 
last function is largely dependent on the specificities of the gastric mucosa, which 
contain specialized cells and glands producing hydrochloric acid and digestive 
enzymes (―Canadian Cancer Society‖ 2017). The gastric mucosa can be divided into 
two main regions: acid-secreting and non-acid secreting. The corpus and fundus are 
acid- and pepsinogen-secreting, whereas the antrum is alkaline-secreting (Soybel 
2005). The gastric lumen transports gastric juice (pH 1-2) during fasting periods. The 
surface epithelium, present in both the antrum and the corpus/fundus regions, secretes 
a mucus layer. The pH is around 5 to 6 inside this mucous layer, in contact with the 
epithelial cell surface (Quigley and Turnberg 1987; Talley et al. 1992). These less 
acidic conditions protect the gastric epithelium but also make it more suitable for 
bacterial colonisation.  
1.1.3 Stomach microbiome 
Numerous properties combine to limit bacterial growth in the stomach. Acidity and 
non-specific proteases are one of the main antibacterial properties of the stomach, but 
others exist. Bacterial growth is also inhibited by lactoferrin, antibacterial peptides 
such as LL-37, β-defensins 1 and 2 and components of gastric mucin and bile acids. 
Degradation of peptidoglycan, which is a cell-wall component of many bacteria, is 
achieved through the surfactant protein D (Algood and Cover 2006). Most ingested 
bacteria are killed in the stomach, but it is never entirely sterile. The mucus layer 
provides protection and an opportunity for survival. The microorganisms found in the 
stomach include those that colonise it, and those that pass through the gastric niche. 
The first organism discovered in the human stomach was Helicobacter pylori (H. 
pylori), then named Pyloric campylobacter (B. Marshall and Warren 1984). The three 
other genera dominating a normal acidic stomach free of H. pylori are Veillonella, 
Lactobacillus and Clostridium. There are, however, various organisms that are more 
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difficult to culture in the laboratory, and 16S rRNA sequencing has revealed more 
diverse genera (128 phylotypes) (Engstrand and Lindberg 2013; Bik et al. 2006).  
1.1.4 Gastric Disorders and Gastric Cancer 
Disturbance of stomach functions can be of many different types, and signs can range 
from slight discomfort to serious complications leading to death. Many  gastric 
diseases in humans are associated with infection by H. pylori (Testerman and Morris 
2014). Even though the signs observed in gastric disorders and diseases are usually 
similar, there is a wide diversity of symptoms that can be used to diagnose stomach 
diseases, ranging from asymptomatic gastritis (in more than 80% of infected 
population) to peptic ulcers (about 15%), gastric mucosa-associated lymphoid tissue 
(MALT) lymphoma (less than 0.5%) and gastric cancer (GC) (0.5-2%) (Figure 1.2) 
(John C. Atherton 2006; Sgouros and Bergele 2006).  
 
 
 
Figure 1.2 Flowchart of the different outcomes of H. pylori infection and 
their link to age and acid production. 
Adapted from (Chung et al. 2005). Large red arrows represent the main 
outcome for each step. 
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The nature of signs and symptoms depends on numerous factors, including age and 
pH (Figure 1.2). For instance, a stomach with high acid production will favour the 
generation of duodenal ulcers or MALT lymphoma, whereas a less acidic 
environment will more likely lead to gastric ulcers or GC (Chung et al. 2005). 
1.1.4.1 Gastritis 
In most cases, gastritis, which is an inflammation of the stomach, is the first and only 
pathologic outcome resulting from an H. pylori infection. More than 80% of people 
infected with H. pylori will only get asymptomatic chronic gastritis, and about 80% of 
chronic gastritis cases are linked to the presence of H. pylori (Nordenstedt et al. 
2013). Gastritis can evolve into different stages or move towards more serious issues. 
Types of gastritis encountered include superficial gastritis (close to asymptomatic), 
diffuse antral gastritis, postgastrectomy (reflux) gastritis, diffuse corporal atrophic 
gastritis and multifocal atrophic gastritis (Correa 1988). The last two stages of 
gastritis are considered pre-cancerous stages, as they are often linked to IM.  
 
 
Figure 1.3: Image enhanced endoscopy of the gastric mucosa. 
Adapted from (Sugano et al. 2015). (A) Narrow band imaging of the gastric 
mucosa. (B) Blue laser imaging of the gastric mucosa. H. pylori negative 
mucosa is shown on the left side images. H. pylori-infected mucosa with 
inflammation is shown on the central images. Intestinal metaplasia is shown 
on the right side images. 
 
Classifications of gastritis (Capelle et al. 2010; Sipponen and Price 2011) are often 
inconsistent, as the information given by available classifications is not very useful to 
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clinicians (Sugano et al. 2015). The Operative Link for Gastritis Assessment (OLGA) 
is a classification of gastritis based on atrophy score and topography (Rugge et al. 
2007). However, conventional endoscopy does not allow  the diagnosis of atrophy and 
IM with certainty (Sugano et al. 2015). New techniques such as image-enhanced 
endoscopy are now available to achieve this classification (Figure 1.3). In general, a 
non-atrophic gastritis (NAG) is close to asymptomatic. 
1.1.4.2 Peptic ulcers 
Peptic ulcer is a non-fatal disease linked to gastritis. Peptic ulcer can be divided into 
two types of ulcer; duodenal or gastric (Figure 1.4), duodenal ulcers being more 
prevalent than gastric cancer in most countries (Calam 1998).  
 
 
Figure 1.4: Endoscopic images of gastric ulcer and duodenal ulcer with 
positions from which the pictures were taken. 
Adapted from (―TabletsManual.com‖ 2017). 
 
Antral-predominant gastritis is associated with duodenal ulcer, whereas pangastritis is 
associated with gastric ulcer (Hwang et al. 2015; Lanas and Chan 2017). More than 
90% of patients with dudodenal ulcer and 58-94% of patients with gastric ulcer are 
infected with H. pylori (Calam 1998), 
1.1.4.3 Gastric cancer 
Incidence rates are decreasing, but remain high. 9% (723,000 deaths) of all cancer 
deaths were due to gastric cancer (GC) in the world in 2012 (Stewart and Wild 2014), 
and 3% in the UK in 2014 (Cancer Research UK 2017b). Large geographical 
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disparities are observed both in terms of incidence and mortality (Stewart and Wild 
2014). The survival rate is extremely poor, with 26% of 5-year survival rate in the 
USA between 1999 and 2005 (Jemal et al. 2010), and 20% in England and Wales 
(―Cancer Research UK‖ 2017c). GC is associated with chronic gastritis resulting in a 
very low acid secretion, and can be an evolution of a gastric ulcer (Hwang et al. 
2015). GC can be split into two types: adenocarcinomas (90% of the GC cases) and 
non-adenocarcinomas (Kelley and Duggan 2003). Only 0.42 to 5.4% of all gastric 
cancer cases are Helicobacter pylori negative (Yamamoto et al. 2015). 
 
Non-adenocarcinoma cancers include non-Hodgkin‘s lymphomas and 
leiomyosarcomas which make up almost 10% of GC cases, and more rare diseases 
and syndromes such as adenosquamous, squamous and undifferentiated carcinomas, 
choriocarcinomas, carcinoid tumors, rhabdomyosarcomas, hemangiopericytomas, and 
Kaposi‘s sarcoma (Kelley and Duggan 2003). Most non-adenocarcinoma cancers are 
rare and not associated with bacterial infection, and therefore will not be discussed 
further in this thesis. The only non-adenocarcinoma cancer discussed in this thesis is 
gastric MALT lymphoma (ML), which is associated with bacterial infection in 90% 
of the cases (Asano et al. 2015). The first description of ML was made in 1983 
(Isaacson and Wright 1983; Son et al. 2010). ML can affect different organs, but our 
interest will focus on gastric ML. It is a tumor occurring in the stomach, a sub-type of 
non-Hodgkin‘s lymphoma (Cohen et al. 2006). ML is less prevalent than GC, 
representing only 7.6% of non-Hodgkin‘s lymphoma cases (―A Clinical Evaluation of 
the International Lymphoma Study Group Classification of Non-Hodgkin‘s 
Lymphoma. The Non-Hodgkin‘s Lymphoma Classification Project.‖ 1997). 
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Figure 1.5: Gastric adenocarcinoma (HE stain). 
Adapted from (Piazuelo and Correa 2013). Three different tumors of 
intestinal type are shown in panel A, B and C. Mucinous adenocarcinoma 
shown in panel D. Two types of tumors of diffuse type in panel E and F. 
 
Histologically, adenocarcinoma can be divided into diffuse (Figure 1.5E-F) and 
intestinal sub-types (Figure 1.5A-C), and more rarely mucinous (Figure 1.5D), 
according to the Lauren classification (Hu et al. 2012). Clinically, two staging 
systems are currently used in the UK: a number system and the tumor, nodes and 
metastasis (TNM) system (―Cancer Research UK‖ 2017a). The intestinal subtype 
predominates in high-risk areas of GC, usually in individuals between 55 and 80 years 
old, and is more common in males. It is characterized by malignant epithelial cells 
that show cohesiveness and glandular differentiation and that are infiltrating the 
stroma (Figure 1.5A-C) preceded by a well-described sequence of histological lesions 
known as Correa‘s cascade (Figure 1.6). 
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Figure 1.6: Correa’s precancerous cascade (HE stain). 
Adapted from (Piazuelo and Correa 2013). A. Normal gastric mucosa 
(magnification x100). B. Nonatrophic chronic gastritis (magnification x100). 
C. Multifocal atrophic gastritis without intestinal metaplasia (magnification 
x100). D. Intestinal metaplasia, complete type (magnification x200). E. 
Intestinal metaplasia, incomplete type (magnification x200). F. Dysplasia 
(magnification x200). 
 
The diffuse type is often found in younger patients compared to the intestinal type and 
is not depending on sex. It is composed of discohesive cells that infiltrate the stroma 
(Figure 1.5E-F). Adenocarcinoma can also be described based on the localisation in 
the stomach, dividing GC into cardia and non-cardia types.  
1.1.4.4 Predisposing factors 
The development of a disease is usually due to interplay of genetic, environmental 
and other factors, such as sex and age. This is the case for gastric cancer. 
1.1.4.4.1  Genetic factors 
A family history of gastric cancer (GC) is a risk factor, as illustrated through the 
famous example of Napoleon Bonaparte (M.-G. Smith et al. 2006; Woolf and 
Isaacson 1961). It is difficult to be certain of the causes of his GC. H. pylori infection 
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may have played a role (Lugli et al. 2007), but there is also speculation of a genetic 
predisposition (Sokoloff 1938). 
The role of mutations in the E-cadherin (encoded by CDH-1) is known in the potential 
development of GC (Becker et al. 1994; Guilford et al. 1998; Carneiro 2012), and is 
hereditary. Mutations in the CDH-1 gene occur preferably in 50% of diffuse type 
adenocarinomas (M.-G. Smith et al. 2006). This is also the case for a polymorphism 
in the interleukin 1β (IL-1 β) gene (E M El-Omar 2001), with odds ratios of 1.6 or 2.9 
for polymorphisms in this gene (M.-G. Smith et al. 2006) and in the tumor-necrosis 
factor α  (TNF-α) gene, with a specific SNP significantly associated with an increased 
risk of gastric cancer  (Yang et al. 2009). Specific combinations of genetic 
polymorphisms in both TNF-α and IL-10 increased the risk of non-cardia gastric 
adenocarcinoma with odd ratios up to 27.3 (Emad M El-Omar et al. 2003). 
1.1.4.4.2  Environmental factors 
Previous dogma suggested that salty and spicy food were responsible for gastric 
ulcers and other gastric disorders. The effect of salt has been confirmed, together with 
other preservatives such as nitrate (Joossens et al. 1996). Salt intake increases the risk 
for gastric cancer by 1.68 (high consumption) or 1.41 (moderately high consumption) 
compared to low consumption (D‘Elia et al. 2012). However, spicy food is more 
likely to have an indirect effect through the acidity variations in the stomach provoked 
by such nutrients. Consuming alcohol is also  increasing the risk for gastric cancer, 
with an odds ratio of 1.39 (Ma et al. 2017). Current smokers are more likely to 
develop gastric cancer, with an odds ratio of 1.69 compared to never smokers (La 
Torre et al. 2009) 
1.1.4.4.3  Other predisposing factors 
The main factor involved in development of gastric cancer (GC) is a bacterial 
infection with Helicobacter pylori. The risk of developing a GC is thought to be 
increased 2-6 fold when the patient is infected with H. pylori (Ford et al. 2014). 
According to a recent review, 89% of non-cardia GC cases are attributable to H. 
pylori infection (Plummer et al. 2015). 
As in most cancers, age is also an important risk factor (J. Christie et al. 1997), with 
most cancer cases observed between 50 and 70 year-old, and only 15% of the cases 
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affecting adults of less than 41 year-old (T. Buffart et al. 2007). Risks are increasing 
faster in female populations than in male populations in some areas (W. Chen et al. 
2016). However, the incidence remains globally higher in men (Ferlay et al. 2015; 
Olbermann et al. 2010). Epstein-Barr virus is also a cause in the tumorigenesis of 
some cases of GC (Camargo et al. 2016; Iizasa et al. 2012). 
1.2 Helicobacter pylori (H. pylori) 
H. pylori is a pathogenic Gram-negative microorganism infecting around half of the 
world‘s population (Peek and Blaser 2002). Its niche is the human stomach, and it was 
classified as a group I carcinogen by the International Agency for Research on Cancer 
in 1994 (IARC 1994). The origins of the association between H. pylori and the human 
species is thought to be at least 100,000 years (Moodley et al. 2012) before the human 
migration from the African cradle (Linz et al. 2007). 
1.2.1 Epidemiology 
 
 
Figure 1.7: Prevalence of H. pylori infection in adult populations in the 
world. 
This figure was made using data found in www.worldgastroenterology.org 
(consulted on 20/02/2017) in a global guideline published in 2010 on 
Helicobacter pylori in developing countries (World Gastroenterology 
Organisation Global Guidelines 2010). High prevalence of more than 90% 
(all of Africa and Bengladesh) is highlighted in red. Medium prevalence, 
between 50% and 90% is highlighted in yellow. Low prevalence of less than 
50% (Western Europe, USA, Canada and Australia) is highlighted in green. 
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The prevalence of H. pylori varies geographically with a global average of about 50% 
(Parsonnet 1998; Taylor and Blaser 1991). Around 74% of people in developing 
countries and 58% in developed countries carry H. pylori (Figure 1.7) (World 
Gastroenterology Organisation Global Guidelines 2010). 
It is usually acquired in childhood, and the microorganism colonises the stomach for 
years before provoking any symptoms. Moreover, even though chronic H. pylori 
infection is very frequent, up to 80% of carriers will never present any symptoms (M. 
J. Blaser and Atherton 2004; Dooley et al. 1989; Algood and Cover 2006). 
1.2.2 Characteristics of H. pylori 
H. pylori is a highly motile bacterium with a spiral or curved morphology and 
efficient flagella (Figure 1.8) (B. Marshall and Warren 1984).  
 
 
Figure 1.8: SEM image of H. pylori. 
This image was taken on a Hitachi S4800 Scanning electron Microscope 
under conditions of 0.5k V for accelerating voltage with 10µA of current. 
Aperture was 2µm for a working distance of 8 µm, and the detector used was 
secondary emission upper. This image was shared by Dr Llinos Harris. 
 
Colonies on agar plates are small, round and translucent. The laboratory conditions 
for growth of H. pylori are reduced oxygen and rich media. H. pylori is associated 
with human disease, with hazard of ingestion, and was therefore classified as a BSL-2 
(biosafety level 2) pathogen. Because of this, important rules regarding hygiene and 
safety are applied while culturing this microorganism (Blanchard and Nedrud 2012).  
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1.2.3 H. pylori niche 
H. pylori can grow at a pH ~5.1, which is the pH of the gastric content immediately 
after food ingestion (Rhee, Park, and Cho 2014). The bacterium can therefore resist 
these acidic conditions when ingested with food, allowing it to colonise the host‘s 
stomach. H. pylori is one of the few microorganisms that can thrive in the human 
stomach (Bik et al. 2006). Laboratory strains of H. pylori obtained from humans can 
be adapted to colonise other species, but it is very rare to find it naturally in non-
human hosts. Other species of Helicobacter specialise in colonisation of other 
animals, but H. pylori is naturally found almost exclusively in humans. The 
composition of the gastric microbiota evolves alongside the H. pylori colonisation 
level and the acidic production of the stomach, with a reduced diversity in H. pylori 
positive stomachs due to the strong dominance of H. pylori in the population 
(Wroblewski and Peek 2016; Andersson et al. 2008), and disease develops following 
colonisation.  
1.2.4 Diagnosis of H. pylori infection 
Diagnostic methods for H. pylori infection can be divided into two categories: 
invasive and noninvasive. A large number of diagnostic tests have been developed but 
there is currently no gold standard based on a single test. A combination of culture 
and histopathological analysis, both obtained from biopsy samples, is an accepted 
standard in clinics (Cosgun et al. 2016). 
Invasive methods include culture (sensitivity between 55% and 56% and specificity of 
100%), rapid urease test (sensitivity over 75% and specificity over 84%), polymerase 
chain reaction (PCR) (sensitivity over 75% and specificity over 84%), fluorescence in 
situ hybridization (FISH) and histopathology (sensitivity over 66% and specificity 
over 94%) (S. K. Patel et al. 2014). All these methods require an endoscopy. Culture 
from human gastric biopsies is useful for testing antibiotic resistance and choose the 
correct treatment, but it is not usable for detection, as only 50 to 70% of infected 
biopsies will be detected as positive in culture, resulting in poor sensitivity (Loffeld et 
al. 1991). PCR-based methods and rapid urease test appear as the best alternatives for 
detection of H. pylori among invasive methods. The rapid urease test presents the 
advantages of a low cost and a fast diagnosis. However the influence of the bacterial 
density can affect the sensitivity (Nishikawa et al. 2000). Noninvasive methods 
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include urea-breath tests (sensitivity over 75% and specificity over 77%), whole blood 
serological tests through Immuno-globulin G enzyme-linked immunosorbent assay 
(ELISA) or finger-prick (World Gastroenterology Organisation Global Guidelines 
2010) (sensitivity of 85% and specificity of 79%) (Rao et al. 2001), stool antigen test 
(SAT) (sensitivity over 67% and specificity over 65%) (S. K. Patel et al. 2014). Urea-
breath test and serological tests are good noninvasive tests with high sensitivity but 
the specificity is below the specificity obtained with invasive tests (Cosgun et al. 
2016; Xie et al. 2009). Moreover, urea-breath test can not be used if the patient 
received antibiotics or bismuth during the month preceding the test.  
Verified infection with H. pylori leads to a choice of empirically prescribed 
treatments, which vary according to the geographic region, the prevalence of H. pylori 
infection, the presence of certain virulence factors, and resistance to antibiotics. Often 
a general approach of a proton pump inhibitor, a macrolide and a β-lactam for 7-10 
days initiates therapy.  
1.2.5 Treatment of H. pylori infection 
The current guidelines state that an infection must be dealt with as soon as it is 
detected (Malfertheiner et al. 2017). The standard treatment has been, for the last two 
decades, triple therapies combining proton pump inhibitors (PPI), amoxicillin and 
clarithromycin or metronidazole. Eradication rates were originally high (>90% during 
the 90‘s), but they decreased during the following years, falling to lower than 70% 
(C.-C. Huang et al. 2017). This failure is caused by a worldwide increase of resistance 
to clarithromycin. Alternative strategies have therefore been proposed to overcome 
this resistance issue, such as quadruple therapy combining PPI, bismuth and two 
antibiotics (C.-C. Huang et al. 2017). A vaccine would be an efficient solution to 
prevent and reduce this global burden. However, there is none available yet, and an 
effective vaccine must protect despite the high variability of strains. Recently, a 
promising vaccine trial was completed in China (Zeng et al. 2015). The prophylactic 
vaccine tested in phase 3 was based on urease B subunit fused with heat-labile 
enterotoxin B subunit. Results showed that this vaccine was effective, safe and 
immunogenic, but the cohort was limited to a single geographic region and longer 
follow-up would be required to link the vaccine with H. pylori related disease 
incidence. Development of this vaccine has been discontinued. Increased global 
efforts are needed to build on these results (P. Sutton and Boag 2018). 
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1.2.6 H. pylori pathogenesis 
Despite the majority of cases being asymptomatic, a wide diversity of disease 
symptoms are caused by H. pylori (Peek and Blaser 2002; Algood and Cover 2006; 
M. J. Blaser and Atherton 2004), amongst them gastric cancer (GC). The causal link 
between H. pylori and GC is strong, according to the Bradford Hill criteria (Bradford 
Hill 1965). H. pylori‘s ability to provoke symptoms in its human host is a complex 
system involving interactions between the bacteria, its host and the environment. This 
thesis focuses mainly on the bacterial aspects. H. pylori virulence and pathogenicity 
factors have been a major research interest since the organism‘s discovery in 1984 (B. 
Marshall and Warren 1984) with the addition of H. pylori virulence factors to a 
virulence factor database (Table 1.1). However, those listed are only the virulence 
factors of Helicobacter pylori with supporting evidence for their role in virulence. 
Many others may exist, and to date may be genes with ‗unknown function‘. 
The review of H. pylori pathogenesis is organised into the major processes involved 
during interaction with the host: colonisation, motility, adhesion, cell vacuolation, 
cytotoxicity, inflammation and evasion from the host immune system (Figure 1.9). 
 
Figure 1.9: Summary of virulence factors linked to H. pylori 
pathogenesis. 
  
 
Table 1.1: Main virulence factors in H. pylori and genes associated. 
This table is based on the Virulence Factors Database (VFDB 2017) consulted on 31/07/2017. 
Process 
Virulence 
factors Full name / description Related genes 
Adhesion 
BabA blood group antigen binding adhesin babA/hopS ; babB/hopT ; babC/hopU 
HopZ H.pylori outer membrane protein hopZ 
SabA sialic acid-binding adhesin sabA/hopP 
Inflammatory activity 
Evasion from host immune system 
Adhesion 
LPS Lipopolysaccharide gluE; gluP; kdtB; lpxB; rfaC; rfaJ; rfbD; rfbM; wbcJ; wbpB 
Buffering of gastric acid Urease Urease ureA; ureB; ureE; ureF; ureG; ureH; ureI 
Evasion from host immune system 
Lewis 
antigen 
Lewis antigen futA; futB; neuA/flmD; neuB 
Motility Flagella Flagella flaA;flaB; flgE_1 
Inflammatory activity 
HP-NAP neutrophil activating protein napA 
OipA outer inflammatory protein hopH 
Cytotoxicity T4SS Type IV secretion system 
cag1; cag2; cag3; cagD; cagF; cagG; cagH; cagI; cagM; 
cagN; cagP; cagQ; cagS; cagU; cagZ; virB1; virB10/cagY; 
virB11; virB2/cagC; virB4/cagE; virB5/cagL; virB6/cagW; 
virB7/cagT; virB8/cagV; virB9/cagX; virD4 
Cell vacuolation VacA vacuolating cytotoxin A vacA 
Cytotoxicity CagA cytotoxin-associated antigen cagA 
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1.2.6.1 Colonisation 
The first stage of H. pylori infection involves colonisation of the stomach. This 
environment is too harsh for most bacteria to colonise, but the mucus can be a shield 
for H. pylori, protecting the bacteria from acidic juice and host defense factors. The 
process of colonisation of the stomach by H. pylori requires three functions: motility, 
adhesion and buffering of gastric acid (Figure 1.10). These three functions will be 
described individually in the following subsections. 
 
1.2.6.1.1  Motility 
In H. pylori, motility is facilitated by three different functions: flagella, chemotaxis 
(tlpB and HP1043) and manipulation of the mucus layer viscosity surrounding the 
micro-organism (nixA, Urease operons). The helical shape of H. pylori is thought to 
enhance motility, and consequently aids the bacteria in penetrating the gastric mucus 
layer. In addition, H. pylori possess flagella (usually 4 to 6 per bacteria), which are 
essential for colonisation (Eaton et al. 1996). Only 3 genes linked to motility are 
described in H. pylori in the Virulence Factors database (VFdb) (VFDB 2017): flaA, 
 
Figure 1.10: Overview of virulence factors involved in H. pylori 
colonisation of the stomach. 
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flaB and flgE_1. Specifically, flaA encodes for the major flagellin, composing the 
filaments in pair with the minor flagellin encoded by flaB. The flgE_1 gene encodes 
for the hook proteins. However, motility is complex and further important genes are 
found in the literature (O′Toole, Lane, and Porwollik 2000). For instance, rpoD, rpoN 
and rliA are 3 sigma factor genes regulating expression of flagellar genes, while flgS 
(sensor kinase) and flgR (response regulator) regulate the transcription of genes 
alongside rpoN. FlhA is also known to bind to FlgS, adding to the complexity of 
motility function (Tsang et al. 2015). A flagellar sheath protein identical to HpaA was 
also identified in H. pylori, but its function is unclear (A. C. Jones et al. 1997). Other 
genes important in motility and flagellar biogenesis are flbA (Tsang et al. 2015), fliI 
(Jenks et al. 1997), flaG, flmH, fliD, flgK, flgL, motA, motB, fliM, fliN and fliG 
(O′Toole, Lane, and Porwollik 2000). Finally, motility may also be facilitated by the 
ability of H. pylori urease to lower the viscosity of mucus around the bacteria (Eaton 
and Krakowka 1994). Alongside motility, chemotaxis is also important in order to 
navigate through the pH gradient and efficiently penetrate the mucus layer. Genes 
involved in H. pylori chemotaxis include tlpA/B/C/D, cheA/V/W/Y/Z/Pep (O′Toole, 
Lane, and Porwollik 2000). 
1.2.6.1.2  Adhesion 
Once H. pylori has entered the mucus it needs to adhere to host cells. This is where 
many outer membrane proteins and adhesins have a role. Amongst them BabA (blood 
group antigen binding protein) (Aspholm-Hurtig et al. 2004), AlpA/B (adherence 
associated lipoproteins) (Senkovich et al. 2011), SabA (sialic acid binding and 
adhesion) (Unemo et al. 2005) and HopZ (outer membrane protein) (Peck et al. 1999). 
Lipopolysaccharide (LPS) and AlpA/B are also crucial, although independant 
(Odenbreit, Faller, and Haas 2002). All these surface components are potential targets 
for host immune defence. However, H. pylori is able to evade most of this defence 
through various mechanisms that we will review later in this introduction (section 
1.2.6.5). 
1.2.6.1.3. Buffering of gastric acid 
The buffering of gastric acid participates in the motility function, but also in 
colonisation in a larger sense, by promoting survival of the bacterium. Modifications 
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of the gastric acid secretion, provoked by H. pylori through IL-1β, also has a more 
direct effect on pathogenicity through its cytotoxic effect on the host cells (Takashima 
et al. 2001). 
Production and excretion of urease neutralise the low pH around the bacteria, through 
the arsR/S, nikR, fur genes (M. D. Jones et al. 2015; Mobley, Hu, and Foxal 1991). 
This neutralisation of pH produces ammonia, which has direct cytotoxic effects on the 
host epithelium. Cytotoxicity is not limited to one gene associated with the 
colonisation process and so further genes will be included in the following 3 sections. 
1.2.6.2 Cell vacuolation (VacA) 
Exotoxins, such as VacA (Vacuolating cytotoxin), can lead to gastric mucosal injury 
through cell vacuolation (Telford 1994). This cell vacuolation increases cell 
permeability and therefore facilitates the supply of essential nutrients (Cover and 
Blaser 1992; Iwamoto et al. 1999; Tombola et al. 2001). However, VacA also 
generates a host immune response through production of mast cell-derived 
proinflammatory cytokines resulting in chemotaxis and activation (Supajatura et al. 
2002). VacA is unique to H. pylori, and the gene coding for it is present in all strains, 
but with significant polymorphisms (J C Atherton et al. 1995). Three highly variable 
polymorphic regions are identified in vacA: The signal sequence region found in two 
versions (s1, s2), the intermediate region found in three different versions (i1, i2, i3), 
and the mid region found in two different versions (m1, m2) (Junaid et al. 2016; M. J. 
Blaser and Atherton 2004). Mature VacA toxin is composed of two domains: a N-
terminal p33 domain and a C-terminal p55 domain, linked by a protease-sensitive 
loop (Junaid et al. 2016). 
1.2.6.3 Cytotoxicity (CagPAI) 
The type IV bacterial secretion system (T4SS) is used by some H. pylori strains to 
inject effectors such as CagA (Cytotoxin associated gene A protein) or Tip-α (TNF-α 
inducing protein) into host cells, provoking multiple effects (Figure 1.11).  
The cag pathogenicity island (CagPAI) is the most studied virulence factor in H. 
pylori. This 40-kb deoxyribonucleic acid (DNA) insertion element contains genes 
encoding the proteins forming this T4SS and the CagA protein that are secreted into 
host epithelial cells (S Odenbreit et al. 2000). The risk of developing gastric cancer 
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(GC) is higher for patients infected with CagA positive strains compared to strains 
lacking CagA (Parsonnet et al. 1997; J. Q. Huang et al. 2003). Adherence factors such 
as blood group antigen binding proteins encoded by the babA gene have also been 
shown to increase the delivery of CagA into the cell (Ishijima et al. 2011). Other 
important genes associated with the CagPAI include tnpA and tnpB, were also 
identified more frequently in strains isolated from patients with GC compared to other 
strains. This highlights its link to GC (Abadi et al. 2014). 
CagPAI is also involved in evasion from host immune system function, by generating 
resistance to phagocyte killing and persistence within macrophages (Ramarao and 
Meyer 2001; Lina et al. 2014). CagPAI positive strains also tend to induce higher 
levels of IL-8 (Akopyants et al. 1998; Brandt et al. 2005; Fischer et al. 2001; Li et al. 
1999; Segal et al. 1997), IL-10 and IL-12. They also increase the levels of nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Brandt et al. 2005; Li 
et al. 1999). Exposure to CagPAI positive strains show an activation of the expression 
of  c-fos and c-jun, forming activator protein 1 (AP-1), a multipotential transcriptional 
factor associated with varied cytokines and chemokines, which can lead to GC 
(Mitsuno et al. 2001). 
 
Figure 1.11: Overview of the role of CagPAI in H. pylori pathogenesis. 
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1.2.6.4 Inflammatory activity 
Symptoms caused by H. pylori are variable, due to the variety of inter-related 
mechanisms. Inflammation (neutrophils, cellular exudate etc) is frequently observed 
in infected stomachs (Figure 1.12). LPS, OipA (outer inflammatory protein), CagA 
and neutrophil-activating protein (HP-NAP or NapA) (D. J. Evans et al. 1995; Satin et 
al. 2000) are all produced by H. pylori during infection of the host stomach. LPS from 
H. pylori is less proinflammatory than LPS from most other Gram-negative species 
(Moran and Aspinall 1998; Pérez-Pérez et al. 1995), due to a specific phosphorylation 
pattern and acylation in lipid A (Muotiala et al. 1992; Chmiela, Miszczyk, and 
Rudnicka 2014). SabA, an outer membrane protein, also participates in the 
recruitment of neutrophils (Unemo et al. 2005) which generate reactive oxygen 
species, leading to bacterial killing but also DNA damage in host cells, ultimately 
leading to gastric cancer. 
 
Figure 1.12: Overview of the inflammatory activity caused by H. pylori 
pathogenesis. 
 
1.2.6.5 Evasion from host immune system 
Inflammation is not only triggered by H. pylori, it is also regulated, resulting in a form 
of escape of the bacteria from the host immune system. For instance, the increase of 
regulatory T-cells provoked by H. pylori through interactins with dendritic cells, 
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results in a reduction of the TH17 immune response (J. Y. Kao et al. 2010). H. pylori 
can also evade the host immune system using a variety of virulence factors (Figure 
1.13).  
 
Figure 1.13: Overview of the mechanisms used by H. pylori to evade the 
host immune system. 
 
As previously described, CagPAI is essential to immune evasion through persistence 
within macrophages, resistance to killing by phagocytes (Ramarao et al. 2000; 
Ramarao and Meyer 2001) and via downregulation of β-defensins (Bauer et al. 2012; 
S. R. Patel et al. 2013). Resistance to phagocytes killing is also achieved through two 
enzymes: superoxide dismutase (Spiegelhalder et al. 1993; Seyler, Olson, and Maier 
2001) and catalase (S Odenbreit, Wieland, and Haas 1996; Ramarao, Gray-Owen, and 
Meyer 2000). Molecular mimicry of molecules Lewis x and y also helps the bacteria 
escaping the immune system, through expression of LPS O antigens (Aspinall and 
Monteiro 1996; Monteiro et al. 1998; Bergman et al. 2006). These Lewis antigens, 
through interaction with Macrophage inducible C-type lectin (Mincle), activate anti-
inflammatory cytokine production (Devi, Rajakumara, and Ahmed 2015). The 
specifically low activity of H. pylori LPS is also a mechanism for the bacteria to keep 
a low profile by avoiding recognition by Toll-like receptors (TLR) (Cullen et al. 
2011). H. pylori flagellin evades recognition by toll-like receptor 5 (TLR-5) (Lina et 
al. 2014; Gewirtz et al. 2004). VacA also plays a role in inhibition of T cells 
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activation (Boncristiano et al. 2003; J. M. Kim et al. 2011; M. Oertli et al. 2013). 
proteins like PgbA and PgbB bind plasminogen, coating the surface of the bacteria 
with host proteins (Jönsson et al. 2004). The capacity of H. pylori to control the 
balance between pro and anti-inflammatory responses, through all the mechanisms 
mentioned above, is the key to its persistence. 
1.2.7 Beneficial effects of H. pylori infection 
Despite the complications previously described (1.1.4), H. pylori colonisation can 
have beneficial effects on its host. For instance, the tuning down of immune system 
mentionned in the previous section is thought to be responsible for a protective effect 
of H. pylori against atopic diseases (Lionetti et al. 2014) such as allergic asthma 
(Mathias Oertli and Müller 2012; Arnold et al. 2011; D‘Elios and Bernard 2010; Y. 
Chen and Blaser 2008), allergies (Hussain et al. 2016), eosinophilic oesophagitis (von 
Arnim et al. 2016) or conventional multiple sclerosis (LI et al. 2007). Therapeutic 
application of H. pylori extract has even been considered to reduce allergic airways 
disease (van Wijck et al. 2018). Other positive effects of H. pylori infection include a 
lesser risk for Barrett‘s oesophagus (Thrift et al. 2012) and obesity (O‘Connor, 
O‘Morain, and Ford 2017). Differentiating between ‗beneficial‘ strains and those 
likely to cause cancer suggests better targeting of patients at risk.  
1.3 Genomics of H. pylori 
1.3.1 First H. pylori genome sequenced 
The first complete genome sequence of H. pylori was published in 1997 (Tomb et al. 
1997). The strain sequenced was named 26695, and was isolated from a patient in the 
United Kingdom suffering from gastritis. This first genome was 1,667,867 base pair 
(bp) with 1590 predicted coding sequences, and an average G+C content of 39%. 
These predicted coding sequences have since then been further described and the list 
has been amended. The list we will use was obtained from the National Center for 
Biotechnology Information (NCBI) in 2014, and contained 1573 genes (or loci). The 
method used for this sequencing was whole-genome shotgun sequencing with the 
Sanger method. Analysis of this first sequence of H. pylori was the basis for much of 
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the available knowledge on H. pylori pathogenesis, acid tolerance, antigenic variation 
and micro-aerophilic character. 
The 26695 genome is often used as a reference strain (and we do the same in this 
thesis), as its genes were well described and referenced in the literature. Furthermore 
this strain is the reference strain used on the PATRIC (Pathosystem Resource 
Integration Center) database (PatricdB 2017b). All genes from the 26695 strain are 
annotated with the nomenclature HP followed by 4 digits. 
1.3.2 Multi-Locus Sequence Typing (MLST) 
Understanding the high variability of outcomes resulting from H. pylori infection 
depends upon an increased knowledge of the population genetic structure and the 
related phenotypic differences between isolates. Among the first DNA sequence 
based techniques that brought a deeper understanding of H. pylori population 
diversity was multi-locus sequence typing (MLST). MLST typing is based on the 
analysis of fragments from 7 house-keeping genes. Therefore, a simple PCR 
amplification is sufficient for MLST typing of isolates. The genes used in H. pylori 
MLST are atpA, efp, mutY, ppa, trpC, ureI and yphC (K. Jolley 2017; Achtman et al. 
1999).  Unlike Campylobacter species, H. pylori is not organized into clear cloud 
clonal complexes, but into clusters of related lineages, depending largely on the 
geographical origin of the samples (Achtman et al. 1999). 
1.3.3 Whole-genome based methods 
DNA sequencing methods determine the order of nucleotides in a DNA molecule. A 
large number of methods and technologies for sequencing were developed since the 
first Sanger sequencing method in 1977 (Pettersson, Lundeberg, and Ahmadian 2009; 
Sanger, Nicklen, and Coulson 1977). Using whole-genome sequencing (WGS) and 
analysis methods on H. pylori isolates, research has built and improved upon earlier 
MLST data.  
1.3.3.1 Analysis of H. pylori genomes 
Whole-genome sequencing has become faster, cheaper, and more efficient, and its 
application to microbiology has changed the face of research in this field. With the 
development of whole-genome sequencing methods, the costs and time associated 
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have decreased drastically (Loman et al. 2012), and the number of available H. pylori 
gene sequences have increased exponentially (Figure 1.14).  
 
 
Figure 1.14: Cumulative number of H. pylori genomes available in NCBI 
from 1997 to October 2017. 
Adapted from (Berthenet, Sheppard, and Vale 2016) presented in Appendix 
A. 
 
At the time of writing (August 2017), 694 H. pylori genomes were available on the 
PATRIC db (PatricdB 2017a), with an average size of 1.63Mb. Sequences of H. 
pylori are now available from almost all areas of the world, and they often come with 
patient data, which allow researchers to perform detailed analysis of, not only the 
genes from MLST, but the whole genome. 
1.3.3.2 Core and Accessory genome 
Comparison of whole genomes of H. pylori reveal two types of genes, based on their 
presence in the dataset of interest: They are accessory and core genes (Uchiyama et al. 
2016). It is important to remember that these definitions are dependent on the dataset 
studied. A gene can be a core gene in one dataset, and an accessory one in a different 
dataset including different strains. 
The core genome comprises all the genes that are found in all the isolates from the 
dataset of interest. For a large dataset with genomes splitted into more than one 
contig, it is common to define core genome as all the genes found in at least 90% of 
the isolates. The size of the core genome will vary according to the size and 
variability of the dataset (Figure 1.15). 
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Figure 1.15: Variations in size of the core and accessory genome 
according to the dataset studied. 
Strains used in this example are from the dataset used in Chapter 5 and Core 
genome is defined as all genes shared by 100% of the strains. 
 
The accessory genome comprises all the genes that are found in at least one but not all 
the isolates from the dataset of interest. It often contributes to the acquisition of 
unique traits by H. pylori strains. The size of the accessory genome will vary 
according to the size and variability of the dataset (Figure 1.15).  
1.3.3.3 A systematic approach to genome analysis 
Among the most promising techniques for studying the bacterial genome are Genome 
wide association studies (GWAS), which were recently applied to Campylobacter, a 
related species within the epsilonproteobacteria (Sheppard et al. 2013). In this 
method, DNA sequence that is over-represented in one phenotype group compared to 
another is identified, in order to link accessory and core genome variations with the 
studied phenotype. This has the distinct advantage that sequence variation associated 
with phenotypes such as virulence can be identified without pre-selection bias. A 
GWAS will be carried out in Chapter 5 on a large dataset of H. pylori, aiming to 
identify genomic elements associated with gastric cancer. Two GWAS methods are 
used in this thesis: a ClonalFrame based method (Didelot and Falush 2007), and 
bugWAS (Earle et al. 2016). Both methods have been recently used in bacteria 
(Monteil et al. 2016; Méric et al. 2014; Sheppard et al. 2013; Suzuki et al. 2016), and 
take recombination and population structure into account which makes them suitable 
for bacterial genomes. However, the ClonalFrame based method relies on clonal 
complexes, and requires pairs of strains to be selected, resulting in a reduction in the 
number of strains included in the analysis. The nature of Helicobacter pylori 
population structure is also challenging for the ClonalFrame based method, as it does 
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not form clear clonal populations. The bugWAS method also has limitations, such as 
the risk of confounding true associations with the result of environment or sampling 
bias. Therefore both methods were used in parallel.  
1.3.4 H. pylori genome variability 
H. pylori has one of the highest known recombination rates, and presents the highest 
genetic variability among pathogenic bacteria (Figure 1.16), with an average number 
of alleles per locus of 11.2, resulting in a mean genetic diversity of 0.735 (Go et al. 
1996).  
 
Figure 1.16: Genetic diversity among electrophoretic types in 
representative species of pathogenic bacteria. 
Adapted from (Go et al. 1996). 
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This rapid evolution and the resulting genomic variability lead to resistance to 
treatment, challenging scientists toward new ways of eradicating infection, and make 
the development of an efficient vaccine difficult. A good example of diversity can be 
seen by the fact that two strains of H. pylori found in different patients (or even in 
patients from a same family) are often extremely different (Kivi et al. 2007). Different 
strains of H. pylori can also colonise a same host (Kibria et al. 2015; J. W. Kim et al. 
2004; Ben Mansour et al. 2016). The H. pylori genome is incredibly diverse, with 
variation in genome size (Dong et al. 2014), gene presence, gene order, and allelic 
profile (Thorell et al. 2016). Despite most strains having an average number of genes 
of about 1637.5 (Dong et al. 2014), the number of genes shared by all strains (core 
genes) from a large size sample of strains (n=100) is closer to 1200. 
The high level of structuring in bacterial populations, the clonal nature of cell 
division,  together with most processes needing many genes, make it difficult to 
identify genomic elements that are directly related to specific cellular function from a 
background of genes that are simply inherited by clonal decent. 
1.3.4.1 Variability linked to geography 
Helicobacter pylori is present in all inhabited continents, but isolates differ in 
different parts of the world (Ierardi et al. 2013). Geographic variations in the 
prevalence of H. pylori are known, but variations are also observed in the genome 
(Falush et al. 2003; Linz et al. 2007). Although H. pylori infection is considered a pre-
requisite for development of most gastric cancers, there is no strict correlation 
between H. pylori prevalence and gastric cancer rates. For instance, H. pylori 
prevalence is extremely high in Africa, but gastric cancer is rare. This is known as the 
African enigma (Holcombe 1992). The reason for this difference is unknown so far, 
but some research showed a genetic instability in the host differing between European 
and African populations that could be part of the answer (T. E. Buffart et al. 2011). 
Resistance to antibiotics is different in each part of the world, which leads to 
variations in the recommended first line treatment (Ierardi et al. 2013). This is due to 
selection pressure caused by antibiotic treatment, or intake of antibiotics from other 
sources (Ling et al. 1996). However, there are other differences which are not linked 
to antibiotic resistance. This is the case for the presence or absence of the CagPAI 
island (Kumar, Kumar, and Dixit 2010; Olbermann et al. 2010; Yakoob et al. 2009). 
This island of genes is more prevalent in strains coming from East Asia than from 
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Europe (Maeda et al. 1998; Yakoob et al. 2009). Variations in the cagA gene, among 
CagPAI positive strains, are also observed. Specifically, the cagA gene is composed 
of repetitions of EPIYA motifs. Different EPIYA motifs are observed, and the motifs 
present and their number of repetitions vary following geographic patterns. For 
instance, East Asian strains show in large majority the motifs: A-B-D where other 
strains present the motifs A-B-C, A-B-C-C. or A-B-C-C-C (Y Yamaoka et al. 2000; 
Xia et al. 2009; HATAKEYAMA 2017). Variations in the VacA gene also match a 
geographic distribution (Diaz et al. 2005; Van Doorn et al. 1999; Maeda et al. 1998). 
1.3.4.2 Variability linked to pathogenicity 
Variations in the CagPAI island and VacA gene are not only linked to geography, but 
have been linked to pathogenicity. For instance, the risk of developing complications 
due to infection by H.pylori is higher for patients infected with CagA positive strains 
compared to strains lacking CagA (Ahmadzadeh et al. 2015; Rizzato et al. 2012; 
Yamazaki et al. 2005; Khatoon et al. 2017; Parsonnet et al. 1997; J. Q. Huang et al. 
2003). Allelic variations in vacA are also associated with pathogenicity (Yamazaki et 
al. 2005). Combination of vacA types s1 and m1 are associated with GC more 
strongly than other types (Kidd et al. 1999; Miehlke et al. 2000). Other genes show a 
link with gastric cancer or with other gastric diseases, for instance for babA, oipA, 
dupA and iceA (Miftahussurur and Yamaoka 2015; S. Y. Kim et al. 2001). 
1.3.4.3 Mechanisms behind variability 
Two forces are driving the variability in bacterial genomes. Replication errors or 
damage which generate point mutations, rearrangements or deletions of various sizes 
on one hand, and horizontal transfer which incorporate genetic material from an 
external source by recombination. The relative rates of those two forces are shaping 
the bacterial population genetic structure (Guttman and Dykhuizen 1994).  
Bacterial mutation rates are generally low. However under strong selective pressure, 
such as antibiotic use or a drastic change in the environment, hyper-mutator 
phenotypes can emerge in the population, with elevated mutation rates. Most of the 
mutations observed are deleterious (Kimura 1967), but some can induce variability in 
the genome that will help the bacteria interact with its environment. For instance, 
phase variation is a famous mechanism consisting in a simple change in the number of 
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repeat of a single nucleotide or a pair of nucleotides that will result in a modification 
in the frame of reading (Bergman et al. 2006; Appelmelk et al. 1999; G. Wang et al. 
2000). This mechanism allows for a quick adaptation of the gene between on and off 
versions.  
Horizontal gene transfer (HGT) or genetic exchange can be divided into two 
mechanisms: Homologous recombination, which consist in the replacement of 
homologous DNA with a sequence from another organism (often from the same 
species) on one hand, and non-homologous genetic exchange, which consist in the 
introduction of DNA segments or whole genes into the bacterial genome. H. pylori 
genomes show evidence of high levels of homologous recombination compared to 
most other bacterial species (Dorer, Sessler, and Salama 2011; Vos and Didelot 
2009).. Non-homologous recombination is also an important source of genomic 
diversity for H. pylori. Large fragments of DNA called mobile genetic elements can 
be transferred into the genome, such as bacteriophages, pathogenicity islands, 
transposons, insertion sequenes, or plasmids. They can be inserted into specific sites 
in the chromosome or be part of the extra-chromosomal DNA, as autonomously 
replicating elements. These mechanisms are central in the evolution of accessory 
genome. As a proof of the importance of non-homologous recombination in the 
evolution of H. pylori, one can mention the CagPAI, a pathogenicity island unique to 
Helicobacter pylori conferring virulence to the strains (Hacker and Kaper 2000; 
Fernandez-Gonzalez and Backert 2014). 
HGT can confer novel function (e.g. antibiotic resistance), but is also of more general 
interest in understanding the driving forces of bacterial evolution. Rapid 
recombination between geographically isolated populations can lead to local genomic 
signatures. For example, several studies have used local signals of recent admixture 
between strains to describe the migration of human hosts (Nell et al. 2013; Linz et al. 
2007). By co-existing for such a long time, the genomes of these two species have 
evolved together leaving traces of human migrations in H. pylori population genomes 
(Falush et al. 2003). The recent admixture occurring in the Americas will be 
investigated in Chapter 3. Geographic signatures are also observed in H. pylori 
prophages (Vale et al. 2017, Appendix B).  
Admixture within H. pylori genomes is also a signal for microevolution. While 
traditional typing technologies may not be sensitive enough to detect variation 
between closely related isolates, such as those in a single-family transmission 
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network, whole-genome sequencing provides opportunities for enhanced resolution. 
Transmission pathways among individuals of the same family have been 
characterized revealing genomic adaptation to child hosts as a probable part of the 
infection pathway (Furuta et al. 2015). Another WGS study focused on multiple 
colonies isolated from a single patient, demonstrating the co-existence of different 
lineages and HGT between isolates from these lineages resulting in a progressive 
genomic convergence (Cao et al. 2015). The variations occurring during long-term 
infection of a mouse model with clinical H. pylori strains will be investigated in 
Chapter 4. 
Finally, signatures of selection have been investigated in H. pylori genomes by 
estimating the ratio of non-synonymous to synonymous substitutions (dN/dS) in 
genes present in more than 90% of a 29 genome collection (Koji Yahara et al. 2016). 
Codons with evidence of diversifying selection (dN/dS>1) were widely distributed, 
accounting for ∼0.2% of the genome, and were commonly associated with gene 
functions of host interaction, cell surface expression and genome maintenance. 
Different methods are available to account for this ratio, depending on the purpose of 
the comparison. This association of specific functions with enrichment of non-
synonymous Single Nucleotide Polymorphisms (SNP) will also be investigated in this 
thesis. 
1.3.4.4 Remarkable strains of H. pylori 
Since the first genome 26695 was sequenced, (Tomb et al. 1997) further strains have 
been isolated and sequenced. Some of them are remarkable, due to either the 
conditions of their isolation or the features of their genomes. The first remarkable 
strain highlighted is an ancient strain of H. pylori sampled from a 5300 year old 
European mummy. DNA from this strain showed no admixture between Asian and 
African H. pylori, which are commonly seen today, therefore suggesting admixture 
between these two populations occurred after this time in Central Europe (Maixner et 
al. 2016). Strains such as this one are especially important in attempts to date 
evolutionary events, but it is very rare to obtain isolates from ancestral human 
populations. For this reason, much of the work to understand past acquisition of genes 
is based upon inference of phylogenies and identifying lineages sharing genes that can 
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be traced to an acquisition event on a phylogenetic tree. This will be the basis for 
chapter 1. 
Two strains, with their genomes published in 2015, are also of interest (Kersulyte et 
al. 2015). They were isolated from a Canadian arctic aboriginal community in 
Aklavik, Northwest Territories, Canada. The population in this region suffers from a 
high prevalence of H. pylori (Carraher et al. 2013). One of these two strains presented 
a new lineage of H. pylori, close to the hspAmerind population. A project involving 
the local population is on-going, which should result in a large collection of samples 
from this isolated population, alongside clinically-linked data. This collection will be 
important for studying mechanisms of evolution in H. pylori, and its link to gastric 
cancer without interference from co-infections of hosts with H. pylori from diverse 
origins. 
1.4 Aims 
Current treatments against H. pylori infection use multiple antibiotic and drug 
regimens. Considering the high risks of developing a cancer, this approach makes 
sense. However, the rise of antibiotic resistance suggests that better antimicrobial 
stewardship is required for the control of H. pylori in the clinic. The versatile nature 
of the H. pylori genome is a sign that part of the risk associated with individual strains 
might be predictable through sequencing of the infecting strain. The final aim of this 
project is to open the way towards new guidelines for treatment, based on sequencing 
of the infected strains, which could reduce the rise of antibiotic resistance. 
Chapter 3 will investigate the genome variability of a global collection of H. pylori 
strains. Two hypotheses will be tested: 
 The genomic variability of H. pylori strains from the Americas reflects the 
history of recent and ancient migrations which built the identity of these 
regions, 
 Core and accessory genomes are evolving in a similar way. 
Chapter 4 will investigate the genome variability occurring in hosts during a long-
term infection, and we will verify the following hypotheses: 
 A H. pylori strain evolves when changing from one host to another, 
 A H. pylori strain infecting a stomach for a long time evolves alongside the 
development of symptoms.  
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Chapter 5 will then focus on a European population of strains to address a range of 
hypotheses: 
 The GWAS method can be applied to H. pylori genome despite its high 
variability, 
 Specific genomic traits in specific genes can be linked with the progression of 
gastric cancer (GC), 
 A risk score can be built in order to target strains with a higher risk for 
triggering GC.  
Finally, Chapter 6 will investigate phenotypic characteristics of strains in relation with 
their genomic variability. It will address the following hypotheses: 
 Motility varies according to the pathology of the patient from which the strain 
was isolated, 
 Immune response is triggered differently according to the pathology of the 
patient from which the strains was isolated, 
 Some genes covary with phenotypic differences observed among strains. 
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2 Material and Methods 
2.1 H. pylori strains 
A large number of strains coming from different collections were used in order to 
perform my analyses (Figure 2.1). I will introduce them briefly and highlight their 
origin and characteristics. Details are available in Appendix C. Collections will be 
presented according to the number of strains. 
 
Figure 2.1: Circular View of a genomic neighbour-joining tree built with 
FastTree from an alignment of the 604 strains used in this thesis based 
on the reference strain 26695 genome. 
The tree was annotated with iTOL (Letunic and Bork 2016) according to the 
geographic provenance, collection from which the strain was obtained, 
pathology associated and use in this thesis. An online version is available for 
this figure at this address: 
http://itol.embl.de/tree/137441153116341501834302#. 
 
The largest collection of strains used is the publically available strains (321 strains). 
Those sequences were obtained from the NCBI Genbank database. They were from 
varied sources, which can be traced back from the publications in which they were 
mentioned. Geographic origin of the samples was global:  
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 86 strains were isolated in Africa,  
 74 were isolated in Asia,  
 17 were isolated in Europe,  
 106 were isolated in North America,  
 4 were isolated in Oceania,  
 33 were isolated in South America,  
 1 was from unknown geographic origin.  
Pathologies associated with those strains comprised: 
 asymptomatic or non atrophic gastritis (NAG) (76 strains),  
 atrophic gastritis (15 strains),  
 gastric cancer (GC) (15 strains),  
 intestinal metaplasia (IM) (9 strains),  
 MALT lymphoma (ML) (4 strains),  
 ulcer (45 strains),  
 various complex, rare or undefined pathologies (27 strains).  
Pathology related information was not available for the 130 remaining strains. 
The second largest collection (79 strains) was shared by Javier Torres. 35 strains were 
from North America (Mexico) and 44 were from South America (Colombia). Isolates 
were already sequenced and assemblies were directly shared with us. Pathologies 
associated comprised: 
 asymptomatic (28 strains),  
 atrophic gastritis (14 strains),  
 GC (14 strains),  
 IM (21 strains), 
 ulcer (2 strains).  
This collection was used in both Chapter 3 and Chapter 5, and sequences were 
published in the publications linked to these two chapters. 
Another large collection (56 strains), used exclusively in Chapter 5, was shared with 
us by Kaisa Thorell. All the strains were originating from Swedish hospitals, and were 
part of a large case-control study (Enroth et al. 2000). Extracted DNA sent to us for 
sequencing comprised strains associated with gastric cancer (20 strains), non-atrophic 
gastritis (20 strains) and atrophic gastritis (16 strains). 
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53 strains were generously shared with us by Francis Megraud. Cultures samples were 
sent to us, from which we were able to extract and sequence DNA. Genomes of these 
strains were used in all chapters, and some of the culture samples were used in chapter 
6. Host pathologies associated with those strains included: 
 asymptomatic (11 strains),  
 GC (14 strains),  
 ML (18 strains), 
 ulcer (10 strains). 
Yoshio Yamaoka shared with us 35 sequences of strains isolated in Asia. Host 
pathology was not known for these strains, but the sequences were very useful as part 
of our global datasets used in Chapter 3  and Chapter 5. 
A small collection of 18 strains cultures was shared with us by Sinead Smith, from 
Dublin in Ireland. DNA was extracted and sequenced in Swansea. Genomes of these 
strains were used in Chapter 3 and Chapter 5. 4 culture samples were also used in 
Chapter 6, alongside the corresponding sequences. 
Another collection was shared from Bordeaux later during my thesis, this time by 
Philippe Lehours. This collection of 17 strains was isolated from two patients 
suffering from ML and used in infection studies in mice models (Chrisment et al. 
2014). The strains were re-isolated after passage in mice and were sent to us for 
sequencing. Genomes from these strains were the basis for Chapter 4.  
Fourteen cultures of strains were sent to us by Alain Burette, from Brussels in 
Belgium, through John Atherton. Pathologies associated with these strains were 
carefully selected, and were equally distributed between asymptomatic (7 strains) and 
GC (7 strains). Those strains were used in Chapter 5 and Chapter 6. 
Six extra cultures of strains were shared with us by John Atherton, from Nottingham, 
in the UK. Pathologies associated with these strains were asymptomatic (4 strains) 
and ulcer (2 strains). They were used in Chapter 5. 
Five strains were from the collection of Jane Mikhail. 3 strains were isolated in 
Singleton hospital, in Swansea, and 2 were shared with her by collaborators (unknown 
geographic origin). All these strains were sequenced in Swansea and used in Chapter 
3 and Chapter 5. 
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2.2 Laboratory 
All laboratory work involving mammalian cells and bacteria was performed inside a 
type 2 biological safety cabinet. All bacterial waste was autoclaved, and cell waste 
bleached or autoclaved. Incubations were achieved in an Air-Jacketed Automatic CO2 
Incubator. Pure cell cultures were kept isolated from cultures involving bacteria in 
two independent incubators in order to prevent cross-contamination. Suppliers for 
equipment are presented in Table 2.1. Suppliers for Consumables are presented in 
Table 2.2. 
 
Table 2.1: List of Equipment 
Equipment Product name Supplier 
Type 2 Biological Safety 
Cabinet 
ScanLaf MARS LaboGene™ 
Incubator Air-Jacketed Automatic 
CO2 Incubator 
NuAire, Inc. 
Hermetic jar Hermetic jar Oxoid™ 
Spectrophotometer Model  3710 Jenway 
Centrifuge Heraeus™ Megafuge™ 
16R 
ThermoFisher Scientific 
Nanodrop spectrophotometer ND1000 NanoDrop Technologies, inc. 
Sequencer HiSeqSystem Illumina, San Diego, CA 
Centrifuge Centrifuge 5415 R Eppendorf 
Plate reader FLUOStar® OMEGA BMG LabTech 
Chemidoc Chemidoc MP system BioRad 
 
Table 2.2: List of Consumables 
Consumables Supplier 
Columbia Blood Agar (CBA) plates Oxoid™ 
Sterile disposable 10μL loop Microspec© 
CampyGen™ sachet Thermo Scientific™ Oxoid™ 
Brucella Broth powder BD BBL™ 
Foetal Bovine Serum (FBS)  Gibco® 
L-shaped spreader Microspec© 
T25 flask Greiner 
Sterile disposable 1μL loop Microspec© 
Cryogenic vial Starlab International© 
Phosphate-Buffered Saline (PBS) Gibco® 
QIAmp DNA Mini Kit Qiagen, Crawley, UK 
RPMI 1640 media Corning® 
TrypLe Express Gibco® 
Dimethyl Sulfoxide (DMSO) Merck 
Trypan Blue stain (0.4%) Gibco® 
Human IL-8/CXCL8 DuoSet kit R&D Systems 
Human CCL4/MIP-1 beta DuoSet kit R&D Systems 
RayBio® C-Series kit RayBiotech, Inc. 
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2.2.1 Culture of H. pylori on solid medium 
Helicobacter pylori strains were recovered from glycerol stocks stored at -80°C. The 
stocks were maintained on ice to avoid thawing, and were spread onto fresh CBA 
plates at room temperature using a sterile disposable 10μL loop. The plates were 
inverted and incubated at 37°C in a hermetic jar with a CampyGen sachet which 
generated and maintained microaerophilic conditions for 4 to 6 days (Blanchard and 
Nedrud 2012). The CampyGen sachet had to be replaced every 2 to 3 days. The 
advancement of growth was checked on this occasion by estimation of the diameter of 
the colonies and the purity of the culture was verified by observation of plates for 
small, round, translucent colonies representative of H. pylori (Blanchard and Nedrud 
2012). Homogeneity was also verified in order to identify potential mixed stocks. A 
verification of the species using the catalase, urease and oxidase tests (Blanchard and 
Nedrud 2012) was not necessary as these were performed prior to original storage. 
2.2.2 Culture of H. pylori in liquid medium 
The medium used for liquid culture of H. pylori was Brucella Broth (BB) (Table 2.3).  
Table 2.3: Composition of Brucella Broth liquid medium 
Brucella Broth powder 28 g/L 
MilliQ water 200 mL 
FBS 10 % 
 
In brief, once enough growth was observed on solid medium, 1mL of BB was added 
to the surface of the plate and pushed to one side using a L-shaped spreader to 
resuspend the colonies. Then, 200 to 400 μL (according to the amount of growth 
observed on plates) of the suspended colonies were aliquoted and added to 10mL of 
BB in a T25 flask. A sterility flask with only BB was cultured in parallel to identify 
potential contamination from the medium. After manual agitation to homogenise the 
bacterial solution, the flasks were incubated at 37°C for 20-24 hours and then checked 
under the microscope for density of the culture and motility of the strains to confirm 
the absence of contaminants and viability of the strains for further experiments 
(Blanchard and Nedrud 2012). 
2.2.3 Enumeration of H. pylori 
Enumeration of H. pylori was performed to ensure quantification of the bacteria/cell 
ratio in co-culture experiments. H. pylori strains were first cultured on plates as 
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described in 2.2.1.  Then, strains were cultured in liquid for 20 to 24 hours as 
described in 2.2.2. Optical density at 600nm was then assessed using a 
spectrophotometer, and bacterial cultures were diluted in BB Table 2.3 to obtain an 
optical density of 0.1 (OD 0.1). These normalised cultures of H. pylori were then 
successively diluted to 1/2,000, 1/10,000 and 1/20,000. 100 µL of these dilutions were 
plated in triplicate on CBA plates and incubated at 37°C under microaerophilic 
conditions until the size of the colonies was sufficient for enumeration (5 to 10 days). 
The number of colony forming units (CFU) in 1 mL of OD 0.1 normalised culture 
was then calculated using the appropriate dilution plates with colonies ranging 
between 25 and 1000. The lower limit of detection was 25 as recommended by 
(Tomasiewicz 1980; S. Sutton 2006). The upper limit was estimated empirically 
based on the small size of the colonies compared to bacteria used as standards and 
their separation on plates (Breed and Dotterrer 1916; Tomasiewicz 1980; S. Sutton 
2006). The average CFU/mL was calculated for each strain, based on the calculation 
protocol presented below.  
 Using the number of colony forming units (𝑛𝐶𝐹𝑈𝑖) for each plate (number of 
plates = N), an average was calculated (𝑎𝐶𝐹𝑈 =
 𝑛𝐶𝐹𝑈 𝑖
𝑁
𝑖=1
𝑁
) 
 All plates for which 𝑛𝐶𝐹𝑈𝑖 ≥ 0.2 ∗ 𝑎𝐶𝐹𝑈 were discarded. (number of 
remaining plates = N*) 
 If 𝑁∗ ≥ 3, a corrected average was calculated (𝑎𝐶𝐹𝑈∗ =
 𝑛𝐶𝐹𝑈 𝑖
𝑁∗
𝑖=1
𝑁∗
). If less 
than three plates remained, a new enumeration was achieved.  
2.2.4 Maintenance of stocks of H. pylori 
New stocks were made from the H. pylori cultures on solid medium (2.2.1) prior to 
experiments, in order to keep a sufficient amount of the original stocks.  
These stocks were made by collecting the colonies on the surface of the plates with a 
1 μL loop and shaking the content of the loop into 700 μL of BB in a cryogenic vial. 
Then, 300 μL of a 50% solution of glycerol was added to the vial prior to vortexing. 
The new stock was then logged into Swansea Microbiology and Infectious Diseases 
(MID) group sample records and stored at -80°C for future use. All H. pylori used 
throughout the thesis period were subjected to minimal passages to avoid laboratory 
linked mutations while obtaining sufficient growth for experiments. 
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2.2.5 Motility of H. pylori 
After culture of H. pylori on solid medium (2.2.1) followed by culture in liquid 
medium (2.2.2), cultures were centrifuged at 3000g for 5 minutes and the supernatant 
discarded. The bacterial pellet was resuspended into 2 mL of PBS and optical density 
(OD) was assessed using a spectrophotometer. Bacterial suspensions were then 
diluted to a normalised OD ranging from 0.5 to 1, according to the minimum OD of 
the batch following first measurement. Then, 0.5 µL of diluted bacteria solution was 
injected in triplicate into the centre of a 6-well agar plate prepared as described in 
Table 2.4. These motility plates were then incubated horizontally at 37°C under 
microaerophilic conditions until measurement, 2 - 6 days after inoculation. 
 
Table 2.4: Composition of the motility assay plates 
Brucella Broth 28 g/L 
Agar 0.37% 
FBS 10% 
MilliQ Water 200 mL 
2,3,5,-triphenyltetrazolium chloride (TTC) 1% 
 
The diameter of growth was measured with a decimetre for each well, and an average 
for each strain i was calculated (𝐷𝑖) (C.-Y. Kao, Sheu, and Wu 2014; C.-Y. Kao et al. 
2012). These average measurements were then corrected to the positive control strain 
(B24) measured on the same day. Formula given by: 𝑀𝑜𝑡𝑖𝑙𝑖𝑡𝑦𝑖𝑛𝑑𝑒𝑥 =
𝐷𝑖
𝐷𝐵24
 . Every 
strain was studied twice to obtain an average index based on two independent 
experiments, and a third replicate was made if the standard deviation for the two 
values of normalised measure was more than 0.1.  
2.2.6 DNA extraction and sequencing from H. pylori strains 
Total DNA was extracted using the QIAmp DNA Mini Kit from solid cultures 
showing sufficient growth. Quantification of DNA was assessed with a Nanodrop 
spectrophotometer prior to sequencing. High-throughput genome sequencing was 
performed using a HiSeqSystem sequencer, and de novo assembling was performed 
using Velvet (version 1.2.08) by Matthew Hitchings and Ben Pascoe. All the contigs 
obtained from our samples were imported into the SheppardLab Bacterial Isolate 
Genome sequence database (BIGSdb http://zoo-
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dalmore.zoo.ox.ac.uk/perl/bigsdb/bigsdb.pl?db=sheppard_hpylori_isolates ) for 
genomic analysis. 
2.2.7 Culture of AGS cells 
AGS cells were cultured in Standard media (S media) composed of RPMI 1640 media 
supplemented with 2 mM of L-glutamine and 10% FBS. They were passaged 1 in 8 
every 2 to 3 days for a maximum of 30 passages before use of a new stock. For cell 
detachment, media was removed, washed with PBS (8 mL) and then incubated with 4 
mL of TrypLe Express, for 8 minutes. Detached cells were removed and neutralised 
in 8 mL of S media prior to centrifugation at 300g for 5 minutes. The media was 
removed and the cells resuspended in fresh S media. Cells were supplemented with 
Penicillin (100 units/mL) and Streptomycin (100 µg/mL) to avoid contamination 
during maintenance. Stocks were regularly made from the earlier passages to ensure 
sufficient stocks of cells for experiments, and were stored in 1 mL aliquots of FBS 
supplemented with 10% DMSO in Liquid Nitrogen. 
2.2.8 Culture of THP-1 cells 
THP-1 cells were cultured in S media. They were passaged 1 in 3 every 2 to 3 days 
for a maximum of 30 passages before use of a new stock. A centrifugation step was 
performed at 300g for 5 minutes to eliminate all remaining old media. The media was 
removed and the cells resuspended in fresh S media. Cells were supplemented with 
Penicillin (100 unit/mL) and Streptomycin (100 µg/mL) to avoid contamination 
during maintenance. Stocks were regularly made from the earlier passages to ensure a 
sufficient resource of cells for the experiments, and were stored in 1 mL aliquots of 
5x10
6
 cells/mL in a solution of FBS supplemented with 10% DMSO in Liquid 
Nitrogen. 
2.2.9 Viability testing 
For both AGS and THP-1 cells, viable cells were enumerated prior to experiments. 
This assay consisted in 1 in 2 dilution of the resuspended cells in Trypan Blue stain 
(0.4%), then enumeration of the viable cells (white cells) using a hemocytometer. The 
average number of cells contained in 5 of the hemocytometer squares was calculated. 
Multiplication by 2x10
4
 was giving the concentration of cells in cells/mL. 
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2.2.10 Infection of AGS / THP-1 cells with H. pylori 
AGS and THP-1 cells were resuspended from a viable culture obtained as described 
in 2.2.7 and 2.2.8 in S media without Penicillin/Streptomycin and diluted to obtain a 
concentration of respectively 50x10
3
 and 100x10
3
 cells/mL. Phorbol 12-myristate 13-
acetate (PMA) was added (10 ng/mL) to the THP-1 cells to differentiate them into 
macrophages (Park et al. 2007), and both types of cells were seeded separately into 24 
well plates (1 mL per well) and incubated for 24 hours at 37°C. 
In parallel, the H. pylori strains were cultured in BB (2.2.2) for 22 hours at 37°C. 
After 22 hours of bacterial growth, the density of the cultures was assessed using a 
spectrophotometer and cultures were diluted down to an OD of 0.1. Bacterial cultures 
were then centrifuged at 3000g for 5 minutes and re-suspended in the same volume of 
S media.  
AGS and THP-1 cells were washed twice with RPMI media supplemented with L-
glutamine without Penicillin/Streptomycin, and 500 µL of the bacterial solution were 
added to the wells, along with 500 µL of S media without Penicillin/Streptomycin. 
PMA at 10 ng/mL (Park et al. 2007) was used as positive control and DMSO as 
negative control. Each sample was studied in triplicate wells. The plates were then 
centrifuged at 300g for 5 minutes at 28°C and incubated for 24 hours at 37°C. 
Supernatant was collected after 24 hours, centrifuged at 4°C at maximum speed (13.2 
rpm) for 10 minutes, the supernatants decanted and then stored at -20°C until 
analysed. 
2.2.11 Concentration of interleukin-8 in supernatants 
Measure of the concentration of interleukin-8 (IL-8) in supernatants from infection 
experiments was obtained by enzyme-linked immunosorbent assay (ELISA) using a 
Human IL-8/CXCL8 DuoSet kit. First, a half-area plate with a flat bottom was 
incubated overnight with 50 µL of capture antibody. Wash buffer (Table 2.5) and 
Blocking buffer (Table 2.6) were freshly made.  
 
Table 2.5: Composition of Wash buffer for ELISA 
PBS tablets 1 per 200 mL 
MilliQ Water 400 mL 
Tween20 200 µL 
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Table 2.6: Composition of Blocking buffer for ELISA 
Bovine serum albumin (BSA) 1% 
PBS 50 mL 
 
Plate was washed three times with wash buffer, and incubated with 150 µL of block 
buffer for one hour minimum. During this incubation step, standards (31.2-2000 
pg/mL) were diluted into PBS and samples were prepared. Samples from AGS cells 
did not need dilution to be in the range of the analysis, but samples from THP-1 cells 
were diluted 1:50 in wash buffer. Plate was washed three times, and 50 µL of 
standards or samples were applied according to plate map recorded. After 1 hour 30 
of incubation, the plate was washed three times, and 50 µL of detection andibody 
were added to the wells. After 1 hour 30 of incubation, the plate was washed three 
times, and 50 µL of streptavidin were added to the wells. After 20 minutes of 
incubation in the dark, plate was washed three times and peroxidase SureBlue was 
added to the wells. After 15 to 20 minutes of incubation, the optical density in each 
well was measured at 450 nm and 570 nm using a plate reader. The online software 
elisaanalysis.com was used to analyse the results, based on the corrected value of OD 
(450-570). An r
2
 of minimum 0.995 was used to ensure reliable results, and for each 
sample the coefficient of variation between technical replicates was of a maximum of 
20%. Each infection of AGS or THP-1 cells by an H. pylori strain was repeated in 
three independent experiments. To reduce experimental variations between 
experiments, the average negative control from each experiment was used as a unit 
value.  
2.2.12 Concentration of CCL4 in supernatants 
Measure of the concentration of Chemokine (C-C motif) ligand 4 (CCL4) in 
supernatants from infection experiments was obtained by ELISA using a Human 
CCL4/MIP-1 beta DuoSet kit. First, a half-area plate with a flat bottom was incubated 
overnight with 50 µL of capture antibody. Wash buffer (Table 2.5) and Blocking 
buffer (Table 2.6) were freshly made. Plate was washed three times with wash buffer, 
and incubated with 150 µL of block buffer for one hour minimum. During this 
incubation step, standards (15.6-1000 pg/mL) were diluted into PBS and samples 
from THP-1 cells were diluted 1:50 in PBS. Plate was washed three times, and 50 µL 
of standards or samples were applied according to plate map recorded. After 1 hour 
30 of incubation, the plate was washed three times, and 50 µL of detection andibody 
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were added to the wells. After 1 hour 30 of incubation, the plate was washed three 
times, and 50 µL of streptavidin were added to the wells. After 20 minutes of 
incubation in the dark, plate was washed three times and peroxidase SureBlue was 
added to the wells. After 15 to 20 minutes of incubation, the optical density in each 
well was measured at 450 nm and 570 nm using a plate reader. The online software 
elisaanalysis.com was used to analyse the results, based on the corrected value of OD 
(450-570). An r
2
 of minimum 0.995 was used to ensure reliable results, and for each 
sample the coefficient of variation between technical replicates was of a maximum of 
20%. Each infection of THP-1 cells by an H. pylori strain was repeated in three 
independent experiments. To reduce experimental variations between experiments, 
the average negative control for each experiment was used to adjust the results of each 
experiment. 
2.2.13 Human Inflammation Antibody Array 
Detection of 40 human proteins was achieved for 4 samples from infection 
experiments. Two samples were obtained from infection of THP-1 cells with each of 
the two strains and two from infection of AGS with each of the same two strains. The 
two strains used were 30950 (gastric cancer and CagPAI positive) and 31235 (non-
cancer strain and CagPAI negative). The assay was performed using the RayBio® C-
Series kit according to the manufacturer instructions and intensity of the spots was 
analysed using ImageJ. Briefly, the membranes were blocked with 2 mL of blocking 
buffer for 30 minutes at room temperature. Blocking buffer was then removed, and 1 
mL of sample was incubated for 3 hours at room temperature. Samples were removed 
by aspiration, and two washes were performed using two wash buffers with volumes 
of 2 mL. After removal of the second wash buffer, 1 mL of biotinylated antibody 
cocktail was added and incubated for 2 hours at room temperature. Membranes were 
washed again with the same two wash buffers, and 2 mL of HRP-streptavidin were 
added to the wells and incubated for 2 hours at room temperature. Membranes were 
washed again with the same wash buffers, and placed on a provided plastic sheet after 
removal of excess buffer. 500 µL of detection buffer mixture were added onto the 
membranes. After two minutes of incubation, the membranes were sandwiched 
between two plastic sheets and chemiluminescence was measured with a Chemidoc 
MP System. For each membrane, the maximum intensity of each spot (grey scale) 
was adjusted to the intensity of the 4 positive control spots from the top right corner. 
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This intensity of each pair of spots was compared between the cancer/non-cancer 
strains on AGS cells or on THP-1 cells. A difference of more than 0.1 in maximum 
intensity was investigated further by quantitative ELISA. 
2.3 Genomics 
2.3.1 BIGSdb 
All the publicly available sequences for H. pylori genomes were uploaded onto the 
Sheppard lab Bacterial Isolates Genomic Sequences database (BIGSdb http://zoo-
dalmore.zoo.ox.ac.uk/perl/bigsdb/bigsdb.pl?db=sheppard_hpylori_isolates ) (K. A. 
Jolley and Maiden 2010). The strains sequenced on site and the ones shared by 
collaborators were also added to allow analysis to be run with both publicly available 
and new sequences. Strains with genome size below 1.3 Mbp were removed from 
analyses for bad quality. Strains with genome size above 1.9 Mbp were checked for 
sample contamination using nBLAST of suspected contigs against public databases 
and removed if contamination was verified. Contamination by the phiX gene, an 
artefact from Illumina sequencing (Mukherjee et al. 2015), was also cleared by 
nBLAST of the phiX gene. All available information about the strains, such as 
geographic or ethnic origin of the patient and symptoms associated, were also added 
to the database (Appendix C). 
2.3.2 Genome Comparator 
The first step of the genomic analysis was to run a genome comparator on the selected 
strains. Genome Comparator is a tool available on BIGSdb (K. A. Jolley and Maiden 
2010). To run a Genome Comparator analysis, strains of interest were selected in the 
database. Then a list of genes was created. This list is usually either the list of genes 
from a reference strain (in our studies, we used the strain 26695), or a pan-genome (a 
list of all the genes present in at least one of the strains from the specific dataset). The 
Genome Comparator performs a gene-by-gene nBLAST (Altschul et al. 1990) 
alignment of all the genes from the given list in all the given strains, and gives back 
different output files, including a results table, an alignment, and an xmfa file. The 
results table shows the presence or absence of all the list genes in each strain, and also 
gives information of the allele version of the gene in each of these strains. The 
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alignments were used to make phylogenetic trees. The xmfa file shows the gene-by-
gene alignment, allowing investigation of specific gene variations in more detail. 
2.3.3 Genomic trees 
Neighbour-joining trees were built using FastTree v2.0 (Price, Dehal, and Arkin 
2010) performed using the High Performance Computing Wales (HPC Wales) system 
(HPC Wales 2017), and annotated with Evolview or iTOL v3 (Letunic and Bork 
2016), based on alignments obtained from the output files from genome comparator 
analysis. 
2.3.4 Pan-genome approach 
The pan-genome approach consists of creating a list of all the genes present in at least 
one strain from our dataset. First the list of strains was selected. The mean size of a 
H.pylori genome was 1.635 Mb and the mean number of genes was 1616, based on 
the 695 sequences publicly available on NCBI Genbank (NCBI 2017). Therefore, any 
strain sequence deviating from the average in terms of either genome size or gene 
numbers was discarded suggesting a sequence of bad quality (low size or low number 
of genes with a lot of truncated genes) or contaminated sequence (high size with a lot 
of genes only found in this specific strain). Once the dataset was established, the fasta 
files of each strain sequence were downloaded from the BIGSdb, and a pan-genome 
was constructed using our group script (described in 2.3.4.1) or Roary (described in 
2.3.4.2). 
2.3.4.1 Pan-genome script 
This method was developed by Leonardos Mageiros for part of his PhD at Swansea 
University (Mageiros, L 2013-2017) (Méric et al. 2014). Execution of the script was 
achieved by me. Genome-Wide Association Study based on ClonalFrame, and all 
minor genomic analysis requiring a pan-genome were performed using a pan-genome 
built with this script (Figure 2.2). Briefly, the fasta files exported from BIGSdb were 
submitted to the Rapid Annotation Sequences Tool (RAST) (Overbeek et al. 2014). 
The list of annotated genes for each of the strains was downloaded from the RAST 
server. Similarity between each pair of open reading frames was checked through a 
BLASTn (Altschul et al. 1990) search and a list of all the genes present in at least one 
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strain of our dataset was created (Sheppard et al. 2013). Genome Comparator and 
another upload into RAST were used to reduce gene duplicates to alleles of a same 
gene. 
 
 
Figure 2.2: Pan-genome creation process using an in-house method 
developed by Leonardos Mageiros. 
The script used RAST annotation files as input and produced a list of one 
allele for each gene present in at least one of the strains (Méric et al. 2014). 
 
2.3.4.2 Roary 
This method was used to run the publicly available bugwas package (Earle et al. 
2016) used in Chapter 5. Lowering the threshold for Roary (Page et al. 2015) was not 
shown to strongly affect the size of the pan-genome, so default parameters were used.  
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2.3.5 FineStructure and ChromoPainter 
FineStructure (Lawson et al. 2012) and Chromopainter (K. Yahara et al. 2013) 
analyses were performed by Koji Yahara in order to identify population structure in 
datasets based on paired similarity of core genome alignments. Preparation of the 
datasets and analysis of the results were achieved by me. Both the heatmap and tree 
from the FineStructure results were used to separate populations among isolates. 
2.3.6 Genome-Wide Association Study 
2.3.6.1 GWAS based on ClonalFrame 
The first GWAS method was based on one previously published on other bacteria 
(Sheppard et al. 2013). It relied on the construction of a pan-genome from the dataset 
chosen and ClonalFrame (Didelot and Falush 2007). Briefly, a tree was built using a 
core genome alignment with FastTree v2.0 (Price, Dehal, and Arkin 2010). Pairs of 
strains were selected around that tree to create two replicate datasets. A pan-genome 
was created using the pan-genome script (Méric et al. 2014) method (2.3.4.1) on the 
joint replicate datasets. This pan-genome was used for each of our two replicate 
datasets as the reference gene list for the GWAS. The genes were split into 30bp 
words, or k-mers. The prevalence of those words in each group of strains (gastric 
cancer or non-cancer) was assessed using a ClonalFrame (Didelot and Falush 2007) 
based model, and the hits were identified. The script execution was performed by 
Leonardos Mageiros. Preparation of the datasets and analysis of the results were 
achieved by me. 
2.3.6.2 GWAS based on bugwas 
The second GWAS method was conducted using a pipeline recently applied in 
another study by Koji Yahara (Suzuki et al. 2016). This method was based on the 
bugwas package (Earle et al. 2016), and was executed in two approaches.  
The first version was a k-mer-based approach (Sheppard et al. 2013) in which the 
genome sequence of each isolate was fragmented into unique overlapping 31-bp DNA 
words, or k-mers, that were used to identify genetic variations. The 31-bp words 
significantly associated with gastric cancer were explored after accounting for the 
inter-dependence of the strains and population structure. The script calculated an n x n 
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relatedness matrix that summarized all genetic covariance among the strains, and 
employed statistical tests for a given k-mer using a linear mixed regression model. 
Unlike the ClonalFrame method, this method does not depend on a single clonal tree 
that is difficult to construct reliably due to the high rate of recombination in H. pylori. 
The second version was a SNP-based approach in which the nucleotides present in all 
positions of each of the genes was compared between pairs of isolates. 
Bugwas, like the ClonalFrame based method, was also based on a pan-genome 
analysis. Annotation was done using prokka, and pan-genome creation was made 
using Roary (2.3.4.2).  Selection of hits was based on the odds ratio and p-value. The 
hits were then analysed individually to investigate their function and the effect of the 
SNPs identified. Execution of bugWAS was performed by Koji Yahara. Preparation 
of the datasets and analysis of the results were achieved by me. 
2.3.7 Accessory genome analysis 
In one of our analyses (see chapter 1), some populations were hybrids derived from a 
few derived populations, and an accessory genome analysis was developed to 
highlight markers of this evolution in the populations. The accessory genome from 
our dataset was studied based on the output of a genome comparator executed on the 
dataset of 401 strains (Appendix C) using the pan-genome script method (2.3.4.1). A 
binary presence/absence matrix was built for all the accessory genes in all the 401 
strains. 
2.3.7.1 Accessory tree 
For each pair of strains, the ratio of genes present or absent out of the total number of 
accessory genes was calculated to create a relatedness matrix. This matrix was then 
used to build a tree using Matlab, and was visualised with Evolview (He et al. 2016).  
2.3.7.2 Accessory plots 
The binary presence/absence matrix was also used to calculate the frequency of 
presence of each individual gene in each FineStructure population of our dataset, 
called prevalence. These data were used to build 3 dimensional plots, using the 
prevalence in each of the three groups selected as coordinates. On the X and Y axis 
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were two suspected ancestor populations, and on the Z axis was the suspected hybrid 
population.  
All the genes were split into 7 categories of profiles:  
 ―no difference between prevalence in the 3 populations‖,  
 ―prevalence in hybrid = prevalence in ancestor 1‖,  
 ―prevalence in hybrid = prevalence in ancestor 2‖,  
 ―prevalence in hybrid = average between ancestor 1 and ancestor 2‖,  
 ―prevalence in ancestor 1 = prevalence in ancestor 2‖,  
 ―prevalence in ancestor 1 = average between ancestor 2 and hybrid‖,  
 ―prevalence in ancestor 2 = average between ancestor 1 and hybrid‖.  
The repartition of the genes in these plots gave indications of the likeliness of the 
hypothesised hybrid population being a hybrid between the two ancestral populations, 
as well as the closeness of the hybrid population to one or another ancestor.  
Statistics were performed based on the distance of each gene from the equi-prevalence 
straight line (X=Y=Z), by comparing each category of genes (apart from the first one) 
in each plot via an ANOVA. In each case, the equality of variances was not verified 
(p-value < 0.05 for Levene‘s statistic test), and sample size (the number of genes) was 
small in some of the categories of genes, so a Dunnett‘s T3 test was chosen to 
perform the ANOVA.  
2.3.8 Analysis of individual gene variations 
Strain differences between individual genes were investigated using BioEdit. Effects 
on the amino-acid sequence were checked using an amino-acid alignment obtained 
from BIGSdb, to differentiate synonymous and non-synonymous hits. Non-
synonymous hits were further studied by creation of figures showing proportion of 
amino-acids in each position according to characteristics of the strains, using 
WebLogo (Crooks et al. 2004). 
2.4 Statistical Analysis 
All statistical analyses were performed using GraphPad Prism. When two groups were 
compared, unpaired t-tests were used. ANOVA analyses were used when more than 
two groups were compared. For each statistical test (except in GWAS analyses), the 
level of significance used (unless otherwise stated) was 0.05. 
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3 Long-term genomic evolution of H. pylori in Americas 
Helicobacter pylori has had the ability to colonise human stomachs for thousands of 
years (Moodley et al. 2012). It can also live within its host for years (Rhee, Park, and 
Cho 2014), and different strains can cohabit within the same host (Cao et al. 2015). 
This long-term colonisation has resulted in co-evolution of human and H. pylori 
genomes in populations around the world. Human migrations have carried the bacteria 
throughout history, and traces of ancient human migrations can be found by studying 
genomic admixture in H. pylori genomes (Falush et al. 2003). The Americas are an 
excellent place to study population admixture, because of the recent history of human 
migration. A rapid colonisation of the New World, principally by European migrants 
and African slaves, massacred indigenous populations. The new-comers brought with 
them pathogens, including H. pylori that were different from native populations. The 
H. pylori species seems to have benefited from this new gene-pool created by this 
human migration, facilitating rapid recombination and mutation (Suerbaum and 
Josenhans 2007).  
The three human populations investigated here include Europeans, Africans and 
Native Americans and each carry genetically distinct populations of H. pylori, named 
hpEurope, hpAfrica1, hpAfrica2 and hspAmerind (Montano et al. 2015; Falush et al. 
2003; Linz et al. 2007). The prefix hp indicates a population and hsp a subpopulation. 
Subpopulations are genetically distinct from each other but less differentiated than 
populations. The relationships between bacterial populations reflect differentiation 
that occurred during the complex migration history of humans (Falush et al. 2003). 
hspAmerind strains are presumed to be descendants of the strains present in the 
Americas prior to 1492, and are a subpopulation of hpEAsia, which is found in East 
Asian countries such as China and Japan. This heritage is linked to the ancient 
colonisation of the New World by Asian populations (Marangoni, Caramelli, and 
Manzi 2014). hspAmerind subpopulation is rarely found, even within groups with 
strong Native American ancestry and may be dying out in competition with other 
strains, possibly due to low diversity within the population (Domínguez-Bello et al. 
2008). hpEurope bacteria are themselves ancient hybrids between two populations, 
whose close relatives are currently found in un-admixed populations in North East 
Africa (hpNEAfrica) and central Asia (hpAsia2). A study of a 5300-year old mummy 
found in central Europe showed that he was infected with H. pylori which was an 
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hpAsia2 type, with little or no African ancestry, suggesting that the admixture 
probably took place within the last few thousand years (Maixner et al. 2016). 
H. pylori is associated with gastric cancer (GC), which is one of the most lethal 
cancers (Parsonnet et al. 1997; Plummer et al. 2015). GC is a global health issue, but 
it is even more so in Latin America, as some countries in this region have among the 
highest mortality rates worldwide (Ferlay et al. 2015). Mortality due to GC is ranked 
3
rd
 in South America and 5
th
 in Central America (Globocan 2012). Mortality rates 
vary between neighbouring countries (for instance 5.6 in Argentina against 15.0 in 
Chile in terms of Estimated age-standardized mortality rates for males per 100,000), 
and within nations (for instance in Colombia with higher rates in mountains 
populations than coastal populations) (Ferlay et al. 2015; Torres et al. 2013). In 
addition, phylogeographic origin of the bacteria, as well as discordant origin of 
bacteria and hosts have been linked to increased risk of gastric cancer development 
(de Sablet et al. 2011; Kodaman et al. 2014). However, these studies were based on 
MLST analysis which compares only seven housekeeping genes, therefore whole-
genome based analysis would increase the resolution for such studies. 
There is a need for better understanding of the dynamics among H. pylori populations. 
MLST is a good tool and was precious to start understanding the link between H. 
pylori populations and their hosts, however whole-genome based methods will bring a 
better resolution. 
The development of whole-genome sequencing makes it possible to study in depth the 
variations in H. pylori genomes and the ancestry of these populations. This will lead 
to a better understanding of the mechanisms leading to such a wide variability in H. 
pylori, and the relationship between this variability and human activities. Recent 
research (Thorell et al. 2017) formed part of this project and is outlined in Appendix 
D. For this study, a global collection of H. pylori genomes, combining both publicly 
available and newly-sequenced genomes, was studied. This study aimed to confirm 
two things. First, that the genomic variability of H. pylori strains from the Americas 
reflects the history of migrations which shaped these regions. Second, that both the 
core and accessory genomes reflect this in a similar way. 
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3.1 Materials and Methods 
3.1.1 Genomic data set 
The data set used in this study was composed of both publicly available strains and 
newly sequenced strains. The original dataset available on the Sheppard lab BIGSdb 
(BIGSdb http://zoo-
dalmore.zoo.ox.ac.uk/perl/bigsdb/bigsdb.pl?db=sheppard_hpylori_isolates ) consists 
of 825 strains. This dataset was processed to remove all sequences from non-human 
sources or those that were of poor quality. A genome comparison was performed 
(2.3.2) and a  neighbour-joining tree was built using FastTree v2.0 (Price, Dehal, and 
Arkin 2010) to identify clones. Clones are defined as strains that are almost identical, 
often isolated from a same patient, either from different areas of the stomach or at 
different time points, or from patients belonging to the same family. The final dataset 
comprised 401 strains. Average number of contigs was 85.9, average length was 
1644038.5 bp and average GC content was 38.95% (Figure 3.1). 
 
Figure 3.1: Distribution of the genomic characteristics of the sequences 
used in a 401 strains dataset. 
 
3.1.2 Chromopainter and FineStructure 
Genes from the reference strain 26695 were searched by nBLAST in the 401 strains 
by genome comparator, in order to prepare core genome alignments used as input for 
ChromoPainter (K. Yahara et al. 2013) (2.3.5). ChromoPainter infers chunks of DNA 
donated from a donor to a recipient. Results are summarized into a co-ancestry 
matrix, highlighting the relatedness of some populations by comparing the profile of 
the strains from this population, and the likeliness of their possible hybridisation. 
FineStructure (2.3.5) (Lawson et al. 2012) uses the co-ancestry matrix to cluster 
  
54 
 
individuals based on paired-similarity. The results from FineStructure are summarised 
in a heatmap.  
3.1.3 Pan-genome approach 
A Pan-genome was built using an in house developed script (2.3.4.1). Briefly, fasta 
files from all 401 strains were downloaded from the BIGSdb and submitted to the 
Rapid Annotation Sequences Tool (RAST) (Overbeek et al. 2014). A list of one allele 
of each gene found in at least one of the strains was then compiled and filtered. The 
final pan-genome for this analysis was composed of 2457 genes. A genome 
comparator executed on the 401 strains from the dataset against this pan genome list 
revealed that 990 of these genes were core genes (present in all the strains from this 
dataset). The 1467 remaining genes were accessory genes (present in at least one, but 
not all strains from this dataset). Truncated genes were considered as present, as 
truncation was in most cases caused by contig limits and therefore did not reflect a 
biological truncation of the genes. 
3.1.4 Accessory genome analysis 
The accessory genome from our dataset was studied based on the table output of a 
genome comparator executed on the dataset of 401 strains using the pan-genome list 
of 2457 genes. A binary presence/absence matrix was built for all the 1467 accessory 
genes from this 401 strains dataset. 
Using this binary presence/absence matrix, an accessory tree was built and annotated 
(2.3.7.1). The binary presence/absence matrix was also used to calculate the 
frequency of each individual gene in each FineStructure population of our dataset 
(called prevalence of the gene). In addition, it was used to build 3-dimensional plots, 
using the prevalence in each of the three groups selected as coordinates (2.3.7.2). 
ANOVA-based statistics were performed to describe the hybridisation using 
Graphpad Prism v6.  
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3.2 Results 
3.2.1 Phylogeny of the data set 
The final data set comprised 401 strains of Helicobacter pylori that were sampled 
globally. The topology of the genomic tree (Figure 3.2: Neighbour-joining tree based 
on the whole-genome alignment of 401 H. pylori strains.) was typical of H. pylori, 
with strains distributed on a cline going from hspEAsia to hpAfrica1 and with 
hpAfrica2 splitting away from the general cline.  
 
 
Figure 3.2: Neighbour-joining tree based on the whole-genome 
alignment of 401 H. pylori strains. 
The population of the strains determined by FineStructure is represented 
through color of the branches. 
 
The geographic origin of these 401 clinical strains of H. pylori isolated in human 
clinical cases can be broken down as described in Table 3.1. 
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Table 3.1: Geographic origin of the 401 H. pylori strains used in 
FineStructure analysis. 
Colonisation group Geographic origin Number of strains 
New World North America 57 
Mexico 35 
Central America 33 
South America 73 
Old World Europe 41 
West Africa 38 
South Africa 43 
Asia 57 
East Asia 22 
Oceania 1 
Experimental 1 
 
3.2.2 Core Genome Analysis 
3.2.2.1 FineStructure 
A FineStructure analysis was performed to identify the populations found among the 
dataset (Figure 3.3). The coloured matrix demonstrates how much of the genomes are 
shared between strains. The darker the colour, the more shared ancestry. Twelve 
populations were identified based on this analysis. Five of them are found mainly in 
the New World. Some populations were more distinct from other populations. For 
instance, hpAfrica2, hspAmerind and hpAsia2 show a large amount of intra-
population importation and a low amount of importation from or to other populations. 
Conversely, hspEuropeColombia and hspEuropeS show almost the same amount of 
importation from or to other populations than intra-population (Figure 3.3). 
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Figure 3.3: Identification of 12 populations of H.pylori in a dataset of 401 
global strains by FineStructure. 
Adapted from (Thorell et al. 2017). Asterisks are for populations mainly 
found in the New World. The colour of each cell in the matrix represents the 
expected number of DNA chunks imported from a donor genome (column / 
x-axis) to a recipient genome (row / y axis). The colour bars indicate the 
geographic origin of the recipient and donor strains. 
 
3.2.2.2 Chromosome painting 
Two chromosome painting analyses were performed and results were arranged to 
show the link between geographic origin of the strains and their population, as well as 
the relationship between populations (Figure 3.4).  
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Figure 3.4: Chromosome painting results showing repartition of the 
global and ancestral population in the world. 
Adapted from (Thorell et al. 2017). Each vertical bar represents one isolate. 
The colour composition of each bar represents the amount of DNA donated 
from each subpopulation in the core genome of the isolate. Panel A is made 
with only old world populations (hspAfrica1SAfrica, hspAfrica1WAfrica, 
hspEuropeS, hpAsia2, hspEuropeN, hpAfrica2 and hspEAsia) from old 
world geographic origin (1 to 6 on map) used as donors. Panel B is made 
using all strains as potential donors. 
 
Each colour represents one of the twelve populations of H. pylori identified with 
FineStructure. On Figure 3.4A, the donor panel used was made with only isolates 
from old world geographical origin (Europe, Africa and Asia) belonging to Old World 
populations (hspAfrica1SAfrica, hspAfrica1WAfrica, hspEuropeS, hpAsia2, 
hspEuropeN, hpAfrica2 and hspEAsia). hspEuropeS seems to have a larger fraction of 
chunks coming from African populations, while hspEuropeN has a larger portion of 
DNA coming from hpAsia2. These two populations also have a larger portion of their 
palette coming from other old world population, compared to hpAfrica1, hpAfrica2, 
hpEAsia and hpAsia2. This is due to the ancient hybridisation between hpAfrica1 and 
hpAsia2 resulting in the modern hpEurope population (Falush et al. 2003). The 5 
other old world populations are highly distinct, showing more than half of their palette 
coming from their own population. 
Our hypothesis is that most of the recombination occurred from Old World to New 
World strains. This OldWorld Painting allows us to investigate the origins of these 
New World H. pylori populations without the more recent admixture that happened 
since the colonisation of New World by Old World human populations.  
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Data shown in Figure 3.4B, on the other hand, uses all strains as potential donors, 
allowing a better view of the recent admixture events, and the relationship between 
New World populations of H. pylori strains. 
Regarding the isolates found in the Americas, some were strains belonging to Old 
World populations, others revealed 5 new subpopulations that were not found in Old 
World territory and included: hspEuropeColombia, hspAfrica1NAmerica, 
hspMiscAmericas, hspAfrica1Nicaragua and hspAmerind. Most of these populations 
were derived from European and African Old World populations (Figure 3.4A). The 
exception was hspAmerind, described in previous research as closely related to 
hspEAsia (Falush et al. 2003), originating from a more ancient colonisation of the 
Americas by Asian people, who formed the Native American population. 
hspEuropeColombia was found mainly in Colombian isolates and demonstrated a 
high level of European ancestry. As shown in Figure 3.4B, this population shows high 
intra-population recombination. hspAfrica1NAmerica and hspAfrica1Nicaragua were 
found in isolates from North America and Nicaragua respectively. Both populations 
showed a high level of African ancestry, but did not show exactly the same pattern 
(Figure 3.4B). hspAfrica1NAmerica showed a dominance of African ancestry, 
whereas hspAfrica1Nicaragua also had imported European and Asian ancestry. 
Global painting (Figure 3.4B) also revealed more intra-population recombination in 
hspAfrica1Nicaragua than there was in hspAfrica1NAmerica. 
As both Finestructure and Chromopainting analyses are based on core genome 
analysis, methods were developed to study the accessory genome in that specific 
aspect of hybridisation of populations. 
3.2.3 Accessory genome analysis 
3.2.3.1 Accessory genome phylogeny 
For each strain, the pattern of presence-absence of each gene was determined by 
genome comparator to calculate frequency (or prevalence) in the different 
populations. A neighbour-joining tree was built based on the presence/absence 
relatedness matrix (Figure 3.5). 
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Figure 3.5: Neighbour-joining accessory genome tree based on gene 
sharing distance (absence and presence of genes). 
This tree was annotated with iTOL (Letunic and Bork 2016). Colour of the 
branches represents the FineStructure population. Red circles indicate strains 
with the Cag Pathogenicity Island (CagPAI), and grey circles indicate strains 
without the CagPAI. An online version is available for this figure at this 
address: https://itol.embl.de/tree/137441153401551509290179# 
 
Figure 3.5 highlights that the accessory genome shows similar segregation of the 
strains as the one found with FineStructure, which was based only on core genome 
(Figure 3.2). However the relatedness of the strains is not only made according to hp 
populations, as some of the populations are now splitted into different areas of the 
tree. Presence of the Cag pathogenicity island (CagPAI) was investigated, as this 
group of genes was often identified as a ‗whole‘ in many of the strains, and we 
hypothesised that this would affect the clustering of strains in this accessory genome 
tree. That was the case, as shown in Figure 3.5, most of the CagPAI positive strains 
clustered in the same area of the tree. Interestingly, most of the CagPAI negative 
European strains (hspEuropeN and hspEuropeS) and hspEuropeColombia cluster with 
the CagPAI negative African strains, whereas CagPAI positive European strains 
cluster with the Asian strains (in large majority CagPAI positive). American 
populations such as hspMiscAmericas and hspAfrica1Nicaragua and 
hspAfrica1NAmerica cluster with the CagPAI positive African strains.  
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3.2.3.2 Accessory genome plots 
Additional analysis of the accessory genome was performed on hpEurope and 3 of the 
New World populations (hspEuropeColombia, hspAfrica1NAmerica and 
hspAfrica1Nicaragua), to verify if their accessory genome profiles were consistent 
with the Chromosome painting and FineStructure results based on the core genome. 
The method led to the creation of 3 dimensional plots using the prevalence in the 
potential hybrid population as vertical axis, and the prevalence in the two ancestral 
populations suggested by chromosome painting on the horizontal axis. A 
randomisation of the group to which the strains belonged was performed as a negative 
control. All strains were allocated to a random group without any population structure 
taken into consideration, and the prevalence in these 3 randomised groups was used to 
build the negative control to check that the model showed divergence in accessory 
genome prevalence which was linked to the population structure (Figure 3.6A). The 
negative control showed genes to be clustered in the centre of the plot (labelled in 
black), with no outliers being closer to one of the axis (labelled in colours according 
to Figure 3.6B). A positive control was also built using data generated for a 
hypothetical ―perfect hybrid‖ population with genes sharing either the exact same 
prevalence than one of the ancestor or the average prevalence between the two 
ancestors (Figure 3.6C).  
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Figure 3.6: Controls used to develop a method for hybridisation analysis 
based on 3-dimensional plots of accessory genomes. 
Adapted from (Thorell et al. 2017) A. Negative control plot, built using 
random population assignment. B. Colour Legend C. Positive control plot, 
built using artificial hybrid population with frequency of genes either 
identical to Ancestor 1 (in magenta), to Ancestor 2 (in orange) or a 50-50 
hybrid (in red). In panels A and C, each dot is a gene, and the coordinates 
correspond to the frequencies of this gene in the three randomised 
populations. The graphs are orientated in order to have genes with identical 
frequencies in all three populations in the centre of the plot. These genes and 
those that had small variations of frequencies are represented in black. Genes 
with greater frequency differences appear in colours, according to the 
triangular legend presented in panel B. Colours used for the text are for genes 
that differ substantially between the population named and the other two. The 
criteria used to say a frequency X is larger than another one Y was [X-Y>= 
0.5], [X>=0.5 and Y<0.1], or [X>0.9 and Y<=0.5]. Colours on the lines are 
used for genes that show high differences in frequency between the two 
populations on each side of the line, with the last one having an intermediate 
frequency.  
 
 
The accessory genome method was applied to different sets of populations (Figure 
3.7). The first set used was hpEurope as a hybrid population from hpAsia2 and 
hpAfrica1. The hpEurope population is understood to be the result of an old 
recombination between hpAsia2 and hpAfrica1 (Falush et al. 2003), based on MLST 
analysis. This was also confirmed by the core genome analysis (Figure 3.3 and Figure 
3.4). The three other hybrid populations studied were hspAfrica1NAmerica, 
hspEuropeColombia and hspAfricaNicaragua, which were identified as hybrids from 
African and European origins in the core genome analysis (Figure 3.4). 
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Figure 3.7: 3-dimensional plots of accessory genomes in hybrid 
populations. 
Adapted from (Thorell et al. 2017). Each dot is a gene, and the coordinates 
correspond to the frequencies of this gene in three populations. The graphs 
are orientated in order to have genes with identical frequencies in all three 
populations in the centre of the plot. These genes and those that had too 
smaller variations of frequencies to be studied are represented in black. 
Genes with greaterfrequency differences are labelled in colours, according to 
the triangular legend. Colours used for the text are for genes that differ 
substantially between the population named and the other two. The criteria 
used to say a frequency X is larger than another one Y was [X-Y>= 0.5], 
[X>=0.5 and Y<0.1], or [X>0.9 and Y<=0.5]. Colours on the lines are used 
for genes that show a high difference in frequency between the two 
populations on each side of the line, with the last one having an intermediate 
frequency. A. Comparison of hpEurope to hpAsia2 and hpAfrica1, from 
strains isolated in old world.B. Comparison of hspEuropeColombia to 
hpEurope and hpAfrica1. C. Comparison of hspAfrica1Nicaragua to 
hpEurope and hpAfrica1. D. Comparison of hspAfrica1NAmerica to 
hpEurope and hpAfrica1. 
 
Plots in Figure 3.7 show different types of hybrids based on the repartition of gene 
prevalence compared to hypothetical ancestors. hpEurope (Figure 3.7A) appear to 
have genes equally distributed between those showing an African profile, those 
showing an Asian profile, and those showing an average repartition between African 
and Asian prevalence. The three other hybrid populations seem to be much more 
driven by one of the ancestors over the other one. hspAfrica1NAmerica (Figure 3.7B) 
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and hspAfrica1Nicaragua (Figure 3.7D) show a larger number of genes with a 
distribution similar to that of hpAfrica1. However, there are more genes of different 
ancestry in hspAfrica1Nicaragua than in hspAfrica1NAmerica which has a more 
linear repartition along the hpAfrica1 line. hspEuropeColombia (Figure 3.7C) has a 
profile close to hpEurope, but with a small drift to the side, showing a significant 
difference in the pattern of prevalence. 
Statistics were performed on the plots from Figure 3.7, based on the distance of each 
gene from the equi-prevalence line.  The ANOVA analysis for the plot from Figure 
3.7A (hpEurope) showed a significantly higher distance for genes belonging to the 
profile ―hybrid = hpAfrica1‖ and ―hybrid = hpAsia2‖ (p-value < 0.05), which 
confirms that the population hpEurope is a balanced hybrid between hpAfrica1 and 
hpAsia2. Regarding New World populations, our accessory genome study identifies 
two types of hybrids. In Figure 3.7B and Figure 3.7D, populations are closer to 
hpAfrica1 than to hpEurope. The ANOVA for these two plots show that only ―hybrid 
= ancestor 1‖ is significantly higher (p-value < 0.05) in distance than the other groups. 
In Figure 3.7C the population is closer to hpEurope than to hpAfrica1, with statistics 
showing that only ―hybrid = ancestor 2‖ is significantly higher (p-value < 0.05) in 
distance than the other group.  
3.3 Discussion 
A large number of strains collected in Northern and Latin America were from 
hpEurope populations, with chromosome painting profiles undistinguishable between 
Old World and New World isolates. These hpEurope strains were clustering into two 
close but distinct subpopulations, which tend to segregate between North and South. 
The southern population showed a higher hpAfrica1 ancestry compared to the 
northern one. This difference in Old World could be explained by a Mediterranean 
melting pot, and there is a cline in the European strain-based tree that is consistent 
with this observation. The New World part of these hpEurope subpopulations can be 
explained by the colonisation history of North and South America. These observations 
draw a direct relationship between human and bacterial ancestries.  
However, human and bacterial ancestries are not always perfectly concordant. 
Colonisation of the Americas by European populations resulted in a new physical and 
dietary environment for the bacteria, as well as a new ethnic mix of hosts. 
Colonisation of a host from a certain ethnic background by a bacteria from a distinct 
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population background can lead to modifications of the host-bacterial interactions, as 
observed in other studies (de Sablet et al. 2011; Kodaman et al. 2014). This can also 
have an effect on long-term evolution. The hspAmerind population is a good example 
of these effects. Strains from this population are extremely rare, even in populations 
with substantial Native American ancestry. Even though this might be biased by a 
more limited access to clinical samples from such populations, there is strong 
evidence that these strains are dying out due to the benefit of hpEurope strains when 
these populations are in a competitive environment (Domínguez-Bello et al. 2008). 
This is reflected in the present study due to the fact that none of the populations only 
found in the New World show a considerable amount of hspEAsia apart from 
hspAmerind. This subpopulation did not mix with the others to produce a new 
subpopulation-it appears to be going extinct. 
Variations observed amongst American populations can be partially explained in 
different ways. First of all, the sample collections from the United States all come 
from Cleveland, which is a large cosmopolitan city, whereas samples from South and 
Central Americas come from hospitals where the patients come from various parts of 
their respective countries. Most of the samples coming from Old World populations 
found in the New World are from the USA, but that could be a reflection of this 
difference in the type of collection. However, there is another plausible explanation 
for this. The prevalence in the USA has been decreasing (Stewart and Wild 2014) for 
the last 2 decades, whereas it is still extremely high in Latin American countries. High 
prevalence increases the possibilities for horizontal transmission and mixed 
infections, which can result in emergence of local populations, whereas a low 
prevalence tends to conserve the original imported populations. 
The long-term evolution of H. pylori strains is in part driven by human history. 
Population migration events can make highly divergent bacterial populations meet 
and those populations can recombine to result in new populations. This evolutionary 
path can be of great importance in understanding host/pathogen interactions, as the 
creation of new populations or the eradication of old populations of H. pylori can be 
linked to prevalence of diseases such as gastric cancer. 
It is interesting to note that the Old World populations identified by FineStructure and 
ChromoPainter matched the ones previously described (Falush et al. 2003). However, 
the increased number of strains and use of whole-genome sequencing instead of 
MLST allowed for the differentiation between two subpopulations which were 
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considered as one in previous studies (Falush et al. 2003): hspEuropeS and 
hspEuropeN. The two populations are closely related, but distinct in terms of 
ancestry, as hspEuropeS has a stronger input in African populations, and hspEuropeN 
has a stronger input in Asian populations. Study of the accessory genome in hpEurope 
strains also confirmed the hybrid origin of this population between Asian and African 
ancestry, which was demonstrated using MLST (Falush et al. 2003) and core genome 
analysis, with FineStructure. This is the first study based on complete accessory 
genome, as most studies are based on core genome analysis. This enabled us to 
investigate the relationship between core and accessory genomes and have a more 
complete picture of the evolution taking place in H. pylori. Accessory analysis of 
hybridisation ancestry is a good way to represent and analyse the prevalence of genes 
between 3 populations. However, it requires more than 20 strains from each 
population, which could be considered a limitation as samples are not always 
available in abundance. 
In conclusion, we succeeded in showing that the genomic variability of H. pylori 
strains from the Americas reflects the migration history. Our study highlighted two 
distinct ancestral hpEurope, that we named hspEuropeN and hspEuropeS, spreading 
to the New World in different ways. These Old World populations mixed in the 
Americas with Asian and African strains to give birth to new populations, unique to 
the Americas. Our study studied both core and accessory genome, and we showed that 
both genomes were evolving in similar ways. Our observations on the link between H. 
pylori and human populations were concordant, showing the same tendancy in the 
different New World populations. 
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4 Rapid genomic evolution in Helicobacter pylori strains infecting 
mice 
Helicobacter pylori can colonise the stomach for years without causing any 
symptoms, but often causes asymptomatic or symptomatic inflammatory responses 
(Correa 1988; Supajatura et al. 2002; D. J. Evans et al. 1995; Satin et al. 2000; Moran 
and Aspinall 1998; Pérez-Pérez et al. 1995; Unemo et al. 2005). This prolonged 
inflammation can also be responsible for the development of various gastric disorders, 
such as gastric cancer but also the less prevalent gastric MALT Lymphoma (ML). The 
exact mechanisms leading to gastric complications remain unclear (Bessède et al. 
2015), but it is thought that the extreme diversity of the H. pylori genome could be 
one answer. A few studies have investigated the effects of long-term host colonisation 
on the H.pylori genome (Israel et al. 2001; Kersulyte, Chalkauskas, and Berg 1999; 
Kuipers et al. 2000). However, there is a need to link this long-term colonisation with 
not only the changes occurring in the bacterial genome, but also with the development 
of disease (e.g ML) and associated symptoms. Murine models of H. pylori 
colonisation have been established (D. H. Kim et al. 2003), with comparable 
symptoms to those observed in humans (She et al. 2003). This model is a good option 
both economically and biologically (S. Zhang et al. 2014), and so an infection study 
was carried out at the Centre National de Référence des Campylobacters et 
Hélicobacters (CNRCH) in Bordeaux (Chrisment et al. 2014). 
The reasons why only part of the population infected with H. pylori develops 
symptoms and the mechanisms underlying the wide range of symptoms that can occur 
are still unknown. In the murine study previously mentionned (Chrisment et al. 2014), 
observation of lesions and markers of low-grade ML similar to those seen in humans 
were made regardless of the infecting strain, which would suggest the importance of 
host (mouse) rather than bacterial factors. However, to add to this complexity, 
symptoms were significantly more acute in one of the ML associated strains (B47). 
This suggests that the diversity observed in H. pylori population may contribute to the 
disease process. The genome evolution of a H. pylori strain during a long-term 
infection was previously studied in a primate model (Liu et al. 2015) and attempts 
were also made in humans (Avasthi et al. 2011), but these studies require very long 
incubation times to be relevant and focused on other pathologies. There is, so far, no 
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study of the evolution of H. pylori strains during the development of MALT 
lymphoma symptoms. A recent publication studied the differences between a specific 
experimental strain (SS1) before and after passage in mice exist but this study was 
only based on one strain, and highlighted variability (Draper et al. 2017). Studies on 
other strains could confirm or complete their observations. 
This chapter uses the isolates from a previous study where neonatal thymectomised 
BALB/c mice were infected with H. pylori strains in order to assess the capacity of 
the strains to promote ML (Chrisment et al. 2014). Two of the strains used in this 
study, B38 and B47, were isolated from European patients suffering from ML. At 
each stage of this study the bacterial strains were isolated from mice and stored, 
offering the opportunity to sequence them and have a deeper look at the variations 
that occur in the bacterial genomic during the long-term colonisation of mice 
stomach.  
This study aims to investigate two statements: i) A H. pylori strain evolves when 
changing its host niche from human to mice; and ii) A H. pylori strain infecting a 
stomach for a long time evolves alongside the development of ML symptoms. 
4.1 Material and Methods 
4.1.1 Isolation of H. pylori from mice 
in vivo experiments took place at Laboratoire de Bacteriologie in Bordeaux 
(Chrisment et al. 2014), prior to this PhD. The two strains selected for this study (B38 
and B47) were capable of colonising the stomachs of BALB/c mice. One of them, 
B38, went through a re-isolation step prior to colonisation experiment in order to 
obtain a sufficient amount of infecting bacteria. They were both CagPAI negative and 
were tested against two control strains also known for their ability to colonise mice 
but not associated with ML. Bacterial strains were cultured under microaerophilic 
conditions at 37°C. The strains were grown on selective agar plates and collected in 
Brucella broth medium. Six-week-old mice were fasted in order to facilitate bacterial 
colonisation, then gavaged for 3 consecutive days with the required strain at a dose of 
10
8 
H. pylori per mouse. When the mice were sacrificed (after 6 weeks, 6 months or 
12 months post-infection), biopsies were used for culture and frozen at -80°C. H. 
pylori culture was performed from the collected stomach tissue, homogenised in PBS 
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and grown on a selective medium under microaerophilic conditions at 37°C for 3 to 
10 days. These bacterial cultures were kept at -80°C until used for DNA extraction 
and sequencing (Figure 4.1). 
 
Figure 4.1: In vivo microevolution of H. pylori. 
Original strains B38 and B47 were both isolated from human patients 
suffering from ML. B38 was passaged through a mouse prior to infection. 
Then both B38 and B47 were administered to mice and re-isolated at defined 
times (6 weeks, 6 months and 12 months) following infection. Infection is 
shown with black arrows. Isolation is shown with red arrows. The strain 
labelled a was already sequenced and published. All other strains were 
sequenced specifically in this genomic study. Strains labelled b were used in 
the change of host analysis. Strains labelled c were used in the long-term 
colonisation analysis. 
 
4.1.2 DNA extraction and sequencing 
The B38 strain sequence was already publicly available. The remaining 21 other 
isolates were DNA extracted and their genomes sequenced (Figure 4.1). Total DNA 
was extracted using the QIAmp DNA Mini Kit (Qiagen, Crawley, UK) according to 
the manufacturer‘s instructions at Laboratoire de Bacteriologie, Bordeaux. The 
samples were whole-genome sequenced at Swansea University. Quantification of 
DNA was assessed with a Nanodrop spectrophotometer prior to sequencing. High-
throughput genome sequencing was performed using a MiSeqSystem (Illumina, San 
Diego, CA), and de novo assembly was performed using Velvet (version 1.2.08). All 
contigs from the 22 strains were imported into the SheppardLab Hp Bacterial Isolate 
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Genome sequence database (BIGSdb http://zoo-
dalmore.zoo.ox.ac.uk/perl/bigsdb/bigsdb.pl?db=sheppard_hpylori_isolates ) for 
genomic analysis (K. A. Jolley and Maiden 2010). 
4.1.3 Genomic analysis 
The average number of contigs for the 21 newly sequenced strains was 67.3, average 
length was 1586210 bp and average GC content was 39.09 % (Figure 4.2). Size of the 
B38 genome was 1576758 bp, on a single contig, with a GC content of 39.2%. 
 
 
Figure 4.2: Distribution of the genomic characteristics of the 21 newly 
sequenced strains. 
These characteristics were analysed using BIGSdb (K. A. Jolley and Maiden 
2010). Characteristics shown are sequence size (A), number of contigs (B) 
and GC content (C). 
 
Coding sequences (CDS) were identified for each strain using RAST (Overbeek et al. 
2014) (Figure 4.3). The average number of CDS in those 22 strains was 1620.6. B38 
derived strains had a smaller number of CDS (1611 on average) compared to B47 
derived strains (1632 on average). This difference was significant (p-value < 0.0001). 
A pan-genome was constructed with all loci present in at least one of the 22 strains 
used in this study, with the genes contained in the reference strain 26695 used as a 
reference gene list to facilitate identification of the genes (see details of the method in 
2.3.4.1). Gene-by-gene alignment was performed by genome comparator (2.3.2) using 
the 1703 CDS sequences of the pan-genome as reference, and the alignments were 
exported from the database to investigate gene-by-gene variations. A neighbour-
joining tree was built from the gene-by-gene alignment of the strains using FastTree 
v2 (Price, Dehal, and Arkin 2010) and annotated with iTOL v3 (Letunic and Bork 
2016).  
B. A. C. 
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The genome comparator tool produced a results matrix which included gene 
prevalence, and different alleles. Key differences measured focused on i) adaptation 
to a new host; ii) changes during the long-term colonisation of this host (Figure 4.1). 
 
Figure 4.3: Number of CDS annotated with RAST in the 22 strains 
isolated from ML patients or after passage in mice. 
 
Gene-by-gene variations were studied using BioEdit. Five types of changes were 
searched for: (i) single nucleotide polymorphism (SNP), corresponding to a change in 
only one position from one nucleotide to another; (ii) double nucleotide 
polymorphism (DNP), corresponding to a change in two neighboring nucleotides; (iii) 
Phase Variation (PV), corresponding to a change in the number of repeats of one or 
two nucleotide; (iv) Deletion or Insertion, inducing a gap in the alignment; (v) Change 
in the number of repetitions of a large sequence. PV and Deletion/Insertion are non-
synonymous, as they are changing the reading frame. Change in the number of 
repetitions of a large sequence is non-synonymous, but usually results in no change in 
the reading frame. SNP and DNP can be either synonymous or non-synonymous. 
Analysis of corresponding amino-acid sequences was achieved based on translations 
from the gene sequences using the online tool ExPaSy. 
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4.2 Results 
4.2.1 Population biology of the H. pylori dataset 
Genomic variability was first verified on a neighbour-joining tree (Figure 4.4).  
 
Figure 4.4: Neighbour-joining tree of the 22 strains isolated from ML 
patients or after passage in mice. 
The tree was built using the alignment produced by the genome comparator 
tool from BIGSdb and annotated with iTOL v.3.There was a clear 
segregation between B38 isolates on the left side and B47 isolates on the 
right side, confirming the isolates came from two distinct strains. 
 
The two strains used, B38 and B47, formed two distinct clusters, confirming firstly 
that they were different strains, as expected, and second that the genomic variations 
occurring during long-term infection in mice are smaller than the genomic difference 
between the two different strains. The results of a genome comparator performed with 
the pan-genome of these two strains and their variants confirmed these differences, 
with 1584 genes showing allelic variations between the two original strains or present 
in only one of them.  
The gene-by-gene comparison of the passaged isolates compared to the isolates 
originally administered showed a higher variability within the B47 isolates than 
within the B38 isolates (64.7 to 82.7 genes presenting variations in B47 against 43 to 
54.3 B38) (Figure 4.5).  
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Figure 4.5: Average number of genes showing allelic variations between 
the different sets of strains derived from B38 (Panel A) and B47 (Panel 
B). 
 
 
For B38 isolates, the number of genes presenting allele variations between isolates 
from a single time-point was lower than the number of genes presenting allele 
variations when compared to the original isolate. It was not the case for B47 isolates, 
in which the number of genes with allele variations between isolates from a single 
time-point was higher than the number of genes presenting allele variations when 
compared to the original isolate (Figure 4.5). 
 
4.2.2 Evolution during change of host 
Effects of the change of host on the strains is studied based on the genes changing 
between the original clinical strain and the batch of strains obtained after a first 
passage of 6 weeks in mice. A larger number of genes changed during the change of 
host in B47 derived strains (53 genes) compared to the number of genes changing 
during the change of host in B38 derived strains (38 genes). After selection of only 
genes with at least 2 identical alleles in the re-isolated strains that are different from 
the original strain allele and suppression of artefacts due to contig limits creating 
truncated genes, only 2 genes have changed in B47 and 10 genes have changed in 
B38. Artefacts due to contig limits were identified as genes for which the truncated 
gene was positioned at an extremity of one of the contigs. The sequence variations 
observed in B38 during change of host were of three types: SNP, PV and 
deletions/insertions (Table 4.1). 
 
A. B. 
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Table 4.1: Changes observed in genes during change of host in strain 
B38 or B47. 
Gene Change in Type of change Effect on Amino-Acid sequence 
HP0217/cgtA B38 PV Change in the length of the protein 
HP0251/oppC B38 PV Change in the length of the protein 
HP0464 B38 
PV Change in the length of the protein 
SNP Alanine to threonine 
HP0499 B38 PV Change in the length of the protein 
HP0685 B47 PV Change in the length of the protein 
HP1054 B38  SNP Tyrosine to Histidine 
HP1088 B38 SNP Arginine to Glutamine 
HP1237 B38 1SNP Synonymous 
HP1243/babA B38 
insertion Change in the length of the protein 
SNP Glycine to Arginine 
SNP Histidine to Tyrosine 
SNP Threonine to Alanine 
HP1251/oppB B47 PV Change in the length of the protein 
HP1252/oppA B38 PV Change in the length of the protein 
HP1365 B38 SNP Histidine to Tyrosine 
 
For strain B47, only PV was observed during change of host. In most of the genes, 
only one sequence variation was identified. However both a PV and a SNP were 
found in HP0464, and 3 SNP and a deletion/addition were found in HP1243.  
Interestingly, one of the genes identified in B38 (HP1252, or oppA) was in close 
proximity to one of the two genes identified in B47 (HP1251, or oppB). Another 
gene, identified only in B38, coded for another protein from the Opp family: HP0251, 
or oppC. All three were identified as going through PV during host transfer. These 
genes code for an oligopeptide ABC transporter substrate-binding protein and two 
oligopeptide ABC transporter permeases. All the phase variations occurring in these 
three genes have had consequences in the length of the protein, causing a shorter 
version of the protein in either the original strain (OppB and OppC) or the reisolated 
strains (OppA).   
HP0217, also known as cgtA, is a gene coding for a beta-1,4,N-
acetylgalactosamyltransferase and has a PV in B38. Both the original strain version 
and the re-isolated strain version were shorter than the version found in the reference 
strain 26695. However the version present in the re-isolated strains is slightly shorter 
than in the original strain.  
HP0464 codes for hsdR, a type I restriction-modification system endonuclease and 
has both a SNP and a PV in B38. Both the SNP and PV are non-synonymous, causing 
an amino-acid change from an alanine in the original strain to a threonine in the re-
  
75 
 
isolated strains, and a shorter version of the protein in the original B38 strain than in 
the re-isolated strains.  
HP0499 codes for a precursor for an outer membrane phospholipase A1 (pldA, or 
DR-phospholipaseA) and has a PV in B38. This PV causes a shorter version of the 
protein in B38 than in the re-isolated strains.  
HP1054 is annotated as a hypothetical protein, but is likely to code for the murein 
hydrolase activator NlpD and shows a SNP variation in B38. This SNP was non-
synonymous, causing an amino-acid change from a tyrosine in B38 to a histidine in 
the re-isolated strains.  
HP1088 codes for a transketolase (tktA) and has a SNP variation in B38. This SNP 
was also non-synonymous, causing an amino-acid change from an arginine in B38 to 
a glutamine in the re-isolated strains.  
HP1237 codes for a carbamoyl phosphate synthase small subunit (pyrAa) and has a 
SNP variation in B38. This SNP was the only synonymous SNP found in this B38 
change of host study. 
HP1243, also known as babA, is the gene that has the most variations in this study 
with 3 SNPs and 1 insertion. This gene codes for the outer membrane protein omp28. 
All 4 nucleotide variations found in this gene were non-synonymous. Effects of the 
insertion were important, creating a shorter version of the protein in the re-isolated 
strains compared to both B38 and 26695 versions. All 3 SNPs were similar in B38 
and in 26695, differentiating the re-isolated strains from the human ones. 
HP1365 codes for a DNA binding response regulator from the OmpR family and has 
a non-synonymous SNP in B38, causing an amino-acid change from a histidine to a 
threonine.  
Finally, HP0685 codes for a flagellar biosynthesis protein FliP and has a PV in B47. 
The Phase Variation in this gene resulted in a shorter version of the protein in the re-
isolated strains than in the original B47 strain.  
4.2.3 Evolution during long-term colonisation 
Changes during long-term colonisation of mice were studied. A larger number of 
genes changed during long-term colonisation in B47 derived strains (79 genes) 
compared to the number of genes changing during long-term colonisation in B38 
derived strains (63 genes). From these, genes for which the change was caused only 
by the change of host, artefacts caused by contig limits, and genes that were not 
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showing at least 2 identical alleles among the strains from a same time-point were 
removed. Artefacts due to contig limits were identified as genes for which the 
truncated gene was positioned at an extremity of one of the contigs. This selection left 
3 genes in B47 derived strains and 4 genes in B38 derived strains. Changes included 
SNP, DNP, PV and long sequence repetition variations (Table 4.2). The two long 
sequence repetition variations observed concerned the same pattern of 21bp, inducing 
a repetition of the amino-acid sequence DDLRVNY.  
 
Table 4.2: Changes observed in genes during long-term colonisation of 
mice in strain B38 or B47. 
Gene Change in Type of change Effect on Amino-Acid sequence 
HP0379 B38 
SNP Aspartic acid to asparagine 
Number of 
repetitions 
DDLRVNY 5 to 14 times 
HP0629 B47 SNP Alanine to Aspartic acid 
HP0651 B38 
SNP Aspartic acid to asparagine 
Number of 
repetitions 
DDLRVNY 5 to 14 times 
HP0855 B38 & B47 PV Change in the length of the 
protein 
HP1041 B47 SNP Glutamic acid to Alanine 
0010_8940_0104 
B38 PV Change in the length of the 
protein 
 
One of the genes, HP0855, presented a variation linked to long-term colonisation in 
both B47 and B38 derived strains.  Again, like in the change of host, the variation 
observed in this gene was a PV. HP0855 codes for an alginateO-acetylation protein 
(algI), with functions linked to cell wall, membrane and envelope biogenesis. 
Two of the genes that were identified as having evolved during long-term colonisation 
of mice with B38 are especially interesting: HP0379 and HP0651. Both code for a 
fucosyltransferase, which has a crucial role in LPS biosynthesis. Each of these two 
genes had a SNP placed inside the same short sequence, replacing an aspartic acid 
with an asparagine in the amino-acid sequence. In addition to this, they also had a 
unique type of variation: there was a repetition of a small sequence (21bp), resulting 
in the amino-acid repeat sequence DDLRVNY from 5 to 14 times. This has been 
described in another study (Rasko et al. 2000). More investigation was necessary on 
these sequences, as they were often found on the extremities of contigs. Completion 
of the missing parts from the genome comparator results for all the versions of 
HP0379 in B38 derived strains was possible, but not for all the versions of HP0651. 
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Two different endings were found in the complete sequences for HP0651, which did 
not allow us to infer the end of the sequence based on the sequences available. 
However, the contig limit was placed after the repetitions in all these incomplete 
genes, thus the count of the number of repetitions is robust. 
The final gene presenting variations in B38 has not been described yet. This gene was 
named 0010_8940_0104 by the RAST annotation, but it was not an nBLAST match 
for any of the 26695 genes during the pan-genome construction. The variation 
observed was a PV, leading to variations in the length of the protein. A pBLAST of 
the longest version found in our study against the proteome of 26695 matched for a 
type IIG Restriction Modification System with 98% of coverage for 91% identity.  
Genes with variations in B47 included HP1041, which code for the flagellar 
biosynthesis protein FlhA. This gene contained a non-synonymous SNP resulting in 
the change from a glutamic acid in the B47 original and 6 weeks re-isolated strains to 
an alanine in the 6 months and 12 months re-isolated strains.  
The final gene, HP0629, also contained a non-synonymous SNP, inducing a change 
from an alanine in B47 to an aspartic acid in the 6 months re-isolated strains. Its 
function was unknown. 
During this long-term colonisation, lesions of the stomach were assessed (see 
(Chrisment et al. 2014) for details). Mucosal inflammation was present in all infected 
mice 12 months post-infection, and absent from the non-infected mice. However the 
level of lymphoid infiltrates was only statistically different from the non-infected 
mice for mice infected with B47. These infiltrates were associated with 
lymphoepithelial lesions, which is a signature of a lymphoma stage. Lesions were 
more extensive and more severe in B47 infected mice compared to B38 infected mice. 
4.3 Discussion 
The variability between the original and re-isolated strains after the first passage in 
mice was quite low compared to what would have been expected from highly 
recombining bacteria. This suggests that the change of host from a human with ML 
symptoms to healthy mice does not affect the strains greatly. This observation 
confirms that studying ML symptoms provoked by H. pylori strains isolated from 
ML-suffering patients using a mouse model is suitable and does not infer changes too 
important in the bacterial strains. This makes this model not only good to study the 
development of ML in the stomach tissues, which was the aims of the Chrisment et al 
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(2014) study, but also to study the bacterial genome and its evolution during 
colonisation and development of symptoms. 
However, despite our results showing genomic variations in H. pylori strains 
colonising mouse models, variability was extremely high between samples from the 
same time-point, mainly due to the fact that the strains are evolving in different hosts, 
and mice are sacrificed at each time point making it difficult to be certain that the 
intermediate time point is truly an intermediate evolution between the original strain 
and the strain found in the 12 months post-infection stomach. Despite the fact that a 
single strain was used to infect the mice, it is also possible that at the re-isolation time, 
a variety of strains were present, undergoing different evolutionary pathways. Only 
one single colony was isolated for each mouse, and this hidden variability could have 
an effect on the results. A wider range of single colonies from different biopsies 
(n=10) of a same animal would help assessing this variability. 
The design of this study did not include an evolutionary control, in the form of the 
strains cultured outside a new host. Such an experiment would have been needed in 
order to ensure that the variability observed was indeed the result of the evolutionary 
response of the bacteria to its new host, and not spontaneous variability (Jee et al. 
2016; Draper et al. 2017). 
Another limitation of this study was the high number of artefacts identified by the 
genome comparator. This could be due to the quality of the sequencing and 
assemblies. Transport of the samples was not optimal, due to a transporter issue, 
which could have affected the quality of the samples, causing a drop in the quality of 
the sequences. However, the sequences were of expected size and content, therefore 
the results once the artefacts were removed should be trusted. Contig sizes were a 
limitation in gene-by-gene alignment methods used in this study. Increased variability 
observed in B47 derived strains compared to B38 derived strains, and the increased 
number of artefacts due to contig limits in B47 could be explained by the fact that the 
B38 genome was a complete genome sequence assembled in a single contig, whereas 
B47 was splitted in different contigs. This could be solved by using another method 
for sequencing, such as Pacific Bio Systems. However, this technology was not 
available in Swansea but is an opportunity for a future collaboration.  
This high variability issue could be improved by increasing considerably the number 
of samples, to allow statistics to be performed on the genomes. Indeed a maximum of 
3 isolates for each time point were available to us for this study, which is too small to 
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perform any sort of statistical measure and can hide some of the variability by the 
chances of not picking them up in our sample population. 
Another way to handle the variability issue would be to use a larger animal model 
which would allow the use of endoscopies instead of sacrifices. Indeed, mouse model 
present limitations. Their small size is one of them, as endoscopies are not impossible 
to perform but involve a lot of critical steps and require specific setups (Brückner et 
al. 2014). The life span is also shorter than the average duration of a H. pylori chronic 
infection in humans, which limits the study of true long-term colonisation and its 
effect on the bacterial genome. Mice also are poor models to study inflammation 
which is a crucial part of the H. pylori infection outcomes. Primates can be 
considered, as shown recently (Liu et al. 2015), but it is a costly model requiring more 
complicated ethical project licences. In addition, the adaptation of human strains to 
primates hosts has been less studied than for mice (Guo et al. 2014; S. Zhang et al. 
2014; Ameri Shah Reza et al. 2012). However, it does present the advantage of a 
longer life-time, closer to the human one, and endoscopies are achievable more easily 
on an animal of such scale. On an intermediate level between mice and primates, one 
could also consider gerbils. Cases of infections with Helicobacter species have been 
described in gerbils, which could also constitute a suitable model (Asim et al. 2015; 
Kodama et al. 2005).  In order to study the evolution of H. pylori strains according to 
the time spent in a specific host, it is also possible to study.families of patients 
infected with H. pylori. Indeed, families are often infected with a common strain, or 
are transmitting their infecting strains to other members of the family. Therefore 
sequencing strains isolated from patients belonging to a same family is a way to 
approximate longitudinal study of the bacterial genome (Raymond et al. 2004; Osaki 
et al. 2015; Raymond et al. 2008; Kivi et al. 2007).. At rare occasions, it is also 
possible to obtain pairs of isolates from a same patient at two different timepoints, 
which is a perfect opportunity to study genome evolution during human infection 
(Kennemann et al. 2011). 
 
Despite those limitations of our model, a number of genes changed in this study, some 
of which presenting interesting patterns of evolution, or linked to functions of 
importance in virulence.  
Outer membrane proteins are present on the cell membrane and are therefore likely to 
be in contact with the host cells and adapting to a new host in the context of the 
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immune response. A number of outer membrane proteins were highlighted in our 
change of host study, such as BabA or members of the Opp family. Interestingly, 
babA was also highlighted in a study of long-term colonisation performed on a 
primate model (Liu et al. 2015), and members of the hop family (comprising babA) 
were identified as showing an increased frequency of imports after 3 years in a human 
host (Kennemann et al. 2011). In their study, a PV was identified in this gene, which 
was not the case during the current study, where an insertion and 3 SNP were 
identified. However, the fact that this gene was highlighted by both these studies 
highlights the importance of babA as a virulence factor for colonisation of a host.  
BabA is one of the main virulence factors in H. pylori (VFDB 2017). The PV 
highlighted in members of the Opp family highlight a possible hot spot for short-term 
evolution of H. pylori strains during change from human to mouse hosts. These phase 
variation mechanisms have been described before in H. pylori and are well-known 
mechanisms for rapid adaptation (Bergman et al. 2006). It is not surprising to find 
them in our experimental conditions and it leads us to hypothesise that this set of 
genes coding for outer membrane proteins is a potential hot spot for evolution in the 
context of a change of host. Changes in oppA and oppB were also described in a study 
comparing the famous mouse-adapted strain SS1 with the pre-change of host 
equivalent PMSS1 (Draper et al. 2017). A number of changes were also identified in 
the long-term colonisation study, such as a gene linked to motility, HP1041, which 
was affected by a non-synonymous SNP. Another interesting mechanism of evolution 
highlighted in the long-term colonisation study was the number of repetition of a 21bp 
sequence in two fucosyltransferase-coding genes. These change highlighted by our 
study in futB, a gene involved in LPS modification, were also highlighted in the 
SS1/PMSS1 study (Draper et al. 2017), confirming that these genes are hot spots. of 
evolution, suggesting that the bacteria adapt to its host‘s stomach while provoking 
changes in it.It is interesting to note that the B47 strain showed a smaller number of 
genes having evolved during change of host and long-term colonisation, compared to 
B38. This B47 strain was also the one which provoked the most advanced and acute 
ML-like symptoms in a significant number of mice (Chrisment et al. 2014). This 
could suggest that B47 was already well-adapted to the ML environment, therefore 
having a faster effect on its new environment to turn it into a ML-like mucosa. 
Although such an adaptation cannot be proven with only these strains, an additional 
study could be carried out with a larger number of strains. 
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In conclusion, changes were observed in the bacterial genome during the passage 
from human to mice host. Some of these changes confirmed the variability observed 
in the study on SS1/PMSS1 (Draper et al. 2017). Strains also evolve during long-term 
colonisation, and evolution seemed to be more important in the strain causing the 
highest damages to the mice stomach. 
  

  
83 
 
5 A Genome Wide Association Study of Helicobacter pylori in 
cancer-causing European strains 
Helicobacter pylori is a Gram negative bacteria that colonises the human stomach. 
Despite the fact that this bacteria has colonised human stomachs for at least 100,000 
years (Moodley et al. 2012), it was only discovered in 1984 (B. Marshall and Warren 
1984). The link between the presence of H. pylori in the stomach and the development 
of peptic ulcer disease is well known (B. J. Marshall n.d.; A. C. Smith 1989; B. 
Marshall and Warren 1984), and this organism can go on to cause gastric cancer in 
some patients (Parsonnet et al. 1997). H. pylori can colonise the stomach for years 
without causing any symptoms (Peek and Blaser 2002). However, the prolonged low 
grade inflammation associated with this colonisation could be responsible for the 
development of various gastric disorders, such as gastric cancer (Wroblewski and 
Peek 2016). Gastric cancer (GC) is the third most common cause of cancer deaths 
worldwide, causing approximately 723,000 deaths every year (Ferlay et al. 2015), and 
treatments are not yet optimal (Shi and Gao 2016). Therefore, recent guidelines have 
encouraged complete clearance of the bacterial infection, in an attempt to prevent 
future complications (Ierardi et al. 2013). However, the procedure for eradication of 
H. pylori is not easy, and increased antibiotic resistance has been reported throughout 
the World (Binh et al. 2015).  
Despite the above, some studies have shown a possible positive impact of H. pylori 
infections in some health-related issues (Whalen and Massidda 2015). The definition 
of health given by the World Health Organization in 1948 (WHO 1948) states that 
―Health is a state of complete physical, mental and social well-being and not merely 
the absence of disease or infirmity‖. Considering the large number of cases where 
colonisation by H. pylori does not provoke serious symptoms, systematic eradication 
of H. pylori might not always be beneficial to the patient‘s health. The long-term co-
evolution between humans and H. pylori might be beneficial for both the bacterium 
and the human host, and the effects of complete eradication of the bacteria are 
unknown, which could result in the rise of other health issues, that could be more 
complex to treat (Vincent et al. 2013). What if it was possible to predict whether a 
strain was going to cause cancer? Would it then be necessary to eradicate the bacteria 
if sufficient relevant proof showed that complications were unlikely? Improved 
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antimicrobial stewardship could reduce the resistance issue, while improving patient 
comfort with low risk of cancer. 
The exact mechanisms leading to complications remain unclear (Bessède et al. 2015), 
but it is thought that the extreme variability of the H. pylori genome could be part of 
the answer. Gastritis is always the first symptom after an H. pylori infection (Sugano 
et al. 2015). After long-term colonisation, symptoms can evolve towards more serious 
issues, or remain stable. Different pathways towards different complications can 
occur. Antral-predominant gastritis is often associated with a higher level of acid 
production, and is more likely to evolve into duodenal ulcers or MALT lymphomas, 
whereas corpus-predominant atrophic gastritis is associated with a lower level of acid 
production, and can lead to gastric ulcers or GC. Pathways towards GC from atrophic 
gastritis include the development of IM and dysplasia. Atrophic gastritis is reversible 
to asymptomatic gastritis, but can also progress towards gastric cancer (Chung et al. 
2005). Even though some genomic factors are known to be associated with cancer, 
such as CagPAI genes and VacA, these genes are not sufficient to explain the 
development of cancerous lesions in some of the patients, while others only get 
superficial symptoms (da Costa, Pereira, and Rabenhorst 2015). There is a need for 
deeper analysis of the differences between cancer-causing strains and non-cancer 
causing strains. Identification of risk genotypes in the bacterial strains could lead to 
new ways to face treatment of the infection. 
Development of GC is not only due to bacterial genomic factors, but could also be 
driven by host genetics (Cristescu et al. 2015) or the environment, and most certainly 
by a combination of those three factors. One study identified an increase in the risk of 
cancer when there is divergence between the host and bacterial population (de Sablet 
et al. 2011). This chapter focuses on bacterial genomics factors, but host and 
environmental factors will be used to explain the variations found in the bacteria 
genome. Another element to keep in mind is the fact that in the event of a H. pylori 
infection, the stomach is not colonised by a unique strain, but a mix of strains, 
sometimes closely related, but sometimes resulting from a mixed infection (Kibria et 
al. 2015; J. W. Kim et al. 2004; Ben Mansour et al. 2016). Therefore linking bacterial 
genotypes with gastric cancer is not straightforward. Studies can be biased by random 
selection of certain strains, and screening applications that could result of such studies 
in clinics could also suffer from this fact and produce false results. 
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The GWAS method has previously been used successfully to study human genetics. It 
has recently been applied to bacterial genomics; through adaptation of the original 
method to take into account specificities of the bacterial genomes (Sheppard et al. 
2013). The challenge faced by using GWAS in H. pylori is its extremely high 
genomic variability. Indeed, H. pylori strains are not organised in clusters like the 
related species Campylobacter. Two strains isolated from two different patients are 
often extremely different, with allelic differences between common genes but also 
genes which are absent in one and present in the other (Alm and Trust 1999). There is 
a clear population structure in H. pylori genomes, which is strongly associated with 
the geographic or ethnic origin of the patient from whom the sample was isolated. 
This creates difficulty when applying methods currently used, increasing the risk of 
obtaining false positive hits. To address this population issue, this study will only 
consider European strains, so that the number of strains is sufficient while reducing 
the effect of population structure. Methods of GWAS based on ClonalFrame, which 
were proven efficient with other bacteria, are not optimal for H. pylori. Therefore, this 
ClonalFrame method will be compared with another method named ‗bugwas‘, which 
does not rely on a pair-wise selection of strains on a tree. Results from bugwas are 
included in a first-author submitted publication which has not been accepted or 
published at the time of writing. 
In this chapter, the feasibility of two different GWAS methods on H. pylori datasets 
will be verified. Specific genomic traits linked to the progression of GC will be 
identified using GWAS. Finally a risk score will be used to lead the way towards a 
better targeting of strains with a higher risk for triggering GC. 
5.1 Materials and Methods 
5.1.1 Dataset 
All 578 publicly available genomes from H. pylori strains and 198 strains sequenced 
in Swansea or by collaborators were used to search for the complete list of genes 
present in the H. pylori reference strain 26695 using a nBLAST (ref Section Genome 
Comparator). Strains that were not from a human clinical source, had an unusual sized 
genome or number of genes were removed (2.3.1), and a tree was built from an 
alignment of the remaining strains using FastTree v2.0 (Price, Dehal, and Arkin 2010) 
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to identify clones, leaving a total of 565 strains. Metadata was retrieved when 
available from existing publication or patient information collected with the strains. 
Those 565 strains were used in a FineStructure (Lawson et al. 2012) analysis in order 
to identify large populations (2.3.5). 
5.1.2 Genome-wide association study based on ClonalFrame 
This GWAS method was based on one previously used in other bacteria (Sheppard et 
al. 2013). This relied on the construction of a pan-genome from the dataset chosen 
and ClonalFrame (Didelot and Falush 2007). A dataset comprising only strains from 
hpEurope populations (identified by FineStructure analysis) was used. Strains isolated 
from patients with gastric cancer (GC), Intestinal Metaplasia (IM) and Atrophic 
Gastritis were part of the Cancer group. Strains isolated from patients with gastritis or 
labelled as normal were part of the Non Cancer group. Strains with unclear or 
unknown pathology, or with pathology which were not part of the cancer pathway, 
were discarded, leaving only 196 strains. A tree of this data set was built using a core 
genome alignment with FastTree v2.0 (Figure 5.1). 
Pairs of strains were selected uniformly spread across the tree to create two replicate 
datasets of 30 and 31 pairs of strains respectively. The pan-genome was created with 
these 122 strains (Appendix E) using the method described in 2.3.4.1. Briefly, the 
complete genomes of the strains were downloaded from BIGSdb (Overbeek et al. 
2014) and annotated using RAST (Overbeek et al. 2014). Similarity between each pair 
of open reading frames was checked through a BLASTn (Altschul et al. 1990) search 
and a list of all the genes present in at least one strain of our dataset was created 
(Sheppard et al. 2013). This pan-genome was then used on the two replicate datasets 
as the reference gene list for the GWAS (2.3.6.1). Then, genes were split into 30bp 
words, the prevalence of the words in each group of strains (cancer or non-cancer) 
was assessed using a ClonalFrame based model (Méric et al. 2014; Sheppard et al. 
2013). A Fisher‘s exact test was used to determine the association score for each 
word, with the following null hypothesis: this word is present in all isolates equally. 
This association score was used to select hits which were then mapped back to the 
reference pan-genome to identify the corresponding genes. Those genes were then 
analysed individually to investigate their function. 
 
  
87 
 
 
Figure 5.1: Neighbour-joining tree based on whole genome sequence 
alignment of 196 strains from Europe used in the ClonalFrame GWAS 
method. 
Leaves are labelled according to cancer status (Cancer group = black circle, 
non-cancer group = white circle). 
 
 
5.1.3 Genome-wide association study based on bugwas 
An alternative GWAS method was used for the larger dataset available (including 
patient data) from a unique FineStructure large population (hpEurope). It was 
composed of 173 strains (Appendix E). Patient information associated with those 
strains and composition of the 3 pathology groups are summarised in Table 5.1.  
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Table 5.1: Composition of the GWAS groups used in the bugwas 
method. 
Pathology Group Precise Phenotype Number of strains 
Gastric cancer 
Cancer 11 
Gastric Cancer 36 
GIST 1 
Stomach fundus tumor 1 
Total 49 
Progressive towards cancer 
Intestinal Metaplasia and Atrophy 1 
Intestinal Metaplasia 2 
Metaplasia 19 
Atrophic Gastritis 14 
Control (with atrophic gastritis) 16 
Total 52 
Non atrophic gastritis 
Asymptomatic 6 
Control (without atrophic gastritis) 23 
Gastritis 40 
Normal 3 
Total 72 
 
The three groups were (i) Gastric cancer (GC), Progressive towards cancer (Prog) and 
Non atrophic gastritis (NAG). Only diagnosis information was used. For strains with 
more information available, full ethics were obtained by collaborators who collected 
the strains. 
A tree based on the alignment of these 173 strains was constructed with genes from 
the reference strain 26695 using FastTree v2.0 and annotated using iTOL v3 (Letunic 
and Bork 2016) (Figure 5.2).  
 
This GWAS method was conducted using a pipeline recently applied in another study 
by Koji Yahara (Suzuki et al. 2016). Two different methods based on the bugwas 
package (Earle et al. 2016) were used. The first was a k-mer-based method, in that 
aspect similar to the ClonalFrame approach (Sheppard et al. 2013), in which the 
genome sequence of each isolate was fragmented into unique overlapping 31-bp DNA 
‗words‘ that were used to identify genetic variations (2.3.6.2). This method was based 
on a pan-genome, built using Roary (with default parameters) after annotation by 
prokka (2.3.4.2). 
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Figure 5.2:   Neighbour-joining tree based on whole-genome sequence 
alignment of all 173 strains from hpEurope derived populations used in 
the bugwas method. 
Colour of the branches represents the population identified by FineStructure, 
and leaf labels represent the GWAS group in which the strain was classified 
based on the pathology of the patient. An online version is available at this 
adress : http://itol.embl.de/tree/811035619577551510828366#  
 
 
 
The second method was based on SNPs instead of k-mers (2.3.6.2). This method 
relied on a global alignment performed using ELS37 strain as a reference, a CagPAI 
positive GC strain. Only the SNPs belonging to a CDS were considered in the 
analysis, for consistency with the k-mer based method. It also had the advantages of 
being less sensitive to the high variable nature of the H. pylori genome, but does not 
pick up genes that are absent from the reference strain ELS37. Therefore, both 
methods were used in combination. 
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As GWAS requires a binary dataset, and the cancer isolates were spread into 3 groups 
(NAG, Prog and GC), two different datasets were used: (i) NAG vs rest and (ii) GC vs 
rest (Figure 5.3). 
 
 
Figure 5.3: Composition of the two GWAS binary datasets. 
 
 
Selection of hits for the bugwas method was made based on the odds ratio (20% 
difference was used as a cut-off) and p-value. The hits were then analysed 
individually to investigate their function and the effect of the genomic variations 
identified. 
5.1.4 Analysis of gene hits 
All the genes containing associated elements identified by the bugwas method were 
investigated individually using BioEdit. Effects on the amino-acid sequence were also 
checked using two distinct alignments: a global alignment based on a cancer strain 
(ELS37), obtained from the SNP GWAS, and a gene-by-gene alignment obtained 
from BIGSdb, using the sequences from ELS37 as reference. These alignments were 
used to differentiate synonymous and non-synonymous hits, using the ExPASy 
translate webtool (http://web.expasy.org/translate/). Non-synonymous hits were 
further studied by creation of figures showing the proportion of amino-acids in each 
position according to the GWAS group of each strain, using WebLogo (Crooks et al. 
2004). 
5.1.5 Non-synonymous enrichment 
The ratio of non-synonymous SNPs to the total number of SNPs was calculated in the 
GWAS hits from the bugwas method. The same ratio was calculated in the 7 MLST 
genes: atpA, efp, mutY, ppa, trpC, ureI, yphC. This calculation was made using the 
―highlight variable sites‖ function in MEGA7 and was limited to SNPs present in at 
least 15% of the strains.  
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5.1.6 Risk score 
The most significant GWAS hits from the bugwas method (level of significance of 10
-
6
) were used for calculation of a rudimentary risk score. First, the correlation between 
the presence of a risk or safe genotype A and the presence of another risk or safe 
genotype B was verified for each isolate pair, using a Pearson‘s correlation test. A 
Pearson‘s correlation of more than 0.9 with a p-value < 0.05 was used to define 
correlated genes. For each genotype, a genotype score (𝑔𝑠) was determined as such: 
(i) For accessory variation: 1 if the gene is present, -1 if the gene is absent; (ii) For 
allelic variation: 1 if the risk genotype is present, -1 if the safe genotype is present, 0 
if another genotype is present. The weight of correlated genotypes was then brought 
to the weight of one genotype for calculation of the risk score (using average 
genotype score). The risk score was calculated using this formula: 
 
𝑅𝑖𝑠𝑘 𝑠𝑐𝑜𝑟𝑒 =   𝑔𝑠 ×−𝑙𝑜𝑔
10(𝑝𝑣𝑎𝑙𝑢𝑒)
𝑓𝑜𝑟  𝑒𝑎𝑐 𝑕  𝑔𝑒𝑛𝑜𝑡𝑦𝑝𝑒  
 
 
5.2 Results 
5.2.1 GWAS based on Clonal Frame 
GWAS based on ClonalFrame showed an abnormally high number of hits. 1724 
genes contained hits with a p-value below 0.05, out of the 2240 genes of the pan-
genome (Figure 5.4). 
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Figure 5.4: Results of the ClonalFrame based GWAS on two datasets of 
30 and 31 pairs of strains highlighting differences between cancer-
related and non-cancer-related strains. 
Portion of the pan-genome between positions 0 to 1.485 correspond to the 
reference genome 26695. The remaining section corresponds to genes from 
the pan-genome which did not match genes from 26695. Blue bands indicate 
positions of genes with an association score over 24. Inner association score 
circle represent all the hits from the ClonalFrame based GWAS. Outer 
association score circle represents association scores restricted to over 24. 
Figure was built using R. 
 
Those hits were filtered by association score to reveal interesting genes. CagPAI 
genes were included in the 71 gene hits with association scores of more than 24 
(Appendix F). Of the 71 genes, 13 were hits in the Virulence Factors Database (Table 
5.2), among them two of the most important CagPAI genes: cagA and cagE. flgL was 
the highest association score recorded amongst genes referenced in the Virulence 
factors database. 
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Table 5.2: Hits with an association score over 24 matching virulence 
factors from the Virulence Factors database (VFDB, 2017). 
Gene Tag Average 
Association 
Score 
Hits in VFdB Functional Group 
HP0068 24 ureG Buffering of gastric acid 
HP0099 24 tlpA Motility and chemotaxis 
HP0295 26 flgL Motility and chemotaxis 
HP0529 24 virB6/cagW CagPAI and typeIV SS 
HP0544 24 virB4/cagE CagPAI and typeIV SS 
HP0547 24 cagA CagPAI and typeIV SS 
HP0685 24 fliP Motility and chemotaxis 
HP0867 24 lpxB LPS 
HP1031 24 fliM Motility and chemotaxis 
HP1119 24 flgK Motility and chemotaxis 
HP1177 24 sabB/hopO + sabA/hopP + hopZ 
+ babA/hopS + babB/hopT 
Outer membrane protein 
HP1243 24 babA/hopS + babB/hopT Outer membrane protein 
HP1582 24 pdxJ Motility and chemotaxis 
 
In addition to these 13 genes, 7 genes were also identified as being linked to functions 
related to virulence, based on their RAST annotations (Table 5.3).  
 
Table 5.3: Hits with an association score over 24 with gene functions 
linked to virulence 
Gene Tag Gene Name Average 
Association 
Score 
Reason of interest 
HP0289  25 Outer membrane protein 
HP0605 hefA 25 Outer membrane protein 
HP0610  24 Cytotoxin (VacA paralog) 
HP0920  26 Membrane protein 
HP0922  25 Cytotoxin (VacA paralog) 
HP1027 fur 24 Buffering of gastric acid 
HP1156 hopI 26 Outer membrane protein 
 
HP1156 (hopI), HP0289 and HP0605 (hefA) code for outer membrane proteins and 
HP0920 codes for a membrane protein. Two genes, HP0922 and HP0610 code for 
cytotoxins and were identified as VacA paralogs. HP1027 (fur) is known to be 
associated with the buffering of gastric acid. Assignment of functions to the genes 
identified with this method showed important links to motility and adhesion (outer 
membrane protein) (Figure 5.5). 
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Figure 5.5: Assignment of functions to genes identified by ClonalFrame 
based GWAS performed on 122 strains belonging to hpEurope derived 
sub-populations. 
 
Prevalence of the 71 genes with an association score over 24 in the complete dataset 
(combining the 2 replicates) highlighted two different types of genomic variations: i) 
accessory variations, with prevalence of the genes showing a difference between 
cancer and non-cancer groups of more than 0.1, and ii) allelic variations, with 
identical prevalence between cancer and non-cancer groups. Of our 71 genes, 5 show 
accessory variations (Figure 5.6).  
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Figure 5.6: Prevalence of top hit genes from ClonalFrame based GWAS 
presenting an accessory variation. 
 
  
95 
 
Of these genes, three (HP1243, HP0544 and HP0547) were previously identified as 
hits in the Virulence Factor db and code for proteins with functions of high 
importance in the CagPAI pathway: babA, cagA and cagE. Another gene from the 
CagPAI island also shows accessory variations: HP0529. The presence of these 4 
genes was higher in the cancer strains than in the non-cancer strains in this dataset. 
Interestingly and in contrast, the last gene, HP1116, showed higher presence in non-
cancer strains than in cancer strains. This gene codes for a hypothetical protein.  
5.2.2 GWAS based on bugwas 
The bugwas GWAS method used 4 different analyses involving two methods (k-mer 
or SNPs) on two datasets (GC vs rest or NAG vs rest) (2.3.6.2). In total, 642 hits (432 
SNPs and 210 k-mers) in 32 genes with a p-value ≤ 10-5 (Table 5.4), and 118 hits (64 
SNPs and 46 k-mers) in 12 genes with a p-value ≤ 10-6 (Figure 5.7, Table 5.4).  
 
Table 5.4: Summary of the hits obtained in 4 bugwas based GWAS 
performed on 173 strains from hpEurope derived sub-populations 
according to patient pathology. 
GWAS experiment 
Number of hits 
with p-value 
Number of hits 
with p-value 
≤10-5 ≤10-6 ≤10-5 ≤10-6 
GC vs others (k-mer) 166 39 20 6 
NAG vs others (k-mer) 44 15 10 2 
GC vs others (SNP) 237 33 4 3 
GC vs others (SNP) 195 31 4 2 
 
 
Amongst the 32 genes identified in our study, 20 were annotated with functions 
known to be associated with virulence of H. pylori, and 12 had unknown functions or 
functions not known to be linked to virulence (Figure 5.8). 
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Figure 5.7: Location of genetic elements associated with gastric cancer 
on ELS37 genome highlighted in 4 bugwas based GWAS performed on 
173 strains from hpEurope derived sub-populations according to patient 
pathology. 
GWAS comparing isolates from patients with (A) non-atrophic gastritis to 
those with gastric cancer and precancerous progression and (B) gastric 
cancer to those with non-atrophic gastritis and precancerous progression. 
Two GWAS tests were performed with bugwas software for each panel, one 
based on SNPs (upper panels) and the other based on k-mers (lower panels). 
Positions of the genomic elements are represented on the horizontal axis. Log 
10 of the p-value for each hit is recorded on the vertical axis. The blue line 
indicates a p-value ≤ 10-6.  
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Figure 5.8: Assignment of functions to genes recording hits with a p-
value ≤ 10-5 in at least one of the 4 GWAS performed on 173 strains 
from hpEurope derived sub-populations according to patient pathology. 
Bars shaded in black represent functions with a direct effect on virulence. 
Bars shaded in grey represent functions with an indirect effect on virulence. 
White bars represent genes with functions not known to be associated with 
virulence in H. pylori. 
 
 
Amongst the 32 genes presenting hits with a p-value ≤ 10-5, 6 genes recorded hits in 
two of the four GWAS tests: HP0102, HP0468, HP0531 (cag11), HP0532 (cag12), 
HP0541 (cag20), HP0544 (cagE/cag23), HP1177 (hopQ), and HP1243 (babA). 
Distribution of gene frequency for these 32 genes showed that 22 genes belonged to 
the core genome (>90%) and 10 were accessory genes (≤ 90%) (Figure 5.9). Two 
major types of genomic variations were identified in the hits highlighted by GWAS: 
accessory variations and allelic variations.  
 
 
Figure 5.9: Prevalence of the genes recording hits with a p-value ≤ 10-5 in 
at least one of the 4 GWAS performed on 173 strains from hpEurope 
derived sub-populations according to patient pathology. 
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5.2.2.1 Accessory variations in top gene hits 
An accessory variation is a difference in the presence of a particular gene between the 
GWAS groups, with prevalence of the gene increasing with the probability of the 
isolate being obtained from a patient with gastric cancer. Prevalence of all the 
accessory genes except one (HP0555) was not equally distributed amongst our 
GWAS groups, showing that presence of all remaining 9 genes was higher in the GC 
group than in the NAG group, with an intermediate prevalence in the Prog group 
(Figure 5.10).  
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Figure 5.10: Distribution of the gene prevalence for the genes recording 
hits in at least one of the 4 bugwas based GWAS performed on 173 
strains from hpEurope derived sub-populations according to patient 
pathology. 
 
The 9 genes with accessory variations were all part of the cagPAI island or coded for 
a gene associated with Cag function (HP1243/babA). Four of these genes (HP0531, 
HP0532, HP0541 and HP1243) had a p-value ≤ 10-6. HP1243 was also the only gene 
with a p-value ≤ 10-6 in both of our SNP-based GWAS tests (GC vs rest and NAG vs 
rest). 
5.2.2.2 Allelic variations in top gene hits 
There were 22 gene hits within the core genome with a p-value ≤ 10-5. In addition, 
HP0555, which was part of the accessory genome, also had allelic variations: 
presence of the gene did not vary, but instead two or more versions of the gene were 
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present in different proportions in each of the GWAS groups, having an effect on the 
population biology. 
The 12 genes with a p-value ≤ 10-6 were further investigated, individually, using the 
genomic alignments obtained by GWAS. Two of those genes (HP0906 and HP1004) 
did not show clear alignments either on data extracted from the GWAS results and on 
gene-by-gene alignments produced using BIGSdb. These alignments issues might be 
responsible for the hits by provoking false positive results. Therefore, they were 
excluded from all further analyses. Analysis of the remaining 10 genes revealed a 
total of 12 genomic variations (Table 5.5), with 4 accessory variations (described 
above in section 5.2.2.1) and 8 allelic variations described below. When more than 
one SNP was identified in a unique gene, they were paired. Out of the 8 sequence 
variations, 6 were non-synonymous, or had non-synonymous effects when associated 
with another SNP found in the same codon. The 2 synonymous variations found were 
in genes where a non-synonymous variation was also identified. 
The ratio of non-synonymous SNPs to the total SNPs in the GWAS hits was 
significantly (p-value of 0.03 with t-student test) higher than the ratio in MLST genes 
(Figure 5.11). 
M
L
S
T
 G
e
n
e
s
G
W
A
S
 H
it
s
 G
e
n
e
s
0 .0
0 .2
0 .4
0 .6
0 .8
p -v a lu e  <  0 .0 5
 
Figure 5.11: Ratio of non-synonymous SNPs to the total SNPs in genes 
recording hits with a p-value ≤ 10-6 in at least one of the 4 bugwas based 
GWAS and in MLST genes. 
Calculation was based on SNPs occurring in at least 15% of the strains. 
 
  
 
Table 5.5: Cancer risk genotypes identified in 4 bugwas based GWAS performed on 173 strains from hpEurope derived sub-
populations according to patient pathology. 
Risk and safe genotypes are over-represented among isolates from patients presenting gastric cancer and non-atrophic gastritis 
respectively, with p-value corresponding to the minimum in each gene (p-value ≤ 10-6). 
Gene name
1 
p-value 
(min) 
Risk 
genotype 
Position
2 
Safe 
genotype 
Frequency
3
  
Effect on Amino-acid 
sequence
4 
Function 
HP1055 [981621-
982565] (-) 
1.4.10
-9 A 798 C 0.469/0.125 
S, associated with  G to A 
substitution at position 797: 
NS with T in safe, A in risk 
Outer membrane protein (Alm, 
2000) 
HP0797 [506543-
507325] (+) 
2.24.10
-8 C + T 
325 and 
334 
T + G 0.592/0.181 NS: L/S in safe , F/A in risk 
Neuraminyllactose-binding 
hemagglutinin (HpaA) 
(Carlsohn, 2006) 
HP1243,babA1 
[1314192-1316405] (-) 
3.99.10
-8 presence all gene absence 0.94/0.51   
BabA (outer membrane protein) 
(Gerhard, 1999) 
HP0747 [317158-
317757] (+) 
1.69.10
-7 GGAA 934 to 937 
AAAA/ 
GGAG 
0.531/0.264 NS: KA in safe, GT in risk 
tRNA (guanine-N(7)-)-
methyltransferase  
HP0709 [598549-
599451] (-) 
2.13.10
-7 A 145 G 0.327/0.153 NS: D in safe, N in risk 
Adenosyl-Chloride synthase  
  A 159 G 0.959/0.792 S 
* HP0532,cag12 
[817677-818519] (+) 
3.62.10
-7 presence all gene absence 0.92/0.61   CagT protein (Censini, 1996) 
HP0468 [925539 - 
927026] (+) 
4.59.10
-7 CGCC 705 to 708 
CACG/ 
TGCG 
0.694/0.514 NS: T in safe, A in risk 
Unknown 
  A 729 G 0.796/0.5 S 
* HP0531,cag11 
[816985-817641] (+) 
5.4.10
-7 presence all gene absence 0.92/0.61   CagU protein (Censini, 1996) 
* HP0541,cag20 
[825334-826446] (-) 
6.6.10
-7 presence all gene absence 0.92/0.61   CagH protein (Censini, 1996) 
1
Position in ELS37 genome [ ], + and – strand is denoted ( ).  
2
Position in gene. 
3
Frequency GC strains/ NAG strains.  
4
The effect on the amino acid sequence is indicated as synonymous (S) and non-synonymous (NS). 
*Correlated genes. 
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Three hits were found in the k-mer GWAS GC vs rest with p-value ≤ 10-6 in HP0468. 
Two variations in the genome were identified in this sequence, one of which caused 
an amino-acid change (Figure 5.12).  
 
 
Figure 5.12:  Allelic variations observed for the two hits found in 
HP0468 and effects on amino-acid sequence. 
A. allelic variations identified based on the k-mer GWAS GC vs rest results. 
Non-synonymous changes are boxed in red, and synonymous changes are 
boxed underlined in red. B. variations in the amino-acid sequence 
correspondent to non-synonymous change in the nucleic acid sequence. 
 
Based on this analysis, the presence of the sequence CGCC in positions 705 to 708 
(three last nucleotides coding for an alanine) was considered a marker for strains at 
risk of causing gastric cancer (GC), whereas sequences CACG or TGCG (three last 
nucleotides coding for a threonine) was considered a marker for strains which are not 
likely to cause GC. Similarly, the presence of an A in position 729 was associated 
with GC-causing strains and a G at the same position was a marker for strains less 
likely to cause GC. 
 
HP0555 was not part of the core genome and did not show a clear presence/absence 
pattern amongst the GWAS groups like the other accessory genes, despite its 
functional association with the CagPAI. Ten hits were found in the k-mer GWAS GC 
vs rest with p-value ≤ 10-6 in HP0555, and all the associated allele variations were 
non-synonymous (Figure 5.13). Like the prevalence pattern for this gene, there was 
no clear selection for one of the alleles in associated cancer groups. Instead, 
associations were observed in the strains belonging to the Prog group, and the two 
other groups showed a similar distribution of alleles. Therefore, a specific allele 
marker for the risk or the safety of the strains could not be identified. 
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Figure 5.13: Allelic variations observed for the hits found in HP0555 and 
effects on amino-acid sequence. 
Allelic variations were identified based on the k-mer GWAS GC vs rest 
results. Non-synonymous changes are boxed in red. 
 
Four hits were found in the k-mer GWAS GC vs rest with p-value ≤ 10-6 in HP0709. 
Two variations in the genome were identified in this sequence, one of which caused 
an amino-acid change (Figure 5.14).  
 
 
Figure 5.14: Allelic variations observed for the two hits found in HP0709 
and effects on amino-acid sequence. 
Allelic variations are identified based on the k-mer GWAS GC vs rest 
results. Non-synonymous changes are boxed in red, and synonymous 
changes are underlined in red.  
 
  
103 
 
Based on this analysis, the presence of the base pair A in positions 145 (coding for 
asparagine) was considered a risk marker for strains causing GC, whereas a G (coding 
for aspartic acid) was considered a marker for strains which were not at risk of 
causing GC. Similarly, the presence of an A in position 159 was associated with GC-
causing strains and a G at the same position was a marker for strains not at risk of 
causing GC. 
 
Twelve hits were found in the k-mer GWAS NAG vs rest with p-value ≤ 10-6 in 
HP0747. Only 1 variation in the genome was identified in this sequence and it caused 
an amino-acid change (Figure 5.15).  
 
 
Figure 5.15: Allelic variations observed for the hits found in HP0747 and 
effects on amino-acid sequence. 
A. Allelic variations identified based on the k-mer GWAS NAG vs rest 
results. Non-synonymous changes are boxed in red. B. variations in the 
amino-acid sequence correspondent to non-synonymous change in the 
nucleic acid sequence. 
 
Based on this analysis, the presence of the sequence GGAA in positions 934 to 937 
(coding for a glycine followed by a threonine) was considered a marker for strains at 
risk of causing GC, whereas sequences AAAA or GGAG (coding for a lysine 
followed by a threonine or a glycine followed by an alanine respectively) were 
considered a marker for strains which are unlikely to cause GC.  
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Only one hit was found in the SNP GWAS GC vs rest with p-value ≤ 10-6 in HP0797, 
which identified a variation in the genome provoking an amino-acid change (Figure 
5.16).  
 
Figure 5.16: Allelic variations observed for the two hits found in HP0797 
and effects on amino-acid sequence. 
Allelic variations are identified based on the SNP GWAS GC vs rest results. 
Non-synonymous changes with a p-value < 10
-6
 are boxed in red. Non-
synonymous changes with a p-value >10
-6 
are underlined in red. 
 
Another SNP was visible on the same sequence and was found to pair with one found 
in position 325. Although it was not originally selected as its p-value was over 10
-6
, it 
remains interesting as it is also a non-synonymous SNP. This second SNP was 
observed in position 334. Based on this analysis, the presence of a C in position 325 
and a T in position 334 (coding for a phenylalanine and an alanine) were considered 
markers for strains at risk of causing GC, whereas a T and a G (coding for a leucine 
and a serine) were considered a marker for strains which are unlikely to cause GC.  
 
Seventeen hits were found in the k-mer GWAS GC vs rest with p-value ≤ 10-6 in 
HP1055, which identified a variation in the genome. This hit was the one with the 
strongest p-value (1.4x10
-9
), but it was synonymous (Figure 5.17). However, when the 
SNP was identified in gastric cancer alongside another, more rarely found SNP, 
positioned 2bp before the first one, it had non-synonymous consequences. This was 
only observed on a small number of strains. 
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Based on this analysis, the presence of an A in position 798 (coding for an alanine) 
was considered a marker for strains at risk of causing GC, whereas a C (coding for a 
threonine when associated with a G in position 796) was considered a marker for 
strains which were unlikely to cause GC.  
 
 
Figure 5.17: Allelic variations observed for the two hits found in HP1055 
and effects on amino-acid sequence. 
Allelic variations were identified based on the SNP GWAS GC vs rest 
results. Synonymous changes with a p-value < 10
-6
 are boxed in red. SNPs 
causing the synonymous change to become non-synonymous are underlined. 
 
5.2.2.3 Risk score 
Based on analysis of accessory and allelic variations in the hits with p-value ≤ 10-6, a 
list of 11 risk genotypes was assembled (Table 5.5). The 3 cagPAI genes (HP0531, 
HP0532 and HP0541) were correlated, based on Pearson‘s correlation analysis. No 
other genes showed correlation. These 11 risk genotypes were used to build a risk 
score (5.1.6). Distribution of risk scores in our dataset was significantly (ANOVA p-
value <0.0001 between the gastric cancer group and each of the other groups) 
associated with the pathology (Figure 5.18).  
 
Strains isolated from patients with gastric cancer all showed risk scores over -25, 
whereas 20% of patients showing only non-atrophic gastritis symptoms had a risk 
score below this limit.  
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Figure 5.18: Assignment of risk scores to 173 strains from hpEurope 
derived sub-populations according to patient pathology. 
Each dot corresponds to the risk score associated with a single strain. This 
risk score was calculated based on the presence of risk or safe genotypes for 
each of the 9 genes considered (Table 5.5).  
 
 
5.3 Discussion 
The GWAS method, applied to H. pylori, can identify genes associated with complex 
phenotypes such as gastric cancer. The choice of the GWAS model must be 
considered with care. Two methods were used in this Chapter, based on two different 
softwares, ClonalFrame and bugwas. Gene functions identified in this chapter were in 
large part linked to host-bacteria interactions. The major function identified, already 
highly associated to gastric cancer, was the injection of CagA through the type IV 
secretion system. Identification of cagPAI genes with both methods supports the 
validity of the GWAS. Functions linked to colonisation, such as motility, buffering of 
gastric acid and adherence were also identified, alongside vacA and vacA paralogs, 
were also highlighted by our results. HP0068, also known as ureG, was a hit in both 
methods, highlighting the important role of urease in pathogenicity. Two genes 
coding for outer membrane proteins were identified in both GWAS: HP1177 (hopQ) 
and HP1243 (babA). Membrane proteins are associated with functions linked to 
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host/bacteria or environment/bacteria interactions, and therefore are likely to be 
linked with pathogenicity. A hypothetical protein, HP0468, was also found in both 
methods. This is the only gene highlighted by both GWAS methods used with 
unknown function. Despite the lack of knowledge about the function of this gene, it is 
likely to have a role in the development of gastric cancer, and therefore should be 
investigated further. 
 
ClonalFrame based methods, although well-adapted for other bacteria species such as 
Campylobacter, was not optimal for highly recombinogenic bacteria such as H. 
pylori. The ClonalFrame based method used in our chapter showed a high number of 
hits, forming a confusing background signal. This is likely to be due to the versatile 
nature of the H. pylori genome and its ability to recombine. The structure in H. pylori 
populations was probably interfering with the results and showing false positive hits. 
More precise data on pathology were also made available to us after completion of 
this method, which would have changed the assignment of a couple of strains from 
this dataset. Despite these limitations, 71 genes with high association scores were 
highlighted, showing both accessory and allelic variations. Most accessory variations 
were CagPAI related, with genes more present in gastric cancer strains than in non 
cancer strains. This group of genes have been previously described as being present in 
a large majority of cancer strains (Parsonnet et al. 1997; López-Vidal et al. 2008). 
Considering the high variability of H. pylori genome, a pattern of presence or absence 
of a gene is reasonably easier to identify, even without the high-speed genomics 
techniques that are now at our disposal. Therefore it is not surprising that the research 
on this group of genes is more advanced than for genes presenting allelic variations. 
However, one of the genes showing accessory variations (HP1116) was more present 
in non cancer strains compared to cancer strains. This suggests that this gene of 
unknown function could have a protective effect against development of cancerous 
pathologies due to H. pylori infection.  
 
Bugwas-based GWAS produced more encouraging results. The environmental and 
host factors did not mask the signal in the GWAS, and genes related to virulence, as 
well as genes which were not previously associated with virulence, were identified 
with associations to healthy or diseased phenotypes. Again, both accessory and allelic 
variations were identified. When two (or more) allelic variations were identified in a 
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unique gene, changes were almost systematically found in the same strains, indicating 
that either the strains derived from two distinct ancestors, one with the changes and 
one without, or that selection pressure selected for those specific traits. Once again, 
genes identified comprised genes belonging to the CagPAI pathway. On top of these, 
genes coding for membrane proteins were identified (HP0555, HP1055). HP1055 was 
shown to be essential in transposon mutagenesis experiments (N. R. Salama, 
Shepherd, and Falkow 2004), but its exact function remains unknown. HP0797, also 
known as hpaA, was originally described as a sialic acid binding protein involved in 
adhesion (D. G. Evans et al. 1993). However it is now thought to be a lipoprotein (A. 
C. Jones et al. 1997; O‘Toole et al. 1995). A recent study also highlighted this gene as 
being essential for in vivo colonisation of the mouse stomach (Carlsohn et al. 2006). 
The product of this gene, HpaA, shows strong immunogenic properties (P. Sutton et 
al. 2007). It has been considered as a target for vaccines development (Tobias et al. 
2017; R. Zhang et al. 2016). Two enzyme-coding genes were also highlighted by the 
bugwas GWAS. HP0709 codes for an enzyme, S-adenosyl-I-methionine hydroxide 
adenosyltransferase. Conflicting annotations were found regarding this gene and its 
product. This enzyme could be involved in either methylation of DNA and proteins, 
or in the synthesis of the branched amino acids valine, leucine and isoleucine (Deng 
and O‘Hagan 2008). HP0747, also known as trmB, codes for a predicted S-
adenosylmethionine-dependent methyltransferase regulated by HP1021 (Pflock et al. 
2007). It is possibly involved in the regulation of acetone metabolism. It was also 
identified in a previous study as a gene with a  large number of radical substitutions in 
fast-evolving regions (Zheng, Roberts, and Kasif 2004). Finally, HP0468 codes for a 
hypothetical protein, poorly conserved outside the Helicobacter genus. A study on 
chemolithoautotrophically enhanced growth of H. pylori identified this gene as being 
upregulated by molecular hydrogen (Kuhns et al. 2016), but no exact function was 
described. 
 
It is important to note that the GWAS presented in this chapter have limitations. Some 
are due to the nature of the bacteria, and can be addressed by a careful choice of 
model. A new phylogenetic approach to GWAS named treeWAS (Collins and Didelot 
2018) has been developed recently, which presents good specificity and power, and 
could limit the potential false-positive hits observed in the two methods used in this 
thesis. 
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Another limitation of this study was the collection of strains used. Due to the need for 
a high number of strains and the use of collections from different origins, it was not 
possible to control for possible confounding effects linked to other gastric cancer risk 
factors (alcohol consumption, smoking, age of the patient, genetic polymorphisms in 
patient genes, ratio male/female…), because information for each factor was not 
available for all strains used in our study. Our results can be impacted by this, and 
future studies should take these effects into account. Moreover, both cancer and non-
cancer groups had some internal variability across pathologies included (Appendix E). 
Strains came from diverse collections across the world, carried out by different clinic 
or research groups using different staging systems to record lesions. Another potential 
bias is the fact that only one strain was included in our dataset for each patient. 
Stomachs can be colonised by multiple strains (Kibria et al. 2015; J. W. Kim et al. 
2004; Ben Mansour et al. 2016). Some of the strains could have been linked to gastric 
cancer, when they were actually not the strains driving the carcinogenesis. This would 
also be a limitation for clinical application. Sequencing one strain from a single 
colony would not be sufficient to make sure that the strain is safe and that the patient 
should not be treated. More than one strain would have to be sequenced. 
 
Moreover, as gastric cancer occurs after a long-term infection, some of the non-cancer 
strains could have subsequently evolved into cancer strains if left longer in their host, 
and causative strains could have disappeared at the time of isolation, or evolved into 
the strains isolated. This variability can limit the power of the GWAS method. 
Moreover, the genes identified as associated with gastric cancer can, indeed drive the 
disease, but can also be the result of the changes occurring in the environment, such 
as disruption of the epithelium and reduction of acidity. The genome of H. pylori 
strains could have evolved alongside those changes in order to adapt and survive in 
this changed environment. GWAS studies on complex phenomenon such as gastric 
cancer, based on strains from healthy or diseased patients, cannot discriminate 
between genomic traits that caused the cancer and genomic traits that were provoked 
by the environmental changes in cancerous regions. 
 
To address this issue, a prospective study would have been preferable, by collecting 
strains from healthy patients and following the evolution of their symptoms. This was 
not possible here but with suitable ethical and clinical support would be a study for 
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the future. Such a study on other mammalian models might be a solution. For 
instance, long-term infection of mice or primates with strains isolated from healthy 
patients and analysis of the consequences on the stomach to assess the in vivo 
virulence of the strain and perform a GWAS. However, not all human strains are easy 
to use for assays in different hosts. Furthermore, another source of variability due to 
interactions of the bacteria with this new host would be introduced (see Chapter 4). 
 
Despite these limitations, GWAS study in H. pylori represents an important advance 
in the way H. pylori is studied in relation to gastric disease. A large diversity is a 
necessity in nature, and the definition of health is not the absence of disease, but ―a 
state of complete physical, mental and social well-being‖. By systematically clearing 
H. pylori from patients, even in the cases where it does not have negative impact on 
its host, this diversity is reduced, and it frees the niche to other pathogens or disorders 
to develop. Moreover, research uncovered positive impacts of H. pylori colonisation. 
A robust GWAS, and a risk score such as the one built in this chapter, could be a 
foundation for a sequencing-based detection method used in clinics to target high-
cancer risk strains and limit the pressure towards global increase of antibiotic 
resistance. 
 
In conclusion, we successfully applied the GWAS method to H. pylori cancer and 
non-cancer strains, by comparing two different methods and using a large dataset with 
a control on the population structure. This study identified genomic traits in 9 genes 
that correlate with gastric cancer. These traits were used to build a risk score that 
could be the first stone towards a new treatment strategy targeting only the strains at 
risk while leaving the others to keep the microbiota balance in place and reduce the 
rise of antibiotic resistance. 
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6 Phenotypic characteristics of Helicobacter pylori European strains 
Helicobacter pylori is a Gram-negative bacteria that inhabits a unique and harsh 
environment, namely the human stomach (B. Marshall and Warren 1984). This 
bacterium is well adapted to such a highly acidic environment, through expression of 
factors such as enhanced motility and secretion of urease. The presence of H. pylori 
induces inflammation in the host stomach, which may progress to more serious health 
complications (e.g. ulcer, mucosa-associated lymphoid tissue (MALT) lymphoma or 
gastric cancer). Indeed, H. pylori is associated with ulcer formation (Chamberlain and 
Peura 1990; Oderda et al. 1990), and increases the risk of gastric cancer from 2 to 6 
times compared to those without H. pylori infection (Parsonnet et al. 1997; 
Wroblewski and Peek 2016; Ferlay et al. 2015). The exact mechanisms linking 
presence of H. pylori in the stomach with gastric cancer are still partially unknown, 
and a more precise view of what links H. pylori colonisation and carcinogenesis is 
essential to be able to treat and prevent cancer development. The genomic variability 
in H. pylori is one of the highest amongst bacteria, due to the ability of this micro-
organism to recombine (Go et al. 1996). Phenotypic variability has also been observed 
between some specific strains of H. pylori.  
Motility is essential for H. pylori pathogenesis in the human host (Eaton et al. 1996; 
O′Toole, Lane, and Porwollik 2000). Most of the genes involved in motility are core 
genes, present in all strains of H. pylori. However, allele variations in these genes are 
common. In addition, a number of genes associated with motility were highlighted in 
the genomic analyses carried out in previous chapters: 
 Highly statistically significant gene hits in Genome Wide Association Studies 
(GWAS) comparing gastric cancer strains with non-cancer strains (Chapter 5) 
(HP0295, HP0685, HP1031 and HP1119, respectively known as flgL, fliP, 
fliM and flgK) 
 Identification of a gene showing Phase Variation (PV) in a MALT Lymphoma 
strain re-isolated from mice (Chapter 4) (HP0685, also known as fliP)  
 Identification of a gene showing a SNP during long-term colonisation in mice 
(Chapter 4) (HP1041, also known as flhA) 
When infecting a host, H. pylori causes inflammation through the mobilisation of 
cells of innate and adaptive immunity (D. J. Evans et al. 1995; Satin et al. 2000; 
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Unemo et al. 2005). Important differences exist between those inflammatory 
pathways. Some research suggests that the type of strain is one of the key variables. 
There is already some evidence of a difference in IL-8 production in response to 
strains possessing the Cag Pathogenicity Island (CagPAI positive) and strains without 
this island (CagPAI negative) (Fischer et al. 2001). NF-κB activation is one of the 
pathways linking CagPAI with IL8 production (Brandt et al. 2005). The role of TLR-
2 and TLR-5 has also been studied and linked to both cagPAI dependant and 
independent signalling (Kumar Pachathundikandi et al. 2011). A complete CagPAI 
island seems to be needed to induce IL-8 production in AGS cells (Nilsson et al. 
2003). The sequence variability observed in cagPAI genes, segregating between East 
Asian-type and Western-type, is also linked to the production of IL-8, with the East 
Asian-type being more virulent (Yuan et al. 2017). In brief, there is a wide variety of 
pathways and actors involved in the CagPAI dependant induction of IL-8. Identifying 
the bacterial genes linked to this IL-8 induction in different types of cells might help 
bringing light on some of these pathways. A large number of genes from the CagPAI 
island, alongside genes with functions associated with CagA secretion were identified 
in GWAS comparing gastric cancer strains with non-cancer strain in Chapter 5. This 
chapter will focus on two functions of H. pylori which were highlighted in the 
previous chapters: i) motility and ii) induction of an immune response in epithelial 
and inflammatory cells. Although motility of H. pylori and inflammation following 
infection has been studied, as described in the previous paragraphs, questions remain 
about the genomic basis explaining the variability of phenotypes between different 
strains. 
Motility will be studied in 56 strains of H. pylori, all isolated in Europe from defined 
patients groups (including gastritis, gastric cancer, MALT lymphoma and ulcer). 
Differences in motility linked to the pathology will be investigated. The genomes of 
these strains will also be studied using whole-genome-based methods to identify a 
genetic basis that could explain phenotypic differences. 
Differences in inflammation triggered by H. pylori strains will also be studied in a 
subset of 15 strains. Two types of cells (epithelial and macrophages) will be infected 
with strains of H. pylori to confirm the importance of CagPAI in generating early 
inflammatory responses, and compare CagPAI positive strains isolated from patients 
with different diseases. Again, genomic analysis will be performed to highlight genes 
that could be involved in the possibility of differential immune responses. 
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Three specific aims will be addressed in this chapter: 
 Motility varies according to the pathology of the patient from which the strain 
was isolated, 
 Immune response is triggered differently according to the pathology of the 
patient from which the strains was isolated, 
 Some genes covary with phenotypic differences observed among strains. 
 
6.1 Materials and Methods 
6.1.1 Dataset 
Thanks to a global effort in collecting samples during endoscopies and isolating 
clinical strains of H. pylori, there is a large collection of strains available to be studied 
in the laboratory. Fifty-seven strains of Helicobacter pylori isolated from European 
patients were used in this study (kind gifts from Dr Alain Burette, Prof Francis 
Megraud and Dr Sinead Smith). These samples come from a wide range of patient 
clinical outcomes (Appendix C):  
 18 strains were isolated from patients with normal mucosa or asymptomatic 
gastritis with no intestinal metaplasia,  
 18 strains were isolated from patients suffering from gastric cancer or 
gastrointestinal stromal tumor, 
 13 strains were isolated from patients suffering from MALT Lymphoma, 
 8 strains were isolated from patients suffering from ulcer.  
6.1.2 DNA extraction and sequencing 
Whole genome sequences for 41 of these strains were already available. The average 
genome size for these strains was 1614846.4 bp and GC content was 39.03%, inside 
the normal range for this species (1.3.3.1). Three sequences were available but failed 
quality control, so they were re-sequenced along with the 13 newly sequenced strains. 
DNA was extracted and sequenced as described in 2.1.6. The average genome size for 
these newly sequenced strains was 1623319.1 bp and GC content was 38.95%. All 
available and newly sequenced strains were entered into BIGSdb to allow genomic 
analyses. 
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6.1.3 Enumeration of H. pylori 
A subset of 10 H. pylori strains (from the 57) were chosen based on the patient groups 
above and their ability to grow reproducibly. These were used in an enumeration 
assay (Table 6.1). Five isolates were cancer strains and 5 were gastritis or control 
strains. Those strains were grown on CBA plates in micro-aerophilic conditions as 
described in 2.2.1. Once sufficient growth was observed on plates, the colonies were 
resuspended into BB media and cultured for 20 to 24 hours at 37°C in an incubator as 
described in 2.2.2. Enumeration was then performed following the protocol described 
in 2.2.3, using 3 different dilutions spread in triplicate. 
 
Table 6.1: Summary of the characteristics of the 10 H. pylori strains used 
for enumaration. 
CagPAI status is defined as positive when more than 90% of the CagPAI 
genes were present 
Strain Name Pathology Cag PAI status Geographic 
provenance 
3697 gastritis Negative France 
3802 gastritis Negative France 
29373 control Negative Belgium 
3699 gastritis Positive France 
3824 gastritis Positive France 
GC23 Gastric cancer Positive France 
GC54 Gastric cancer Positive France 
GC65 Gastric cancer Positive France 
30950 Gastric cancer Positive Belgium 
38185 Gastric cancer Positive Belgium 
6.1.4 Motility of H. pylori 
Fifty-six H. pylori strains (Table 6.2) were grown on CBA plates as described in 
2.2.1. 
 
Once sufficient growth was observed on plates, the colonies were resuspended into 
BB media and cultured in liquid media for 20 to 24 hours at 37°C in an incubator 
(2.2.2). A motility assay was then performed as described in section 2.2.5 with 
normalised cultures aliquoted onto motility agar plates. The motility was measured in 
triplicate wells at least twice for each strain and the diameter of growth was compared 
to the positive control (strain B24) in order to minimize experimental bias due to 
differences in growth (C.-Y. Kao, Sheu, and Wu 2014; C.-Y. Kao et al. 2012). 
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Table 6.2: List of the 56 H. pylori strains used for a motility assay and 
pathology associated. 
Strain Name Pathology Strain Name Pathology 
29009 control 31181 control 
33375 control 3735 gastritis 
SSR2 mild chronic gastritis SSR5 moderate chronic gastritis 
SSR13 moderate chronic gastritis 3755 gastritis 
3770 gastritis 3802 gastritis 
3824 gastritis 3754 gastritis 
3745  gastritis 3697 gastritis 
3699 gastritis 30908 normal 
31235 normal 27935 gastric cancer 
28861 gastric cancer 34320 gastric cancer 
GC11 gastric cancer GC23 gastric cancer 
GC26 gastric cancer GC27 gastric cancer 
GC31 gastrointestinal stromal 
tumor 
GC34 gastric cancer 
GC54 gastric cancer GC65 gastric cancer 
GC30 gastric cancer GC69 gastric cancer 
21580 gastric cancer 30950 gastric cancer 
38185 gastric cancer 19027 gastric cancer 
GC62 gastric cancer B23 MALT lymphoma 
B24 MALT lymphoma B25 MALT lymphoma 
B26 MALT lymphoma B27 MALT lymphoma 
B29 MALT lymphoma B30 MALT lymphoma 
B31 MALT lymphoma B37 MALT lymphoma 
B40 MALT lymphoma B41 MALT lymphoma 
B44 MALT lymphoma B47 MALT lymphoma 
3843 Ulcer ANT170 Ulcer 
BON254 Ulcer CHA185 Ulcer 
GRA185 Ulcer PHI092 Ulcer 
3738 Ulcer 3774 Ulcer 
6.1.5 Infection of AGS and THP-1 cells with H. pylori 
Fifteen strains of H. pylori were used in two independent infection experiments using 
AGS and THP-1 cells (Figure 6.1).  
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Figure 6.1: Protocol used for infection of AGS or THP-1 cells with H. 
pylori strains. 
AGS and THP-1 cells were grown in RPMI media supplemented with L-
glutamine and 10% Foetal bovine serum (FBS) as described in 2.1.7 and 
2.1.8. In parallel, H. pylori strains were grown on blood agar plates until 
sufficient growth was observed (2.2.1). AGS and THP-1 cells were seeded in 
24 well plates at 50x10
3
 and 100x10
3
 cell/mL respectively (2.2.9). THP-1 
cells were differentiated into macrophages, and both AGS and differentiated 
THP-1 cells were incubated for 24 hours at 37°C (2.2.10). In parallel, the H. 
pylori strains were cultured in liquid and diluted to an OD of 0.1 (2.2.2). 
Cultures were induced with PMA as positive control and DMSO as negative 
control (2.2.10). Each sample was done in triplicate wells. Supernatants were 
collected after 24 hours, centrifuged at 4°C at maximum speed for 10 
minutes then stored at -20°C until analysed. 
 
Five of the strains used in this experiment were from patients with gastric cancer, and 
10 were from patients with gastritis. CagPAI status is defined as positive when more 
than 90% of the CagPAI genes were present. Amongst the gastritis strains, 5 were 
cagPAI positive and 5 were cagPAI negative. All the gastric cancer strains were 
cagPAI positive (Table 6.3). For each strain, infections were repeated in triplicate, 
during at least two independent experiments. 
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Table 6.3: Summary of the characteristics of the 15 H. pylori strains used 
for infection of AGS and THP-1 cells. 
CagPAI status is defined as positive when more than 90% of the CagPAI 
genes were present 
Strain Name Pathology Cag PAI status Geographic 
provenance 
3697 gastritis Negative France 
3745 gastritis Negative France 
3802 gastritis Negative France 
29373 control Negative Belgium 
31235 control Negative Belgium 
3699 gastritis Positive France 
3824 gastritis Positive France 
29009 control Positive Belgium 
30908 control Positive Belgium 
31181 control Positive Belgium 
GC23 Gastric cancer Positive France 
GC54 Gastric cancer Positive France 
GC65 Gastric cancer Positive France 
30950 Gastric cancer Positive Belgium 
38185 Gastric cancer Positive Belgium 
 
6.1.5.1 Human Inflammation Antibody Array 
Detection of 40 human proteins was carried out on 4 samples obtained from infection 
experiments. Two samples were obtained from infection of THP-1 cells with two 
strains and two from infection of AGS cells with the same two strains. The two strains 
used were 30950 (CagPAI positive gastric cancer strain) and 31235 (CagPAI negative 
non-cancer strain). The assay was performed using the RayBio® C-Series kit 
according to the manufacturer instructions and intensity of the spots was analysed 
using ImageJ as described in 2.2.13. Only differences of more than 0.1 were 
considered for further confirmatory investigation using ELISA. 
6.1.5.2 Interleukin-8 and CCL4 ELISA 
Concentrations of interleukin-8 (IL-8) were measured using an ELISA kit (DuoSet) in 
half-area 96-well plates in all samples from infection of AGS or THP-1 cells 
following the protocol described in 2.2.11. Concentrations of CCL4 were measured 
using an ELISA kit (DuoSet) in half-area 96-well plates only in samples from 
infections of THP-1 cells following protocol described in 2.2.12. 
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Each infection experiment with a strain of H. pylori on AGS or THP-1 was repeated 3 
times. To reduce experimental variations between experiments, the average negative 
control from each experiment was used as a unit value. 
Supernatants from THP-1 cells were highly concentrated in cytokines, therefore 
dilutions were needed for both IL-8 and CCL4 ELISA to obtain concentrations in the 
kit range. For IL-8 concentration, dilutions in PBS did not show linear variation of 
concentration with dilution, therefore dilutions were achieved in wash buffer 
(containing Tween) to disaggregate proteins. Dilutions of 1 in 50 in wash buffer were 
chosen for IL-8 (Figure 6.2A). Dilutions of 1 in 50 in PBS were chosen for CCL4 
(Figure 6.2B). Positive and negative controls were not diluted. Results presented in 
sections below are concentrations in non-diluted supernatants. 
 
Figure 6.2: Concentration of IL-8 (A) and CCL4 (B) in dilutions from 
supernatants obtained after 24h infection of differentiated THP-1 cells 
with H. pylori strains 
A. Concentration of IL-8 in diluted supernatants. Diluent used was wash 
buffer. Range of detection was between 31.2 and 2000 pg/mL. B. 
Concentration of CCL4 in diluted supernatants. Diluent used was PBS. 
Range of detection was between 15.6 and 1000 pg/mL. 
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6.1.6 Genomic analyses  
Two types of genomic analyses were performed based on the phenotype results. For 
both methods, the dataset was divided into groups according to the results of the 
studied phenotype. A binary dataset was created separating strains in the upper and 
lower 33
rd
 percentiles for each phenotype. Both genomic analyses were based on a 
genome comparator (2.3.2). 
6.1.6.1 Identification of genes associated with phenotypes 
This first analysis was based on a genome comparator performed with the genes from 
a pan-genome built using the reference strain 26695 genes and all 57 strains used in 
phenotypic assays following the method described in 2.3.2. This genome comparator 
aimed to show whether some of the genes had higher incidence over the range of 
phenotypes. Non-accessory variations were also investigated briefly by observation of 
the allele numbers obtained by genome comparator. Functions of the genes were 
searched for on NCBI and PATRICdb, and interactions of the gene products with 
other proteins were queried on PATRICdb. 
6.1.6.2 Attribution of functions to genes targets 
The second analysis was a genome comparator (2.3.2) performed using all genes 
identified in chapters 3, 4 and 5. This analysis aimed to link the genes highlighted in 
silico to phenotypic characteristics of the strains studied in vitro. 
6.2 Results 
6.2.1 Enumeration of H. pylori 
An enumeration experiment was performed on 10 strains of H. pylori, from different 
collections and associated with different symptoms (Table 6.1). The number of colony 
forming units (CFU) per mL of a bacterial solution with OD=0.1 was variable (Figure 
6.3A). There was no significant difference in calibrated counts of H. pylori from 
gastritis or gastric cancer patients (Figure 6.3B). The average for these 10 strains was 
1.58.10
7
 CFU/mL of OD 0.1 bacterial solution, which is consistent with values found 
in the literature (Blanchard and Nedrud 2012). This average was used to estimate the 
concentration of bacteria used in the remaining experiments. 
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Figure 6.3: Enumeration carried out on 10 clinical H. pylori strains. 
A. Each dot represents the number of colony forming units per mL of OD 0.1 
bacterial solution calculated from one plate. Strains in black are gastric 
cancer strains. Strains in grey are gastritis strains. Plain circles represent 
CagPAI positive strains and empty circles CagPAI negative strains. B. Each 
dot represents the average number of colony forming units per mL of OD 0.1 
calculated from at least 3 plates for one strain. No significant difference was 
observed between gastritis and gastric cancer strains (t-student). 
 
6.2.2 Variability of motility in H. pylori 
The relationship between the motility of 56 strains (Table 6.2) and disease 
background was investigated (Figure 6.4).  
 
Figure 6.4: Motility measured in H. pylori strains from different patient 
pathology. 
Each dot represents the average motility score for one strain, measured at 
least twice and corrected using the measure for control strain B24. Star 
represents a p-value < 0.05 between groups (one-way ANOVA). 
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Differences in motility between disease types were only statistically significant 
between gastric cancer strains and MALT lymphoma strains (p-value < 0.05 with one-
way ANOVA). However, the standard deviations for MALT lymphoma and ulcer 
strains were much smaller compared to gastric cancer and normal/gastritis strains. 
6.2.3 The host-immune response triggered by H. pylori 
Fifteen strains of H. pylori chosen for their disease background and CagPAI status 
(Table 6.3) were used to infect AGS or THP-1 cells to investigate inflammatory 
cytokine response to the live bacteria. Supernatants from these co-cultures were used 
in three experiments focusing on a cytokines screen using a human inflammation 
antibody array and further confirmatory ELISA assays. 
6.2.3.1 Human Inflammation Antibody Array 
Four samples of supernatants from infection experiments were used to perform a 
human inflammation antibody array assay. This assay aimed to identify human 
cytokines produced by AGS and THP-1 cells when challenged by different strains of 
H. pylori. The strains used were 30950 (a cag-PAI positive cancer strain) and 31235 
(a cag-PAI negative non-cancer strain). Optimised exposures of the assay membranes 
are presented in Figure 6.5. 
 
Figure 6.5: Human inflammation antibody array comparing a clinical H. 
pylori isolate associated with cancer (30950) against one associated with 
gastritis (31235). 
Each antibody is present in duplicate. In the top right corner are the two 
positive controls, followed by the two negative controls. IL-8 is boxed in 
black. CCL4 is boxed in grey. Complete map of the array is available in 
Appendix G. A. AGS challenged with strain 30950 of H. pylori. B. AGS 
challenged with strain 31235 of H. pylori. C. THP-1 challenged with strain 
30950 of H. pylori. D. THP-1 challenged with strain 31235 of H. pylori. 
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In AGS cells the only strong difference between the cancer and non-cancer strains 
was for IL-8, with intensities of 0.82 and 0.32 respectively. This difference in IL-8 
was also detected in THP-1, but was not as strong as for AGS cells, with intensities of 
1.46 and 1.13 in the cancer and non-cancer strains respectively. 
 
Other important differences revealed by this screening procedure were observed in 
THP-1 cells, between cancer and non-cancer strains, in the MIP-1 family (CCL3, 4 
and 15), and for IL-10, IL-12 p70 and I-309 (TCA-3/CCL1). These differences were 
weaker than the ones observed for IL-8, but were over 0.1, which was our defined 
threshold. 
 
This screening assay successfully identified two cytokines of interest, IL-8 and CCL4, 
which were further investigated by ELISA assays on a larger number of strains in 
order to confirm the observed difference in the two test strains. IL-8 was investigated 
in both AGS and THP-1 supernatants. CCL4 was investigated in THP-1 supernatants. 
6.2.3.2 IL-8 response to H. pylori infection in AGS cells 
IL-8 was measured in supernatants from AGS cells infected with 15 H. pylori strains 
in triplicate. Most of the strains showed little variation between replicate experiments, 
with the exception of 4 of the CagPAI-positive non-cancer strains (Figure 6.6A).  
 
CagPAI negative strains induced no IL-8 response. A statistically significant 
difference was observed between CagPAI-positive and CagPAI-negative strains 
(Figure 6.6B) in non-cancer patients.  
 
Despite a trend towards non-cancer strains inducing a higher IL-8 production in AGS 
cells, there was no significant difference compared to the CagPAI positive strains 
causing cancer (Figure 6.6B). 
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Figure 6.6: Concentration of IL-8 in supernatants obtained after 24h 
infection of AGS cells with H. pylori strains. 
IL-8 was measured by ELISA assay and adjusted to the negative control for 
each experiment. Grey dots represent gastritis strains and black represent 
gastric cancer strains. Plain circles are for CagPAI positive strains and empty 
circles for CagPAI negative strains. A. Each dot represents the average 
concentration of IL-8 from triplicate wells of the same experiment. B. Each 
dot represents the average from 3 independent experiments for one strain. 
Star represents a significant difference between the groups, with a p-value < 
0.05 (One-way ANOVA). 
  
6.2.3.3 IL-8 response to H. pylori infection in THP-1 cells 
The production of IL-8 in relation to CagPAI status has been largely studied in 
epithelial cells. Little is known about the influence of CagPAI to trigger the 
production of IL-8 in other types of cells associated with gastric disease, such as 
macrophages. To address this, an infection experiment using differentiated THP-1 
cells as model macrophages was carried out, based on the cytokine array data.  
Despite the difference in IL-8 production between the two sample strains used in the 
human inflammation antibody array, measurement of IL-8 in supernatants from the 
infection of THP-1 cells with 15 strains of H. pylori did not show differences, either 
with respect to cancer diagnosis or CagPAI status of the strains (Figure 6.7B). A 
closer look at the results from individual strains also shows a very wide variability 
between replicates from the same sample (Figure 6.7A). 
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Figure 6.7: Concentration of IL-8 in supernatants obtained after 24h 
infection of differentiated THP-1 cells with H. pylori strains. 
IL-8 was measured by ELISA assay and adjusted to the negative control for 
each experiment. Grey dots represent gastritis strains and black represent 
gastric cancer strains. Plain circles are for CagPAI positive strains and empty 
circles for CagPAI negative strains. A. Each dot represents the average 
concentration of IL-8 in triplicate wells from the same experiment. B. Each 
dot represents the average from 3 independent experiments for one strain. 
6.2.3.4 CCL4 response to H. pylori infection in THP-1 cells 
Based on the results from the membrane assay showing a difference in CCL4 
response from THP-1 cells between one cancer and non-cancer isolate, further 
samples were investigated by ELISA.  
 
All 15 samples previously described for study of IL-8 concentration in co-culture with 
THP-1 were used for this experiment. Variability between replicates with the same 
strain was significantly lower than for IL-8 in the same samples (Figure 6.7A and 
Figure 6.8A). The results showed production of CCL4 in all samples, without a clear 
difference between strains causing cancer and strains causing gastritis. No statistical 
difference was observed between groups of strains based on disease or CagPAI status 
(Figure 6.8B). 
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Figure 6.8: Concentration of CCL4 in supernatants obtained after 24h 
infection of differentiated THP-1 cells with H. pylori strains. 
CCL4 was measured by ELISA assay and adjusted to the negative control for 
each experiment. Grey dots represent gastritis strains and black represent 
gastric cancer strains. Plain circles are for CagPAI positive strains and empty 
circles for CagPAI negative strains. A. Each dot represents the average 
concentration in IL-8 from triplicate wells in the same experiment. B. Each 
dot represents the average from 3 independent experiments for one strain. 
 
6.2.4 Genomic origin for phenotypic variability 
6.2.4.1 Pan-genome of strains used in phenotypic analyses 
The pan-genome built from the set of 57 strains used for phenotypic assays included a 
total of 1913 genes. A genome comparator using this pan-genome as a reference and 
the 56 strains dataset identified 1319 core genes (present in more than 90% of these 
strains), and 594 accessory genes (Figure 6.9).  
6.2.4.2 Identification of genes associated with motility 
The 56 strains used for the measurement of motility were ranked according to motility 
score. These scores were used to separate strains into three 33
rd
 percentiles:  
 19 strains with low motility,  
 18 strains with average motility,  
 19 strains with high motility.  
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Figure 6.9: Composition of the H. pylori pan-genome based on the 56 
strains used in phenotypic assays. 
Core genome (black bar) was composed of all genes present in at least 90% 
of the strains. Accessory genome (white bars) was composed of all genes 
present in at least 1 strain, but less than 90% of the strains. 
 
High and low motility strains were then compared using a genome comparator to 
identify genes with function linked to an increase in motility. This analysis 
highlighted 139 genes showing a difference of more than 0.2 in prevalence between 
high and low motility (Figure 6.10). Of these genes, 62 were present in the reference 
strain 26695. 
 
Figure 6.10:   Pan-genome approach showing the number of genes with a 
difference in prevalence of more than 20% between high motility strains 
and low motility strains. 
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Only genes with a greater prevalence in high motility strains compared to low motility 
strains was studied further. The 43 genes from 26695 genome were located across the 
genome (Figure 6.11). Details for 26695 genes (outside the CagPAI island genes and 
HP1243 described below) are presented in Table 6.4. Fifteen genes were not found in 
the 26695 genome.  
 
 
Figure 6.11: Position (in 26695 genome) of the 43 genes showing an 
increased prevalence in high motility strains. 
Direct link to motility identifies genes for which the function is linked to 
motility (flagella, urease, chemotaxis). Product interactions are based on 
queries on the interactions of the gene products in PATRICdb revealing links 
to motility. 
 
HP1243 and cagPAI genes 
HP1243 codes for babA, an outer membrane protein known to be highly associated 
with the CagPAI pathway. This pathogenicity island is associated with gastric cancer. 
HP1243 gene was highlighted as having higher presence in high motility strains in 
our motility assay.  
The CagPAI island has been divided in the literature into two distinct zones: cagII 
(composed of 14 genes) and cagI (composed of 13 genes). Among the 14 genes 
composing CagII, only 12 were showing increased prevalence in high motility strains.  
  
 
 
Table 6.4: Genes with increased prevalence in high motility strains, product functions and predicted interactions. 
Interactions referenced in this table were obtained on PATRICdb. Only relevant interactions are listed. 
Locus 
tag 
Product Predicted interactions 
Flagella Urease Chemotaxis Others 
HP0033 ClpA (ATP-dependent Clp 
protease ATP-binding 
subunit) 
HP0753 
(fliS) 
   
HP0052 Putative type II DNA 
modification enzyme  
HP0325 
(flgH) 
   
HP0053 Hypothetical protein     
HP0054 Adenine/cytosine DNA 
methyltransferase 
    
HP0462 Type I restriction-
modification system, 
specificity subunit S 
   HP0523 
HP0503 Hypothetical protein     
HP0504 Hypothetical protein     
HP0892 YafQ (mRNA interferase)  HP0073  HP0893, HP0315 (vapD), HP0967 (vapD) 
HP0893 Hypothetical protein    HP0892 
HP0990 Hypothetical protein    HP0527, HP0528, HP0315 (vapD) 
HP1079 ATP/GTAP phosphatase  HP0068, HP0072  HP1243 (babA) 
HP1192 secreted protein involved in 
flagellar motility 
HP0115, 
HP0601, 
HP1585 
HP0068, HP0069, 
HP0070, HP0072, 
HP0073 
HP0019, HP0103, 
HP0393, HP0599, 
HP1067 
HP0520, HP0528, HP0532, HP0537, HP0540 
HP1366 type IIS restriction enzyme 
R 
   HP1578 (LPS biosynthesis protein), HP1208 (ulcer 
associated) 
HP1367 type IIS restriction enzyme 
M1 
   HP1578 (LPS biosynthesis protein), HP1208 (ulcer 
associated), HP1209 (ulcer associated), HP0527 
HP1368 type IIS restriction enzyme 
M2 
   HP1578 (LPS biosynthesis protein), HP1208 (ulcer 
associated), HP1209 (ulcer associated), HP0527 
HP1383 modification system S 
subunit 
   HP1208 (ulcer associated) 
HP1433 Hypothetical protein     
HP1438 lipoprotein    HP0523 
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Genes not found in 26695 
Fifteen coding sequences with increased prevalence in high motility strains were not 
part of the annotated 26695 genome used as a reference for the construction of the 
pan-genome. Annotations from RAST did not aid in elucidating the functions for 
these genes. Twelve genes were annotated as hypothetical proteins. One gene was 
annotated as an RloF (R-linked ORF F) (005_4_1517). The remaining two genes were 
closely positioned in the genome of the strain in which they were found. One was 
annotated as coding for a transposase (004_3_0002), and one for a mobile element 
protein (004_3_0003). 
6.2.4.3 Identification of genes associated with cytokine production in 
AGS or THP-1 cells 
The 15 strains used for infection work were ranked by the concentration of either IL-8 
in AGS cells, IL-8 in THP-1 cells or CCL4 in THP-1 cells. A genome comparator was 
performed using these 15 strains and the pan-genome constructed on the set of 57 
strains in order to identify differences in prevalence between strains associated with 
high production of these cytokines in AGS or THP-1 cells and strains associated with 
low production of these cytokines in AGS or THP-1 cells. Only genes with 
differences of more than 0.5 in prevalence between groups were considered relevant 
(Figure 6.12).  
 
This analysis highlighted very clearly (prevalence of 1 in high producing strains 
against prevalence of 0 in low producing strains) a link between most cagPAI genes 
and IL-8 production in AGS cells, and with babA. babA was also identified in our 
GWAS analysis as a risk factor for gastric cancer, and has been associated with 
CagPAI. Confirmation of the relevance of these genes (cagPAI genes and babA) with 
the cytokine production is already present in the literature (Ishijima et al. 2011; 
Fischer et al. 2001). A few other genes were covarying with IL-8 production in AGS 
cells, with a lower difference (0.6) between high and low producers. Amongst them 
were the replicates of tnpA and tnpB, which were also identified in the study of IL-8 
in THP-1 cells. tnpA has been linked to more severe disease (Abadi et al. 2014; 
Mattar et al. 2010), but its exact role has so far not been identified. Our finding could 
be a lead to further investigation on the link of tnpA and tnpB with IL-8 production. 
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HP1499 was identified as more frequent in non atrophic gastritis patients than in 
gastric cancer or duodenal ulcer, and HP0962 was specific to gastric cancer strains 
(Romo-González et al. 2009), but no role was identified regarding IL-8 production. 
One of the cagPAI genes, HP0524, encodes for a protein belonging to the TraG-like 
protein (Schröder et al. 2002), therefore traG and the two genes positioned around 
traG, HP1003 and HP1005, could be linked to immune response, but there is so far 
no proof of it. HP0079, HP0356, HP0462, HP0593, HP0682, HP1078, HP1276, 
HP1366/1368, HP1471, HP1517/1518/1519 were all uniquely identified by our study. 
 
 
Figure 6.12: Position (in 26695 genome) of the main genes with increased 
prevalence in strains triggering a high production of cytokines. 
Only genes with a difference in prevalence of at least 0.5 between low and 
high cytokine are represented. 
 
6.2.5 Attribution of functions to genes highlighted by genomic 
analyses 
A genome comparator was performed on the 57 strains dataset using all 110 genes 
highlighted in previous chapters of this thesis. It showed that 93 genes were core 
(present in more than 90% of the strains from this dataset) and 17 were accessory. 
6.2.5.1 Motility 
Prevalence of the genes highlighted in previous chapters was compared in high and 
low motility strains. A large majority (14 out of 17) of the accessory genes showed a 
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variation of more than 0.1 between prevalence in high and low motility. Two genes 
which were part of the core genome in the global dataset were also identified to be 
core in one of the motility groups but accessory in the other one, with a difference in 
prevalence of more than 0.1 (Figure 6.13). 
 
Figure 6.13: Genes highlighted in previous chapters showing a difference 
in prevalence between strains with high and low motility. 
 
A threshold of 0.2 difference in prevalence was used to select genes covarying with 
motility, leaving 12 genes. 
Two genes showed a higher prevalence in low motility strains than in high motility 
strains, namely HP0855 and HP1004. HP0855 showed significant genomic variation 
based on PV in both strains studied in long-term colonisation in mice. HP1004 was a 
hit in the bugwas GWAS with a strong p-value of 2.73.10
-7
. Function of this gene is 
unknown as it codes for a hypothetical protein. The difference in prevalence observed 
suggests that the function of this gene implies a reduction of strain motility. 
All other genes showed a higher prevalence in high motility strains compared to low 
motility strains. These included cagPAI genes (HP0524, HP0528, HP0529, HP0531, 
HP0532, HP0540, HP0541, HP0544, HP0547) and genes known to be associated 
with CagPAI (HP1243 also known as babA).  
An investigation of gene-by-gene alignment of the 7 non-accessory risk genotypes 
identified in Chapter 5 was performed using Bioedit. This analysis recorded an 
increased proportion of the risk genotype in low motility strains for HP0797 (Figure 
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6.14A) and HP0747 (Figure 6.14B), and an increased proportion of the safe genotype 
in low motility strains for the synonymous change of HP0468 (Figure 6.14C). Other 
genotypes did not show increase or decrease related to motility. 
 
 
Figure 6.14: Proportion of risk and safe genotypes from Chapter 5 
showing an increased or decreased allele presence according to motility. 
A. Non-synonymous allelic change identified in HP0797. B. Non-
synonymous allelic change identified in HP0747. C. Synonymous allelic 
change identified in HP0468. 
 
6.2.5.2 Triggering of cytokine production 
Prevalence of highlighted genes and IL-8 production in AGS cells 
Prevalence of the genes highlighted in previous chapters was also compared in strains 
triggering high and low production of IL-8 in AGS cells. All but one (HP1045), 
accessory genes showed a variation of more than 0.1 between prevalence in high and 
low motility. However, as the number of strains used in infection experiments was 
much lower than in the motility assay, the threshold was increased to 0.5. This limit 
identified 10 genes previously identified in this thesis, all of them part of the CagPAI 
island (HP0524, HP0528, HP0529, HP0531, HP0532, HP0540, HP0541, HP0544, 
  
133 
 
HP0547) or associated with CagPAI (HP1243 also known as babA) that were absent 
from all 5 strains triggering low production of IL-8 in AGS cells and present in all 5 
strains triggering high production of IL-8 in AGS cells. HP0527, also part of the 
CagPAI island, was also absent from all 5 strains triggering low production of IL-8 in 
AGS cells, but was only present in 3 out of the 5 strains triggering high production of 
IL-8 in AGS cells (difference in prevalence of 0.6). 
 
Prevalence of highlighted genes and IL-8 production in THP-1 cells 
Prevalence of the genes highlighted in previous chapters was also compared in strains 
triggering high and low production of IL-8 in THP-1 cells. Difference in prevalence 
was lower than in AGS cells. No gene presented a difference in prevalence of more 
than 0.5 between groups of strains in this comparison.  
 
Prevalence of highlighted genes and CCL4 production in THP-1 cells 
Prevalence of the genes highlighted in previous chapters was finally compared in 
strains triggering high and low production of CCL-4 in THP-1 cells. Difference in 
prevalence was again lower than in IL-8 production in AGS cells. However, one gene, 
HP1004, was present in all 5 strains triggering high production of CCL4 and only 
present in 2 of the 5 strains triggering low production of CCL4, therefore presenting a 
difference in prevalence of 0.6. HP1004 was a hit in the bugwas GWAS with a strong 
p-value of 2.73.10
-7
. The function of this gene is unknown as it codes for a 
hypothetical protein. It was identified as being more present in low motility strains.  
 
Non-accessory risk genotypes and cytokine production 
An investigation on gene-by-gene alignment of the 7 non-accessory risk genotypes 
identified in Chapter 5 was performed using Bioedit for each cytokine. Analysis of the 
production of IL-8 in AGS cells recorded an increased proportion of the risk genotype 
in low producers strains for HP0747 (Figure 6.15A) and both synonymous and non-
synonymous changes of HP0468 (Figure 6.15B-C). An increased proportion of the 
risk genotype in low producers strains for the non-synonymous change of HP0709 
(Figure 6.15D) was also identified. Other genotypes did not show increase or decrease 
related to production of IL-8 in AGS cells. 
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Figure 6.15: Proportion of risk and safe genotypes from Chapter 5 
showing an increased or decreased allele presence according to ability to 
trigger IL-8 production in AGS cells. 
A. Non-synonymous allelic change identified in HP0747. B. Synonymous 
allelic change identified in HP0468. C. Non-synonymous allelic change 
identified in HP0468. D. Non-synonymous allelic change identified in 
HP0709. 
 
Analysis of the production of IL-8 in THP1 cells recorded an increased proportion of 
the risk genotype in low producers strains for HP1055 (Figure 6.16A) and both 
synonymous and non-synonymous change of HP0468 (Figure 6.16B-C). An increased 
proportion of the risk genotype in high producers strains for the non-synonymous 
change of HP0709 (Figure 6.16C) was also identified. Other genotypes did not show 
increase or decrease related to production of IL-8 in THP1 cells. 
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Figure 6.16: Proportion of risk and safe genotypes from Chapter 5 
showing an increased or decreased allele presence according to ability to 
trigger IL-8 production in THP1 cells. 
A. Non-synonymous allelic change identified in HP1055. B. Synonymous 
allelic change identified in HP0468. C. Non-synonymous allelic change 
identified in HP0468. D. Non-synonymous allelic change identified in 
HP0709. 
 
Analysis of the production of CCL4 in THP1 cells recorded an increased proportion 
of the risk genotype in low producers strains for the synonymous change of HP0709 
(Figure 6.17C) and both synonymous and non-synonymous changes of HP0468 
(Figure 6.17A-B), and an increased proportion of the safe genotype in low producers 
strains for the non-synonymous change of HP0709 (Figure 6.17C). Other genotypes 
did not show increase or decrease related to production of CCL4 in THP1 cells. 
 
Noticeably, the same increase was observed for all 3 cytokine production experiments 
regarding the three risk genotypes HP0468 (synonymous and non-synonymous) and 
HP0709 (non-synonymous). 
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Figure 6.17: Proportion of risk and safe genotypes from Chapter 5 
showing an increased or decreased allele presence according to ability to 
trigger CCL4 production in THP1 cells. 
A. Non-synonymous allelic change identified in HP0468. B. Synonymous 
allelic change identified in HP0468. C. Synonymous allelic change identified 
in HP0709. D. Non-synonymous allelic change identified in HP0709. 
 
6.3 Discussion 
The study of phenotypic characteristics of clinical strains of H. pylori isolated from 
patients for whom pathologies were described sheds light on the phenotypic diversity 
observed in sets of strains.  
Motility is essential for colonisation, as a strain with no motility will not be able to 
colonise the stomach long term, but not all strains with efficient motility will be 
responsible for strong inflammation and progress towards gastric cancer. Motility is 
only a pre-requisite for the pathogenicity of the strains to take its part, and it is only 
indirectly linked to the development of complications in the host (1.2.6). Despite what 
was previously described (C.-Y. Kao et al. 2012) motility was not associated with the 
pathology associated with the strains in our experiment. However, a wide variability 
was observed amongst our collection of isolates. Differences in terms of standard 
deviations were also observed between pathologies. This could be explained by the 
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smaller number of isolates available for MALT lymphoma and ulcer, but could also 
be representative of a difference in the type of disease. MALT lymphoma and 
duodenal ulcer are associated with a high level of acid production in stomach, 
whereas gastric cancer is associated with a low level of acid production. H. pylori 
strains isolated from MALT lymphomas and ulcers might be better adapted to a high 
level of acidity, therefore reducing their motility capacity in the more neutral 
conditions used in this in vitro experiment. 
Pathologies left aside, a number of genes were highlighted as important in relation to 
motility. One of them, HP1192 was already associated with motility in a motility 
assay involving deletion and over-expression mutants for this specific gene (Tsao et 
al. 2009). Products of other genes with increased prevalence in high motility strains 
were interacting with colonisation-related genes. This was the case for the famous 
cagPAI genes (Vannini, Roncarati, and Danielli 2016) and babA gene (Rad et al. 
2002). Products of HP0033, and of the group of 3 genes HP0052, HP0053 and 
HP0054 were respectively interacting with flagellar proteins fliS and flgH (J. S. Kim 
et al. 1999). Products of the couple of genes HP0892 and HP0893 as well as product 
of HP1079 were interacting with urease gene products HP0073, HP0068 and HP0072 
(Mobley, Hu, and Foxal 1991). Finally, some genes had never been associated to 
motility and/or were coding for unknown functions, which were found with higher 
prevalence in higher motility isolates: HP0462, HP0503/HP0504, HP0990, 
HP1366/HP1367/HP1368, HP1383, HP1433 and HP1438. These genes could be 
associated with high motility and would require further research, for instance by 
motility assays or colonisation experiments on mice with mutant strains. 
IL-8 and CCL4 were identified in a semi-quantitative human inflammation antibody 
assay as being differently produced in infection experiments with strains isolated from 
cancer patient compared to a non-cancer patient. The smaller difference in IL-8 
concentration for THP-1 cells compared to AGS cells can be explained by higher 
concentrations in the THP-1 supernatants. In the membrane assay, samples were 
diluted 1 in 2 for both types of cells, and therefore the dots corresponding to IL-8 in 
THP-1 cells showed close to saturation intensities. The compactness of high 
concentrations could reduce the observed difference. Measurement of the cytokines in 
different types of mammalian cells significantly confirmed the role of CagPAI genes 
in the epithelial cells host response (Ahmadzadeh et al. 2015; Hammond et al. 2015; 
Censini et al. 1996). IL-8 production in AGS cells was lower in gastric cancer cagPAI 
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positive strains compared to non cancer cagPAI positive strains, which could suggest 
that the gastric cancer strains could more easily elude the inflammation developed by 
the epithelial cells and allow the bacteria to trigger other routes of inflammation in 
order to develop cancer. However this difference was non-significant, and the number 
of strains used very small. Pathology set aside, a number of genes were highlighted as 
covarying with the IL-8 productions in AGS cells, on top of them are the cagPAI 
genes and genes related to the CagPAI, such as babA, tnpA and tnpB (Abadi et al. 
2014). Other genes covarying with IL-8 production in AGS include HP0079 
(membrane protein), HP0462 (type I restriction-modification system specificity 
protein), HP0593 (DNA methyltransferase (Banerjee and Rao 2011)), HP1276, 
HP1499 (restriction endonuclease) and HP1519. 
No difference was highlighted regarding both IL-8 and CCL4 production in THP-1, 
neither according to CagPAI status nor pathology. Considering the human 
inflammation antibody assay was using samples diluted only 1 in 2, whereas the 
ELISA measures were using dilutions of 1 in 50, the disaggregation of the proteins 
obtained by dilution in wash buffer could have altered the results. The higher 
concentrations observed in THP-1 cells could be due to the nature of the cells which 
are prompt to adapt and react in a stronger way than AGS cells. Pathology set aside, a 
number of genes were highlighted as covarying with the IL-8 productions in THP-1 
cells, among them are tnpA and tnpB, which were also covarying with the IL-8 
production in AGS cells. HP0356, HP0962 (acyl carrier protein), HP1078, HP1366 
(type IIS restriction-modification system endonuclease), HP1367 (type IIS restriction-
modification system methyltransferase) and HP1471 were also co-varying with IL-8 
production in THP-1 cells. HP0682 was covarying with both cytokines tested in THP-
1 cells, IL-8 and CCL4, but its function is unknown as it is described as a hypothetical 
protein. Also covarying with CCL4 in THP-1 cells were HP1003, HP1005, traG 
(involved with T4SS (Schröder et al. 2002)), HP1517 and HP1518. 
Genes identified in the previous results chapter (specifically chapter 4 and 5) also 
showed co-variations with motility or cytokine production, which shed light on the 
potential mechanisms involving those genes with change of host, long-term 
colonisation or gastric cancer. 
Experiments such as knocking out some of the genes identified could help confirm the 
questions remaining on the exact functions linked to motility and triggering of 
immune response in the host (O‘Toole, Kostrzynska, and Trust 1994; Schmitz, 
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Josenhans, and Suerbaum 1997; C.-Y. Kao, Sheu, and Wu 2014). This approach 
would be especially interesting on genes for which function is unknown but are 
highlighted in more than one aspect of our study. Other phenotypic experiments could 
also have been carried out on this set of clinical strains in order to link disease 
development in the host with phenotypic characteristics of the strains, and to identify 
potential genes linked to these variations. Reactive Oxygen Species produced by host 
cells when undergoing stress, could for instance be an interesting approach to the 
study of H. pylori strains (Satin et al. 2000). Infection of THP-1 and AGS cells co-
cultures by H. pylori strains could also be performed, to model interactions between 
these three actors during chronic inflammation caused by the bacteria (Fox et al. 
2015). 
In conclusion, variations in motility are not linked to the pathology of the patient 
infected. However, some genes are co-varying with motility and could be investigated 
further. Immune response measured in co-culture experiments with clinical strains 
varies with the pathology of the patient from who the strain. Genes already known to 
be associated with triggering of IL-8 production in epithelial cells were identified in 
our study but new ones were also co-varying with cytokine triggering phenotype. 
These could be targets for experiments in order to confirm or dispute the association. 
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7 General Discussion 
This chapter will focus on answering the questions defined in introduction using the 
whole results exposed in previous chapters. More precisely, the two first results 
chapters, Chapter 3 and Chapter 4, focused on defining the genome evolution 
occurring in H. pylori species, addressed four hypotheses: 
 The genomic variability of H. pylori strains from the Americas reflects the 
history of recent and ancient migrations which built the identity of these 
regions, 
 Core and accessory genomes are evolving in a similar way, 
 H. pylori strains evolve when changing from one host to another, 
 H. pylori strains infecting a stomach for a long time evolve alongside the 
development of symptoms.  
Mimicking genomic variability of H. pylori strains, a wide phenotypic variability is 
observed in clinical strains. This was addressed in Chapter 6, with three hypotheses: 
 Motility varies according to the pathology of the patient from which the strain 
was isolated, 
 Immune response is triggered differently according to the pathology of the 
patient from which the strains was isolated, 
 Some genes covary with phenotypic differences observed among strains. 
Finally, GWAS methods were used on H. pylori clinical strains in an attempt to 
identify genomic traits linked to gastric cancer (GC). Three hypotheses were tested in 
Chapter 5: 
 The GWAS method can be applied to H. pylori genome despite its high 
variability, 
 Specific genomic traits in specific genes can be linked with the progression of 
GC, 
 A risk score can be built in order to target strains with a higher risk for 
triggering GC.  
Limitations of the methods used in this study, as well as leads for future research, will 
also be discussed. 
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7.1 Genome evolution in H. pylori 
The H. pylori species is particularly diverse (Dorer, Sessler, and Salama 2011). 
Genomic variation can be observed at different levels. Firstly, traces of the history of 
human migrations are conserved in its genome, due to their long co-existence (Falush 
et al. 2003; Moodley et al. 2012). This was studied by MLST methods for old patterns 
of migrations such as the ones originating in the current European population (Falush 
et al. 2003). Indeed, European H. pylori populations are known to be a mix of Asian 
and African populations. This was confirmed in a published study (Thorell et al. 
2017) based on complete genomes (see Chapter3), both in the core genome, through 
the use of FineStructure and Chromopainter (3.2.2), and in the accessory genome 
through the use of a new method of analysis of accessory 3-dimentional plots (3.2.3). 
These higher resolution methods, combined with the large global dataset which 
included 198 strains from the Americas, allowed the identification of more recent 
events of migration which are part of the history of the Americas, highlighting 
differences between regions of this continent (Marangoni, Caramelli, and Manzi 
2014). Different subpopulations were newly identified in the Americas, with different 
levels of inputs from hpAfrica1 and hpEurope. Both core and accessory methods were 
confirming this evolution in a similar way.  
However, the genome of H. pylori not only comprises traces of ancient hosts, but also 
evolves over a shorter scale (Cao et al. 2015; Avasthi et al. 2011). Colonisation of a 
human host by H. pylori usually occurs in childhood, but can persist for years without 
any symptoms (O‘Ryan et al. 2015; Dooley et al. 1989). During this time, a single 
strain of H. pylori can evolve, adapting to this host and sometimes causing gastritis or 
more severe outcomes such as gastric ulcer (Lanas and Chan 2017), MALT 
lymphoma (ML) (H.-C. Wang et al. 2015) or gastric cancer (GC) (Wroblewski and 
Peek 2016; Figura et al. 2016). Different strains of H. pylori can also co-habit, 
increasing the potentiality of genomic evolution through recombination (Cao et al. 
2015; Kersulyte, Chalkauskas, and Berg 1999). An attempt to assess the usability of 
murine model to study long-term colonisation evolution of H. pylori genome was 
made in Chapter 4. The isolation of strains of H. pylori after colonisation of a mouse 
host for different durations was an opportunity to study the evolution of a single strain 
in its host during long-term colonisation, and to assess the changes occurring in H. 
pylori strains when changing host. The two strains used in this study were originally 
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isolated from human patients suffering from ML (Chrisment et al. 2014). Gastric 
lesions similar to those observed in the human original host developed in the infected 
mice after long-term colonisation, suggesting a bacterial origin to the symptoms over 
a host pre-disposition. The genomic study made on these strains showed that specific 
changes were observed during the change of host (4.2.2), and during long-term 
colonisation (4.2.3). The genomic evolutions that were observed were of different 
types, backed-up by literature: PV (Appelmelk et al. 1999; Bergman et al. 2006), SNP 
(Furuta et al. 2015), deletion/insertion (Tsang et al. 2013) and repetition of a 21bp 
sequence (Rasko et al. 2000). Functions of the genes evolving in this study comprised 
outer-membrane proteins (Furuta et al. 2015), LPS biosynthesis (Stefan Odenbreit, 
Faller, and Haas 2002; Chmiela, Miszczyk, and Rudnicka 2014; Appelmelk et al. 
1999) and flagella (C.-Y. Kao et al. 2012; O′Toole, Lane, and Porwollik 2000), which 
are all crucial for colonisation. 
7.2 Phenotypic variations in H. pylori strains 
Strains of H. pylori are not only variable in terms of genomes. Indeed, in most cases, 
genomic variations affect the phenotypes of the strains. A collection of European 
clinical isolates was gathered in order to study the phenotypic variations amongst 
them (Chapter 6). The focus of our experiments was to target phenotypes that were 
both (i) achievable for large number of isolates (ii) representative of the virulence of 
the strains. No significant variation was found in motility between isolates from 
different pathology. However, the ability to trigger an IL-8 response in AGS cells was 
higher in gastric cancer isolates than in non cancer isolates reflecting the presence or 
absence of the CagPAI island genes (Li et al. 1999; Sheh et al. 2013; Khatoon et al. 
2017). No difference in the ability to trigger either an IL-8 or CCL4 response in THP-
1 cells was associated with the pathology of the isolates. However, 113 genes were 
co-varying with the phenotypic variations measured in our set of isolates. These 
covariations highlighted genes already known to be associated with such phenotypes 
(CagPAI genes and babA with IL-8 in AGS cells), but also genes that were not 
expected to covary with those phenotypes. Studying those genes, to confirm or refute 
their association with phenotypes could be of interest to better understand the 
mechanisms behind pathogenicity of H. pylori strains. 
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7.3 Prediction of virulence 
GWAS methods, initially developed for human genomics, have been increasingly 
used in bacterial genomics (Power, Parkhill, and de Oliveira 2016; P. E. Chen and 
Shapiro 2015; Alam et al. 2014; Sheppard et al. 2013). These methods, relying on a 
statistical analysis of the prevalence of genomic traits in strains for which a binary 
phenotype can be clearly identified, are powerful tools to investigate the virulence of 
H. pylori strains. Application of GWAS to clinical strains of H. pylori from a single 
population (hpEurope) highlighted 12 genotypes associated with gastric cancer 
(Chapter 5). These genotypes were used to build a risk score that could allow 
prediction of the virulence of a strain. 
In the different chapters of this thesis, a large number of genes were highlighted, 
linked to different evolutionary mechanisms. Markers of evolution in an animal 
model, linked to both change of host or long-term colonisation, were identified in 
Chapter 4. Co-variations of certain genotypes with phenotypes such as motility or 
immune system triggering were highlighted in Chapter 6. Finally association of some 
genomic traits with gastric cancer was verified using different GWAS methods in 
Chapter 5. All these genes are referenced in Appendix H. Some of these genes were 
highlighted by independent aspects of this thesis work, as well as other studies from 
the literature. Independent studies converging towards individual genes are also a way 
to understand and predict virulence of a strain. In total, 35 genes were highlighted for 
more than one reason in this work. cagPAI genes and babA have already been highly 
studied, and can be considered positive controls. Other genes highlighted at least 
twice in this thesis are presented in Table 7.2. This list of genes could be investigated 
more deeply to understand the functional reasons behind their identification in this 
study. 
7.4 Clinical applications of genomic-based prediction of virulence 
Genomic-based prediction of virulence using GWAS presents the advantage of not 
being based on assumptions of the function of the genes. In our method, all the genes 
from all the strains from the dataset are equally considered, allowing the identification 
of potential new virulence factors. In this work, a first attempt of risk score was made. 
Such a tool could be of use in clinics, to decide whether or not the infection should be 
treated. Indeed, most of the infected population remains asymptomatic (Dooley et al. 
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1989). On the other hand, the consequences, when the infection is not asymptomatic, 
can be lethal (Ferlay et al. 2015). For this reason, the current guidelines are to treat an 
infection as soon as it is detected (Malfertheiner et al. 2017). All lines of treatment for 
H. pylori infections being based on a combination of antibiotics, the resistance issue is 
on the rise (Ierardi et al. 2013). A more careful use of antimicrobial therapy, reserved 
to those with the most virulent strains, could be a solution to the rise in antibiotic 
resistance. Risk score, in combination with evaluation of symptoms, could determine 
the choice of treatment. 
 
Table 7.1: Summary of places in this thesis where cagPAI genes and 
babA were highlighted 
Gene 
Tag 
Gene 
name 
Chapter 2 Chapter 3 Chapter 4 
Change of 
Host 
ClonalFrame 
GWAS 
bugWAS Motility IL-8 in 
AGS 
HP1243 babA X X X + + 
HP0544 cag23  X X + + 
HP0524 cag5   X + + 
HP0528 cag8   X + + 
HP0529 cag9  X  + + 
HP0531 cag11   X + + 
HP0532 cag12   X + + 
HP0540 cag19   X + + 
HP0541 cag20   X + + 
HP0547 cag26  X  + + 
HP0520 cag1    + + 
HP0522 cag3    + + 
HP0523 cag4    + + 
HP0525     + + 
HP0526 cagZ    + + 
HP0527 cag7   X  + 
HP0530     + + 
HP0534 cag13    + + 
HP0537 cag16    + + 
HP0538 cag17    + + 
HP0539 cag18    + + 
HP0542 cag21    + + 
HP0543 cag22    + + 
HP0545 cag24    + + 
HP0546 cag25    + + 
 
 
  
 
 
Table 7.2: Genes highlighted in one or more study in this thesis 
Gene tag Gene 
name 
description Chapter 2 Chapter 3 Chapter 4 
Change 
of Host 
Colonisation ClonalFrame 
GWAS 
BugWAS Motility IL-8 in 
AGS 
CCL4 in 
THP-1 
HP0068 ureG urease accessory protein 
UreG 
  X X    
HP0462 hsdS type I restriction-modification 
system specificity protein 
    + +  
HP0468  hypothetical protein   X X    
HP0503  hypothetical protein   X  +   
HP0685 fliP flagellar biosynthesis protein 
FliP 
X  X     
HP0855  peptidoglycan O-
acetyltransferase 
 X      
HP1004  hypothetical protein    X   + 
HP1177 hopQ membrane protein   X X    
HP1252 oppA oligopeptide ABC transporter 
substrate-binding protein 
X  X     
0010_9_0525  hypothetical protein     + +  
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Leaving less virulent populations of H. pylori in place could also be beneficial. 
Indeed, a small number of studies have highlighted beneficial effects of H. pylori 
infection for the host (O‘Connor, O‘Morain, and Ford 2017). These positive effects 
do not outweigh the negative effects, but if one could predict the virulence of the 
strain, this could change the treatment regimens in the future. Sequencers are 
becoming cheaper and easier to use, and it becomes more and more realistic to be able 
to use such techniques for standard diagnosis in a public health context (Pallen, 
Loman, and Penn 2010). New sequencers are developed and some of them are small 
and portable, such as the Oxford Nanopore MinION (Lu, Giordano, and Ning 2016; 
Walter et al. 2017). It could soon be a reality to sequence the strain from a biopsy, run 
an application and obtain a risk score, used to help the clinician in the decision to treat 
the infection. 
7.5 Limitations of the thesis 
Although prediction of virulence through GWAS methods shows promises, there are a 
number of limitations to this method, some of which could be avoided by future 
research on the subject. The first limitation is the fact that GWAS requires a binary 
dataset. H. pylori linked pathologies are not binary, and therefore choices have to be 
made to turn the dataset into a usable binary dataset. The robustness of this binary 
dataset relies on the quality of information given with the sequences. Moreover, 
virulence of H. pylori expresses itself in many different ways, and there are many 
outcomes with symptoms often highly divergent. In our study, genotypes linked to 
gastric cancer were identified, leading to the construction of a risk score.  
This risk score was built as a short proof of concept study. Indeed, there was no 
dataset at the time of this work to allow validation of the risk score in an independent 
dataset. A validation in a dataset outside hpEurope, the population used in the creation 
process, could be considered, but the genomic differences between two H. pylori 
populations are too important and there is a high risk that the risk score could not be 
used in another population. For these reasons, the risk score built in this thesis should 
not be used as it is for clinical decisions. A GWAS and risk score should be 
performed for each H. pylori population, validated on independent datasets, and the 
relevant risk score should be used in clinics, based on the population to which the 
clinical isolate belongs. Population can be determined quickly by the position of the 
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isolate on a reference phylogenetic tree containing 5 isolates per main population 
(Vale et al. 2017). 
Finally, all genomic analyses rely on clinical isolates. As it is considered unethical to 
not treat a patient when the infection is detected, it is impossible to have isolates from 
symptomatic patients before the development of the symptoms. This is a limitation, as 
symptoms can develop after a long-term infection during which the infecting strain 
can evolve. Considering the slow and large alterations of the stomach in some of the 
outcomes, such as gastric cancer, it is highly possible that the strain triggering the 
cancer is not present in the same version anymore, if at all, at the time of sampling. 
This is therefore a bias, which could lead to GWAS identifying genomic traits 
common to strains able to survive in the gastric cancer conditions, instead of genomic 
traits common to strains triggering this gastric cancer. 
Limitations in terms of isolates used also impact Chapter 4. Indeed, this analysis 
relied on only 2 clinical strains from MALT lymphoma patients. Each of these two 
strains were used to infect mice, but only 3 isolates were re-isolated for each time-
point, which is a very low number for genomic analysis. A larger number of isolates 
would be necessary to increase the reliability of the results and allow statistics to be 
made. 
7.6 Future directions 
If this thesis work could be taken further, different leads could be followed. First, 
there is a need for strong GWAS based not only on gastric cancer strains, but also 
ulcer or MALT lymphoma. More rigorous patient data associated with the strains 
used would also increase the quality of such analyses. To achieve this, a large number 
of strains would be needed, with information about the patients, and controlled 
population structure. Indeed, GWAS requires a large number of strains to be robust (a 
minimum of 100 strains per binary group), due to its fundamental principle based on 
statistics. A collaborative project named Helicobacter pylori Genome Project (HpGP), 
presented at the European Helicobacter and Microbiota Study Group (EHMSG) 
conference in 2017 (http://ehmsg.org/2017/programme.htm), is leading the way 
toward an increase in quality and volume of H. pylori strains collections. Once 
suitable collections are available, it will be possible to achieve GWAS, on different 
datasets corresponding to the different outcomes of an H. pylori infection, which will 
give us a more global view of the virulence of H. pylori. These GWAS will have to be 
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achieved on different Hp populations, to take into account the differences between 
those populations (Thorell et al. 2017). Validation of risk scores using independent 
datasets from the same population are also a necessity for risk scores to be used in 
clinics. 
A new GWAS method, based on phylogeny (Collins and Didelot 2018), could also be 
considered in order to account for population structure and recombination while 
achieving a high power and specificity. Indeed, despite the recombination being taken 
into account in the two methods used in this thesis, these methods presented 
limitations in terms of specificity. 
Even with strong datasets made available for GWAS studies, and optimal GWAS 
methods, validation of the genotypes identified in genomics studies remains essential. 
This can be done with conventional laboratory methods such as creation of mutants, 
and studies of these mutant strains in vitro and in vivo (Schmitz, Josenhans, and 
Suerbaum 1997; C.-Y. Kao, Sheu, and Wu 2014). Even though construction of mutant 
strains was not an option during this thesis, phenotypic studies were achieved. They 
could have been taken further through the co-culture of H. pylori clinical strains AGS 
in combination with THP-1 (Fox et al. 2015). This would model more closely the 
reality of the stomach environment. pH could also be controlled, as we  identified a 
few genes related to the buffering of pH in our genomic studies. Relationship between 
H. pylori and other components of the gastric microbiota could also be investigated. 
Long-term colonisation in vivo experiments would also be highly valuable to H. 
pylori research. Animal models such as the one presented in Chapter 4 could be taken 
further, with larger number of replicates, but also with controls for the evolution of 
the experimental strains in a laboratory or in different hosts. Colonisation of healthy 
human hosts and genomic analysis of original and re-isolated strains from such 
experiments would also shed light on the genomic aspects of long-term colonisation 
by H. pylori. Such a study would require strong ethics, and a research group from 
Germany presented an on-going project that could address this question at the CHRO 
conference in September 2017 (http://www.chro2017.com/content.php?PAGE=11). 
In conclusion, multi-disciplinary collaborations are the key to a complete picture of H. 
pylori role in the diverse clinical outcomes following infection. And this picture, 
when complete, will have to be included in a bigger one, by taking into account the 
role of host genetics and environmental factors in the development of disease, as well 
as the complex interactions between these three interdependent factors. 
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Appendix A: Published article: Recent “omics” advances in Helicobacter pylori 
This review article was published in the Helicobacter Journal in 2016 on invitation by Prof Francis 
Megraud. 
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Appendix B: Published article: Genomic structure and insertion sites of Helicobacter 
pylori prophages from various geographical origins 
This research article was published in the Scientific Reports Journal in 2017 by Filipa Vale. My 
participation in this article was in identification of populations of the H. pylori genomes used. 
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